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Abstract 
Members of the myosin heavy chain genes (MYHs) are expressed in a complex, sequential 
fashion during skeletal muscle development and growth of fish. A greater understanding of the 
transcriptional regulatory mechanisms of these MYHs expression in different muscles would 
provide insight into how these muscles are established and maintained in fish. Therefore, the 
5’-flanking regions of different MYHs of fish were analyzed for the spatial and temporal 
regulation by using transient and stable transgenic techniques in zebrafish embryos. MYHM743-2 is 
highly expressed in fast muscle fibers of torafugu embryos and larvae. Combining both transient 
and stable transgenic analyses, we demonstrated that the 2,075 bp 5’-flanking sequence was 
sufficient for its expression in skeletal, craniofacial and pectoral fin muscles (Chapter 2). We 
discovered that the serum response factor (SRF)-like binding sites are required for promoting 
MYHM743-2 expression, whereas myoblast determining factor (MyoD) and myocyte enhancer 
factor-2 (MEF2) binding sites participate in the transcriptional control of MYHM743-2 expression in 
fast muscle fibers (Chapter 2). Again, MYHM86-2 exhibited restricted expression in slow muscle 
fibers of torafugu embryos and larvae. Combining both transient and stable transgenic 
approaches, we demonstrated that the 2,614 bp 5’-flanking sequence of MYHM86-2 contains a 
sufficient promoter activity to drive gene expression specific to superficial slow muscle fibers 
(Chapter 3). The transcriptional mechanism that prevents MYHM86-2 expression in fast muscle 
fibers was mediated through Sox6 binding elements (Chapter 3). It was further discovered that 
nuclear factor of activated T cells (NFAT) binding elements play a key role and myocyte 
enhancer factor-2 (MEF2) binding elements participate in the transcriptional regulation of 
MYHM86-2 expression (Chapter 3). The relationship of MYHs expression with muscle fiber 
formation has not been well understood in fish. Therefore, we further discovered that MYHM2528-1 
is involved in hyperplastic muscle growth of torafugu (Chapter 4). In conclusion, the 
transcriptional regulation of these development-dependent MYHs in fish consists of a complex 
process that is often regulated by a cohort of transcriptional factors.  
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General Introduction 
1.1 General Background 
1.1.1 General features of myotomal muscle of teleost fish 
In teleosts, skeletal muscle is characterized by the sequential arrangement of segmental 
myotomes in a complex three-dimensional structure. Each myotome contains a deeper part where 
muscle fibers are arranged in a helical fashion and a superficial region lying directly beneath the 
skin, where muscle fibers are run parallel to the body axis. This distinct arrangement of muscle 
fibers is related to the requirement to produce equal shortening of sacromeres at different body 
flexures (Alexander, 1969; Rome and Sosnicki, 1990). In mammals, most of skeletal muscles 
contain a mixture of various fiber types, enabling individual muscles in providing long-lasting, 
low-intensity contractions, together with first burst of activity. In contrast with mammals, muscle 
fibers types in teleost are anatomically separated into distinct locations (Fig 1-1). Fast twitch 
fibers locate deeply in the myotomal muscle, whereas slow twitch fibers are present at lateral 
superficial to the myotome (Sanger and Stoiber, 2001).  
Fiber types in fish can be separated by the histochemical demonstration of ATPase (Fig. 1-1). 
Fast twitch fibers constitute the majority of myotomes (70-100%) and are usually larger in 
diameter than slow muscle fibers in teleosts (Greer-Walker and Pull, 1975; Altringham and 
Johnston, 1982). Fast muscle fibers have a sparse capillary network (Johnston, 1982; Egginton 
and Sidell, 1989; Sanger and Stoiber, 2001) and contain a low density of mitochondria (Johnston, 
1982; Egginton and Sidell, 1989; Sanger and Stoiber, 2001). Fast muscle fibers fatigue and 
contract faster than other fiber types (Altringham and Johnston, 1982; Johnston and Salmonski, 
1984; Langfeld et al., 1989). They are recruited to power rapid bursts of movement e.g. escape 
responses when a predator appears (Altringham et al., 1993; Altringham and Ellerby, 1999). 
Slow twitch fibers are usually comparatively smaller in diameter than the other types of 
myotomal muscle fibers (Greer-Walker and Pull, 1975; Altringham and Johnston, 1988). Slow 
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muscle fibers are located in a narrow superficial strip adjacent to the lateral line known as 
lateralis superficialis (LS) with a wedge-shaped thickening in the region of the horizontal septum. 
In addition to LS slow muscle, another type of slow muscle is located at the median fins in fish 
belonging to the order Tetradontiformes, termed erectors and depressor (ED) slow (Fig. 1-1) 
(Winterbottom, 1974). In addition, slow muscle fibers are also widely found to contain high 
volume densities of mitochondria (Johnston, 1982; Egginton and Sidell, 1989; Sanger and Stoiber, 
2001), contract slowly (Altringham and Johnston, 1982; Johnston and Salmonski, 1984; Langfeld 
et al., 1989), and are supplied with a dense capillary network (Egginton and Sidell, 1989; Sanger 
and Stoiber, 2001). All these distinct features of slow muscle fibers reflect their functional role in 
sustained and steady swimming activities fuelled by aerobic metabolism (Johnston et al., 1977; 
Rome et al., 1984; Altringham and Ellerby, 1999). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1-1: Anatomical location of fast and slow muscle fibers in torafugu (upper two) and their 
differentiation by ATPase (lower two) (Adapted from Akolkar et al., 2010). LS-Lateralis 
superficialis; ED-Erectors and depressors. 
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In addition to the above major fiber types, minor ones such as intermediate or pink muscle fibers 
(Scapolo and Rowlerson, 1987; Gill et al., 1989), tonic fibers (Zowadowska and Kilarski, 1984; 
Sanger et al., 1997) and red bim fibers (van Raamsdonk et al., 1980) have been reported in fish. 
The intermediate, or pink muscle, is composed of intermediate twitch muscle fibers, which are 
usually intermediate in diameter and constitute 10%~20% of total teleost myotomal 
cross-sectioned area (Johnston et al., 1977; Langfeld et al., 1989). They are located between slow 
and fast muscles and have intermediate contraction speeds and fatigue-resistance compared to 
slow and fast muscle fibers (Altringham et al., 1993; Altringham and Ellerby, 1999). Like slow 
twitch fibers, intermediate fibers have orientation parallel to the axis of body (Scapolo and 
Rowlerson, 1987). The other fiber types such as red rim fibers and tonic fibers form a relatively 
small part of myotomal muscle and are considered to contribute less significantly to the 
swimming of fish. 
1.1.2 Teleost myogenesis 
Myogenesis refers to the process required for muscle development and growth, which involves 
expansion of existing muscle fibers (hypertrophy) and the generation of new muscle fibers 
(hyperplasia). This process is a common phenomenon to all vertebrates and consists of serial 
complex cell events, including the specification, activation, proliferation, differentiation, 
migration and fusion of the cells (Fig. 1-2). Three major phases of myogenesis have been 
observed in a variety of teleost species, namely embryonic myogenesis, stratified hyperplasia 
(SH), and mosaic hyperplasia (MH) (Rowlerson and Veggetti, 2001; Johnston, 2006). The 
relative timing and importance of individual phases vary considerably between species. In 
species with determinate growth that have a small maximum body size such as guppies (Poecilia 
reticulate) (Veggetti et al., 1993), the first two phases of myogenesis give rise to the majority of 
muscle fibers. On the other hand, MH gives rises to the majority of muscle fibers in species 
which show indeterminate growth and reach a large body size (Johnston, 2006).  
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Fig. 1-2: A simple and general model for vertebrate myogenesis (Johnston et al., 2009). 
 
Pioneering work establishing patterns of teleost embryonic muscle development was largely 
performed in zebrafish. During development, it was first demonstrated that the spatial separation 
of teleost muscle types occur in the embryo, where slow and fast muscle fibers originate from 
two separate subpopulations of muscle pioneers (adaxial cells and lateral presomitic cells) in the 
somites (Devoto et al., 1996). The adaxial and lateral presomitic cells can be distinguished in the 
segmental plate on the basis of their morphologies and position (Devoto et al., 1996) as well as 
the expression of genes such as myod (Weinberg et al., 1996) and snail (Thisse et al., 1993). 
Initially, adaxial cells are located at each side of the notochord prior to segmentation at the level 
of the horizontal septum (HS) as a epithelia-like sheet monolayer flanking each side of the 
notochord (Devoto et al., 1996). Adaxial cells are relatively larger and more regularly shaped 
than the surrounding lateral presomitic cells that surround them (Devoto et al., 1996). The 
specification of adaxial cells to follow the slow muscle differentiation program depends crucially 
on inductive signals from the notochord and floorplate mediated by members of the hedgehog 
protein family (Wolff et al., 2003). The acquisition of hedgehog signals by adaxial cells results in 
the induction of the expression of transcriptional repressor Blimp1/Prdm1 (von Hofsten et al., 
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2008). Blimp1/Prdm1 inhibits both fast muscle differentiation and expression of Sox6 
transcriptional repressor (von Hofsten et al., 2008), function of which is to inhibit slow muscle 
differentiation (Hagiwara et al., 2007, 2011; von Hofsten et al., 2008).  
Recent studies further indicate that the region previously thought to contain lateral presomatic 
cells (Devoto et al., 1996) is composed of two distinct cell populations, lateral-anterior and 
lateral-posterior somite cells (Fig. 1-3A). These three distinct cell populations are rearranged 
through a series of whole somite rotation events in order to give rise to embryonic slow and fast 
muscle fibers as well as the myogenic progenitor cells (MPCs) used for subsequent myogenesis. 
During the whole somite rotation, lateral anterior and posterior cells are rearranged into the 
lateral-external and later-medial cell layer (Fig. 1-3B). At late segmentation the 90 degree somite 
rotation is completed leading to the formation of a distinct external cell layer (ECL) sourced from 
the lateral anterior somite cells (Fig. 1-3C). Additionally, the adaxial cells start to migrate both 
laterally and radially (Fig. 1-3C). The migrated adaxial cells eventually form a single layer of 
embryonic slow muscle fibers between ECL and embryonic fast muscle fibers (Fig. 1-3D). 
Subsequently, some cells from ECL migrate into the myotome though the slow muscle layer 
giving rise to fast muscle fibers in distinct zones as SH (Fig. 1-3E). It has been suggested that 
ECL plays an important role in other subsequent postembryonic muscle fiber production although 
this remains to be proven. 
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Fig. 1-3: Schematic illustration of the patterning of slow and fast muscle fibers during embryonic 
and early postembryonic stages (Adapted from Lee, 2010). The transverse views of somites 
during early and mid segmentation stage indicate the distinct origins of anterior somite cells 
(anterior) and embryonic fast myoblast (posterior). 
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Following embryonic myogenesis, new muscle fibers are continued to be added from the 
so-called “germinal zones” by a distinct process termed SH (Fig. 1-4). SH has been widely 
identified in many species (review in Rowlerson and Veggetti, 2001) and provides the major 
source of new muscle fibers during late embryonic and early postembryonic growth. SH gives 
rise to distinguishable gradients in muscle fiber diameter from the peripheral to the deep 
myotomes (Fig. 1-4) (Rowlerson and Veggetti, 2001). SH occurs after the completion of 
segmentation according to the identification of new muscle fibers by their gene expression 
pattern in zebrafish (Barresi et al., 2001), pearlfish (Steinbacher et al., 2006) and brown trout 
(Steinbacher et al., 2007). Initially, new slow muscle fibers are mostly added into the 
dorsal-ventral extremities of the existing single slow muscle layer (Barresi et al., 2001) whereas 
new fast muscle fibers are widely added at the border of the slow muscle layer, the periphery of 
the existing fast myotome and dosal-ventral extremities of the myotome (Steinbacher et al., 2006, 
2007).  
Following SH, the final phase of hyperplasia occurs through MH (Rowlerson and Veggetti, 2001). 
In contrast to SH, MH involves the proliferation of a population(s) of precursor cells which 
subsequently migrate and fuse to form myotubes on the scaffold of existing fibers to produce a 
mosaic of muscle fiber diameters in a myotome across section (Fig. 1-4) (Rowlerson et al., 1995). 
In fast muscle, muscle fiber recruitment continues until ~40% of the maximum fork length 
(FLmax) (Weatherley et al., 1988; Johnston et al., 2003; 2004). In teleost which are larger than 
40 % FLmax, muscle fiber recruitment is stopped unless the muscle becomes damaged in which 
case new fiber formation is initiated to repair the injury (Rowlerson et al., 1997). Following the 
end of muscle fiber recruitment all subsequent growth is by fiber hypertrophy alone, which 
requires the accretion of additional nuclei to maintain the myonuclear domain size within certain 
limits (Johnston et al., 2003, 2004). In contrast, slow fiber number continues to increase with 
body length to the maximum body size (Johnston et al., 2004). 
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Fig. 1-4: Hyperplastic growth of trunk muscle in zebrafish larvae (Adapted from Patterson et al., 
2008). A: Methylene blue stained section showed stratified hyperplastic growth. B: Methylene 
blue stained section showed mosaic hyperplastic growth (red arrowheads). 
1.1.3 Characteristics features of myosin heavy chain  
The primary function of skeletal muscle is to produce contractile force via the formation and 
maintenance of a highly specialized contractile apparatus. Such motile functions are basically 
attributed to the major muscle proteins, myosin and actin. Myosin is highly conserved, ubiquitous 
actin-based motor protein that drives a wide range of motile processes in eukaryotic cells. It 
consists of various types divided into 9–11 classes. Conventional type class II includes the 
extensively studied group of sarcomeric myosins, a motor protein that interacts with actin to 
generate the force for muscle contraction (Berg et al., 2001). Sarcomeric myosin consists of two 
myosin heavy chains (MYHs) of about 200 kDa and four light chains of about 20 kDa. It consists 
of an N-terminal half of each heavy chain folds into globular head, called subfragment-1 (S1), 
with two light chains (Fig. 1-5). In contrast, C-terminal halves of two heavy chains, called rod, 
fold into α helices necessary for thick filament formation and maintaining force (Weiss and 
Leinwand, 1996). Myosin is organized in situ into thick filaments in which the heads of the 
myosin molecules protrude from the thick filaments surface and form cross-bridges with 
actin-containing thin filaments. Each cross-bridge is thought to be composed of two myosin 
heads containing a site for ATP hydrolysis and an actin binding site necessary for converting 
chemical energy into mechanical force. S1 can be further cleaved into three fragments of 25, 50 
and 20 kDa, while rod can be subdivided into subfragment 2 (S2) and light meromyosin (LMM) 
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fragment (Fig. 1-5). Several MYHs have been found in vertebrates, which show strong amino 
acid sequence homology with each other. The regions that vary in amino acid sequence between 
MYHs are largely confined to two external loops associated with the ATP (loop 1) and actin sites 
(loop 2) in S1 (Weiss et al., 1999). This diversity is thought to play a crucial role in determining 
speed of contraction and motor function in a particular category of muscle fibers. 
 
 
 
 
Fig. 1-5: The structure of sarcomeric myosin molecule (Adapted from Watabe and Ikeda, 2006) 
1.1.4 Developmentally regulated myosin heavy chain gene expression in fish 
Vertebrate genomes contain a variety of MYHs with different functional properties that are 
encoded by multigene family (Weiss and Leinwand, 1996). Mammalian muscles have at least 11 
sarcomeric MYH genes (MYHs) and their development- and tissue-specific expressions 
contribute to the formation of various muscles with diverged muscle-fiber types such as 
embryonic, neonatal, fast, slow, and cardiac ones with different functional properties (Weiss et al., 
1999). In contrast to mammals, fish possess highly diverged MYH multigene family where 
MYHs numbers are much more, possibly due to the additional round (3R) genome duplication 
(McGuigan et al., 2004). For example, 29 fast-type MYHs have been identified in common carp 
Cyprinus carpio (Kikuchi et al., 1999) and 20 sarcomeric MYHs in torafugu Takifugu rubripes 
(Ikeda et al., 2007). Studies on expressed MYHs have shown a complex 
developmental-stage-specific expression isoforms in different tissue types that continues 
throughout much of the life cycle in fish (Mascarello et al., 1995; Johanston et al., 1998).  
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MYHs are expressed sequentially during development in fish. Among MYH family members, 
expression patterns of multiple MYHs has been characterized during embryonic development of 
certain fish species such as zebrafish Danio rerio (Bryson-Richardson et al., 2005; Elworthy et 
al., 2008), common carp Cyprinus carpio (Ennion et al., 1999; Nihei et al., 2006), rainbow trout 
Onchorhynchus mykiss (Rescan et al., 2001), medaka Oryzias latipes (Ono et al., 2006) and 
torafugu Takifugu rubripes (Ikeda et al., 2007; Akolkar et al., 2010; Asaduzzaman et al., 2013). 
In zebrafish, adaxial cells are earliest to express slow-type MHY, smyhc1, well before their 
migration towards the lateral surface of myotome (Bryson-Richardson et al., 2005; Elworthy et 
al., 2008). Bryson-Richardson et al. (2005) also showed that adaxial cells co-express fast-type 
MYH, myhc4, well before their radial migration. Another developmentally regulated myhz2, 
embryonic and tail muscle-specific MYH, is expressed in protruding-mouth larvae but not 
detected in adult fish (Peng et al., 2002). In medaka, three genes are predominantly expressed 
during development; mMYHemb1 in embryos and mMYHL1 and mMYHL2 in larvae (Ono et al., 
2006). In rainbow trout, fast-type MYH is expressed in adaxial cells before the expression of 
slow-type MYH (Rescan et al, 2001). In common carp, two fast-type MYHs named MYHemb1 
and MYHemb2 and their homolog Egg22 and Egg24 have been characterized during embryonic 
and larval development (Ennion et al., 1999; Nihei et al., 2006; Ikeda et al., 2010). In torafugu, 
our laboratory members showed detail expression patterns of MYHs during development and 
adult stages (Ikeda et al., 2007; Akolkar et al., 2010). MYHM743-2 is found be predominantly 
expressed in fast muscle fibers whereas MYHM86-2 and MYHM5 are found to be expressed in slow 
muscle fibers during embryonic and larval development (Ikeda et al., 2007; Asaduzzaman et al., 
2013). These lines of information indicate that each MYH showed strictly regulated temporal and 
spatial expression pattern during development of fish, and that the formation of an individual 
muscle component is closely related to the temporal expression of specific MYH.  
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1.1.5 Experimental fish species: torafugu and zebrafish 
Takifugu rubripes, also called as torafugu, is one of the most popular marine fish cultured in 
Japan and has a higher market price (Kikuchi et al., 2006). Therefore, it became increasingly 
important to collect adequate information on the muscle development and growth of torafugu. It 
is the second vertebrate to have its genome sequenced at draft level (Aparicio et al., 2002). 
Although only one-eighth the size of the human genome (_365 Mb), the Takifugu genome has a 
similar number of predicted gene loci, and 75% of its putative peptides have homologs in the 
human proteome (Aparicio et al., 2002). In addition, torafugu genome is compact, generally with 
short introns and a low proportion of repetitive elements (Brenner et al., 1993; Aparicio et al., 
2002; Hedges and Kumar, 2002), making this organism an ideal tool for comparative genomics 
as well as for evolutionary research (Elgar et al., 1996; Venkatesh et al., 2000). The availability 
of the torafugu genome sequences greatly facilitates the identification of MYHs (Ikeda et al., 
2007) and detailed expression analysis showed their complex expression pattern regulated in 
tissue- and development-specific manners (Akolkar et al., 2010; Asaduzzaman et al., 2013). 
However, the regulatory mechanisms involved in the spatio-temporal expression of MYHs have 
remained unknown. 
Although torafugu represent excellent models for comparative genomic studies, their applications 
for functional genomics studies such as in vivo reporter analysis to understand the regulatory 
mechanism of a specific gene expression were found to be largely limited by the difficulties of 
routinely rearing and breeding them in the laboratory compared to other experimental teleost 
models (Alestrom et al., 2006). There are several important features of zebrafish making it an 
ideal experimental animal (Fig. 1-6). Differences in the appearance between male and female 
zebrafish are easily distinguishable (Fig. 1-6A). In the laboratory, a pair of zebrafish can produce 
approximately 30-50 embryos per spawning, possible in every week, throughout the whole year 
depending on the level of maturity (Fig. 1-6A). Zebrafish eggs are transparent and relatively large 
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(~0.7 mm in diameter) compared to other teleost of a similar size (Fig. 1-6A). Embryogenesis is 
rapid and all major organs develop within 24 hr (Fig. 1-6A). During the first 24 hours of 
development, embryos are completely transparent, allowing the visualization of developing 
organs, even deep inside living embryos. The generation time is also relatively short requiring 
3-4 months (Fig. 1-6A). Therefore, it was possible to use zebrafish for the first vertebrate 
large-scale genetic screens which generated a large number of mutants and stable transgenic lines 
with various phenotypes (Fig. 1-6B). Therefore, zebrafish is an economic animal model system to 
generate transgenic lines and are easily accessible to transient reporter analysis for quantification. 
In addition, transgenic zebrafish that express fluorescent protein under the control of 
tissue-specific promoters are useful tools for following cell movements, visualizing dynamic 
gene expression patterns, and dissecting regulatory transcription elements in live embryos (Long 
et al., 1997; Motoike et al., 2000; Zhang and Rodaway, 2007). 
 
 
 
 
 
 
 
 
 
   
 
 
Fig. 1-6: The utilization of zebrafish as model system (modified from Lee, 2010). (A) General 
features of zebrafish that make them excellent laboratory models. (B) Transgenic approaches in 
zebrafish embryos are possible. 
A 
B 
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1.1.6 Transcriptional regulation of muscle-specific gene expression 
Cell-autonomous activation of myogenesis in different regions of the embryo is controlled by a 
series of complex transcriptional regulatory networks that ultimately result in the expression of 
members of the basic helix-loop-helix domain-containing myogenic regulatory factors (MRFs), 
which include myogenic factor 5 (myf5), myogenic differentiation 1 (Myod1, also known 
as MyoD), Myf6 (also known as Mrf4) and myogenin (Myog) within nascent and differentiating 
myoblasts. MRFs are responsible, in concert with a myriad of cofactors, for directing the 
expression of genes that are required to generate the contractile properties of a mature skeletal 
muscle cell. These genes act downstream of, or in parallel with, the paired domain and 
homeobox-containing transcription factors paired box gene 3 (Pax3) and 7 (Pax7) in different 
phases of myogenesis in the embryo and adult. Other important transcription factors in 
differentiation of skeletal muscle fibers are the myocyte enhancer factor 2 (MEF2) family 
members, which bind to an A/T-rich sequence existing in many muscle-specific promoters and 
enhancers (Jordan et al., 2004; Berkes and Tapscott, 2005). These are believed to underlie the 
expression of most, if not all, muscle-specific genes. Serum response factor (SRF), a MADS 
(MCM1, Agamous, Deficiens, SRF) box transcription factor related to MEF2, also regulates 
skeletal, as well as cardiac and smooth muscle genes by binding a DNA sequence known as a 
CArG box (Norman et al., 1988; Miano, 2003). Like MEF2 and other MADS box transcription 
factors, SRF activates transcription by associating with a variety of signal-responsive and cell 
type-restricted cofactors.  
Another pathway postulated as having a regulatory role in fiber type-specific gene expression is 
the calcineurin-NFAT (nuclear factor of activated T cells) pathways (Chin et al., 1998). 
Calcineurin is a phosphatase that dephosphorylates the NFAT family of transcription factors (Rao 
et al., 1997). Binding of calcium to a calmodulin-calcineurin complex stimulates serine/ 
threonine phosphatase activity of calcineurin, the major substrates of which are NFAT 
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transcription factors. Dephosphorylation of NFATs by calcineurin promotes their translocation 
from the cytoplasm to the nucleus, where they bind a cognate nucleotide recognition sequence 
(Rao et al., 1997) in slow-specific genes, and stimulate transcription of target genes. MEF2 is 
also activated by calcineurin as well as by calcium-calmodulin kinase and may activate 
transcription of some slow fiber-specific genes (Wu et al., 2000, 2001). 
Sox6, a member of the Sox family of transcription factors, is a multi-faceted transcription factor 
involved in the terminal differentiation of fetal skeletal muscle during myogenesis (Higawara et 
al., 2007). It directly represses the transcription of multiple myosin and sarcomeric genes by 
binding to conserved cis-elements in their promoters (Quiat et al., 2011). In zebrafish and mice, 
Sox6 functions as a transcriptional suppressor of slow fiber-specific genes (Higawara et al., 2007; 
von Hofsten et al., 2008). To date, transcriptional regulatory regions have been mapped for a 
small number of skeletal muscle-specific MYHs in fish. 
1.2 Objectives of the study 
Teleost fish represent a good model for studying vertebrate myogenesis, since slow and fast 
muscle fibers are arranged in anatomically discrete layers and myotube production is not 
restricted to early developmental stages, reflecting the large difference between embryonic and 
final adult body size (Johnston et al., 2003). Muscle development of fish has been extensively 
investigated with zebrafish especially focusing on the expression of muscle-specific genes and 
those encoding transcriptional factors that regulate the expression of muscle proteins in relation 
to the fate of muscle formation (Xu et al., 2000; Hinits and Hughes, 2007). Myosin is the major 
structural and functional protein of muscle which requires specific expression of MYH isoforms 
during development. As in mammalian skeletal muscles, MYHs of fish are also expressed in a 
sequential fashion during development and growth. 
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The Takifugu genome has been proposed as a model for rapid characterization of vertebrate genes 
due to its smallest size among vertebrates (Brenner et al., 1993). Thus, the organization of MYHs 
in the torafugu genome database was investigated, revealing that it contains 20 sarcomeric MYHs 
which formed four clusters on the genome (Watabe and Ikeda, 2006; Ikeda et al., 2007). Their 
detailed expression analysis of torafugu MYHs showed their complex expression patterns 
regulated in tissue- and development-specific manners (Akolkar et al., 2010; Asaduzzaman et al., 
2013). Although a considerable progress has been made in elucidating the molecular genetics 
underlying the development-dependent muscle-specific expression of MYHs in mammals, little is 
currently known regarding the molecular mechanisms governing MYHs expression in fish and 
much remain unknown or not clearly known regarding the following aspects. Whether the 
5’-flanking sequences of MYHs of fish, which are phylogenically far from zebrafish in teleost 
lineage, would function similarly in zebrafish model system for functional genomics studies? 
What are the factors regulating the expression of MYHs in different muscles in fish to provide a 
more clear insight into how these muscles are established and maintained? Whether the same or 
different transcription factors regulate the fiber type-specific expression of MYHs in the same 
species of fish? Whether or not MYHs are involved in secondary muscle development and growth 
by hyperplasia in fish and how are their expressions regulated transcriptionally? The present 
study was carried out in order to understand the above concerns in torafugu by using zebrafish 
embryos for transient and transgenic analysis. The topics involved in the present study are as 
follows- 
 transcriptional regulation of fast muscle-specific MYH, MYHM743-2, during skeletal muscle 
development of torafugu 
 transcriptional regulation of slow muscle-specific MYH, MYHM86-2, during skeletal muscle 
development of torafugu 
 expressional regulation of MYHs associated with hyperplastic muscle growth in fish 
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1.3 Outline of the thesis 
This thesis is composed of general introduction (Chapter 1), three research chapters (Chapters 2, 
3 and 4) and general discussion (Chapter 5). Chapter 1 briefly reviewed the general features of 
myotomal muscle and myogenesis of teleost fish, characteristic features of MYH, 
developmentally regulated expression of MYHs in fish, torafugu and zebrafish as model fish 
species for genomics and muscle development study and lastly, the transcriptional regulation of 
muscle-specific gene expression. The research (Chapter 2-5) followed a step-wise approach. The 
first approach (Chapter 2) demonstrated the transcriptional regulation of embryonic/larval 
fast-type torafugu MYH, MYHM743-2, expression. Here, we analyzed the 2,075 bp 5’-flanking 
region of torafugu MYHM743-2 to examine the spatial and temporal regulation by using transgenic 
and transient expression techniques in zebrafish embryos. The results of this chapter clearly 
demonstrated that multiple cis-elements (MyoD, MEF2 and SRF) in the 5’-flanking region of 
MYHM743-2 function in the transcriptional control of its expression. The next step (Chapter 3) was 
stimulatory and inhibitory mechanisms of slow muscle-specific MYH, MYHM86-2, expression in 
torafugu. In this chapter, we described an important Sox6 mediated-fast muscle-specific 
repression mechanism for governing slow muscle-specific expression of MYHM86-2. We further 
discovered that NFAT binding elements play a key role and MEF2 binding elements participate 
in the transcriptional regulation of MYHM86-2 expression. The last step (Chapter 4) examined the 
expressional regulation of MYHs associated with hyperplastic muscle growth in fish. In this 
chapter, we demonstrated the involvement of MYHM2528-1 in both SH and MH of torafugu. In this 
chapter, we also demonstrated that expression patterns of two zebrafish MYHs, myhz1 and myhz2, 
are complementary to each other. In general discussion (Chapter 5), major conclusions of the 
previous chapters were integrated and interpreted, strength and weaknesses of the followed 
approaches were outlined, and suggestions for further studies were given.
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CHAPTER 2 
 
 
 
 
Multiple cis-elements in the 5′-flanking region of 
embryonic/larval fast-type of the myosin heavy chain gene of 
torafugu, MYHM743-2, function in the transcriptional regulation 
of its expression 
 
 
 
The content of this chapter was published as: 
 
 
 
 
M. Asaduzzaman, S. Kinoshita, B. S. Siddique, S. Asakawa and S. Watabe. 2011. Multiple 
cis-elements in the 5′-flanking region of embryonic/larval fast-type of the myosin heavy chain 
gene of torafugu, MYHM743-2, function in the transcriptional regulation of its expression Gene 
489: 41-54.  
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Abstract 
The myosin heavy chain gene, MYHM743-2, is highly expressed in fast muscle fibers of torafugu 
embryos and larvae, suggesting its functional roles for embryonic and larval muscle development. 
However, the transcriptional regulatory mechanism involved in its expression remained unknown. 
Here, we analyzed the 2,075 bp 5’-flanking region of torafugu MYHM743-2 to examine the spatial 
and temporal regulation by using transient and stable transgenic techniques in zebrafish embryos. 
Combining both transient and transgenic analyses, we demonstrated that the 2,075 bp 5’-flanking 
sequences was sufficient for its expression in skeletal, craniofacial and pectoral fin muscles. The 
immunohistochemical observation revealed that the zebrafish larvae from the stable transgenic 
line consistently expressed enhanced green fluorescent protein (EGFP) in fast muscle fibers. 
Promoter deletion analyses demonstrated that the minimum 468 bp promoter region could direct 
MYHM743-2 expression in zebrafish larvae. We discovered that the serum response factor 
(SRF)-like binding sites are required for promoting MYHM743-2 expression and myoblast 
determining factor (MyoD) and myocyte enhancer factor-2 (MEF2) binding sites participate in 
the transcriptional control of MYHM743-2 expression in fast skeletal muscles. We further 
discovered that MyoD binding sites, but not MEF2, participates in the transcriptional regulation 
of MYHM743-2 expression in pectoral fin and craniofacial muscles. These results clearly 
demonstrated that multiple cis-elements in the 5’-flanking region of MYHM743-2 function in the 
transcriptional control of its expression. 
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2.1 Introduction 
A major structural protein which is expressed during differentiation of myoblast and myotube in 
vertebrates is sarcomeric myosin heavy chain (MYH) encoded by highly conserved multigene 
family. It exists as a variety of isoforms adapted to function in individual muscles according to 
physiological requirements during development. These isoforms are evolved from primordial 
MYH genes (MYHs). During muscle fiber development, each MYH shows a complex expression 
pattern that continues throughout life cycle (Mascarello et al., 1995; Johnson et al., 1998). Fish 
are known to possess highly conserved MYH multigene family, although MYHs are much more 
than their higher vertebrate counterparts (Watabe and Ikeda, 2006; Ikeda et al., 2007). A higher 
number of MYHs expressed in fish is the result of many environmental factors such as water 
temperatures and physiological requirement in different developmental stages, resulting in 
changes of the composition of muscle-fiber type (Hirayama and Watabe, 1997; Watabe, 2002; 
Liang et al., 2007). Among MYHs family members in fish, specific MYHs are expressed during 
embryonic and larval development. Such expression patterns of MYHs have been reported in 
some fish species such as rainbow trout Oncorhynchus mykiss (Rescan et al., 2001), common 
carp Cyprinus carpio (Ennion et al., 1999; Nihei et al., 2006), medaka Oryzias latipes (Ono et al., 
2006, 2010), torafugu Takifugu rubripes etc. (Ikeda et al., 2007), providing some basic insight 
into embryonic and larval muscle development. These lines of information indicate that the 
expression of MYHs contribute to the formation of specific muscle-fiber types during 
development of fish in response to various internal and external stimuli. However, the molecular 
mechanisms of MYHs expression in fish remained mostly unknown. 
Based on the primary structure, sarcomeric MYHs of fish are classified into fast and slow/cardiac 
types (McGuigan et al., 2004; Ikeda et al., 2004, 2007), and the fast type is further grouped into 
adult and embryonic types (Ikeda et al., 2010). Genomic structure analysis of torafugu revealed 
that fast-type MYHs in scaffold M743 (Fugu genome database Ver 3.0) form gene cluster C and 
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classified into an embryonic fast type (Ikeda et al., 2007) with its orthologous genes, all of which 
have also been reported to be expressed predominantly during embryonic and larval development 
in common carp (Nihei et al., 2006), medaka (Ono et al., 2006; Liang et al., 2007; Ono et al., 
2010), and zebrafish Danio rerio (Berdougo et al., 2003; Bryson-Richardson et al., 2005; 
Wallace et al., 2005). The expression patterns of sarcomeric MYHM743-2 in early developmental 
stages of torafugu were analyzed by our laboratory members. MYHM743-2 appeared to be expressed 
at the somite formation stage (about 10-14 somites) which corresponds to 3 days post fertilization 
(dpf) and continued through successive embryonic and larval development but not in adult 
skeletal muscle (Yasmin et al., 2011). The whole mount in situ hybridization revealed that the 
transcripts of MYHM743-2 were localized in fast muscle fibers of torafugu embryos and larvae 
(Ikeda et al., 2007). However, the transcriptional mechanisms in regulating the expression of 
MYHM743-2 are not well defined. Transcriptional regulatory regions have been mapped for a small 
number of skeletal muscle-specific genes in fish, identifying both unique and shared cis-acting 
elements (Du et al., 2003; Kobiyama et al., 2006; Chen et al., 2007; Liang et al., 2008). Therefore 
it is important to identify cis-acting elements located at various distances upstream or 
downstream of the promoter responsible for the expression of torafugu MYHM743-2.  
The early steps in skeletal muscle development are controlled by combinatorial interactions 
between the members of myogenic regulatory factors (MRFs) (Bergstrom et al., 2002; Berkes 
and Tapscott, 2005), MADS box transcription factors (Jordan et al., 2004; Berkes and Tapscott, 
2005) and paired-box transcription factors (Pax3 and Pax7) (see reviews by Rawls and Olson, 
1997; Buckingham, 2001). So far, the transcriptional activities of MYHs have been extensively 
investigated on the fast skeletal MYHs of mammals (Lakich et al., 1998; Swoap, 1998; Allan et 
al., 2005; Harrison et al., 2011) and fish (mainly carp and medaka) in a temperature dependent 
manner (Gauvry et al., 1996; Kobiyama et al., 2006; Liang et al., 2008). However, it is still far 
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from comprehensive understanding of the transcription factors functioning in the regulation of 
embryonic and larval fast-type MYHs expression in fish.  
The purpose of the present study was to identify the cis-regulatory regions within the upstream 
promoter that induce torafugu MYHM743-2 promoter activity by transient and stable transgenic 
analysis. The transient analyses by using expression vector containing various deletion and 
mutation forms of the 5’-flanking region of a particular gene are useful for identifying cis-acting 
elements responsible for its expression. Here, we used zebrafish to investigate the regulatory 
mechanisms involved in the expression of torafugu MYHM743-2. We reported previously the 
isolation of the upstream promoter region of torafugu MYHM743-2 and demonstrated that the 2.1 kb 
5’-flanking region regulated developmental muscle-specific expression in zebrafish embryos 
(Yasmin et al., 2011).  
In this study, we have characterized torafugu MYHM743-2 expression using both transient and 
transgenic analyses in zebrafish embryos. Combining both transient and stable transgenic 
analyses, we demonstrated that the 2,075 bp 5’-flanking sequences was critical for its 
muscle-specific expression in skeletal, craniofacial and pectoral fin muscles. A minimal promoter 
region containing SRF-like binding site was defined to direct MYHM743-2 expression. We 
discovered that the SRF-like binding sites are required for promoting MYHM743-2 expression in 
myotomal compartments and MEF2 and MyoD binding sites participate in the transcriptional 
regulation of MYHM743-2 expression in myotomal compartments with other transcriptional factors. 
We further discovered that MyoD binding sites also participate in the transcriptional regulation of 
MYHM743-2 expression in craniofacial and pectoral fin muscles. 
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2.2 Experimental procedure 
2.2.1 Experimental fish and tissue sampling 
Adult torafugu (Japanese pufferfish, Takifugu rubripes, Tetraodontidae) (body mass about 1 kg) 
grown in the Department of Aquatic Bioscience, The University of Tokyo, was used for the 
collection of different tissues such as fast, lateralis superficialis (LS) and erectors and depressors 
(ED) slow skeletal muscles of the trunk and cardiac muscles. Artificial fertilized eggs of torafugu 
were collected from Oshima Fisheries Hatchery, Nagasaki, Japan, brought to The University of 
Tokyo and reared at 18–20 °C in a tank at the Department of Aquatic Bioscience. About 50 
embryos each from 1 to 7 days post fertilization (dpf) and an equal number of larvae from 8, 10 
and 16 dpf were collected. About 50 embryos of zebrafish each at 2, 6, 20 and 36 hours post 
fertilization (hpf) and an equal number of larvae from 48 and 72 hpf were collected from the 
zebrafish rearing facility in the Department of Aquatic Bioscience. All the samples were 
snap-frozen in liquid nitrogen (-196  oC) and kept at -80 oC for RT-PCR.  
2.2.2 Total RNA preparation and template cDNA synthesis 
Total RNAs were prepared from each developmental stage of torafugu and zebrafish by using an 
ISOGEN solution (Nippon Gene, Tokyo, Japan) following the instruction of the manufacture. 
Around 50 embryos and larvae of torafugu and zebrafish were homogenized in 1 mL of Isogen. 
The homogenates were centrifuged at 12000 g for 10 min and supernatants were transferred to 
new tubes. About 0.2 mL of chloroform was added to each sample and the mixture was shaken 
vigorously for 20s and incubated at room temperature for 15 min. After centrifugation at 12000 g 
for 20 min at 4 oC, an upper aqueous layer was pipetted out for isopropanol precipitation. RNA 
was precipitated by the addition of 0.5 mL isopropanol and 2 μL ethachinmate (Nippon Gene, 
Tokyo, Japan) and kept at -80 oC for 20 minutes. RNA was pelleted by centrifugation again for 
30 min, washed with 70% ethanol, briefly air-dried, and resuspended into 100 μL 
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diethylpyrocarbonate-treated water. To avoid any possible contamination with genomic DNAs, 
the RNA preparation was treated with Turbo DNA-freeTM (Applied Biosystem, Foster, CA, USA) 
at 37 oC for 1 h. The integrity of RNA was determined by electrophoresis on a 1.2% 
formaldehyde-denatured agarose gel followed by staining with ethidium bromide. The quantity of 
RNA was determined by measuring optical density at 260 nm with a DU530 Life Science 
UV-Visible spectrophotometer (Beckman Coulter, Fullerton, CA, USA). The isolated RNA was 
used immediately or stored at -80 oC. 
cDNA templates for use in RT-PCR were synthesized using SuperScript III reverse transcriptase 
(Invitrogen, Carlsbad, CA, USA) in accordance with the manufacturer’s recommendation. Briefly, 
2 μg of total RNAs were mixed with 0.5 μL of 10 μM oligonucleotide (dT)-tailed primer (Table 
2-1) and 1 μl of 10 mM dNTP solution and the mixture was heated at 65 oC for 5 min and chilled 
on ice. Then in vitro transcription was carried out at 50  oC for 60 min in a 20 μL reaction 
mixture containing 40 units of ribonuclease (RNase) inhibitor (Invitrogen), 1 units of 
Superscript™ III reverse transcriptase (Invitrogen), I μL 0.1 M dithiothreitol and 4 μL of 5× first 
strand buffer (250 mM Tris–HCl, pH 8.3, 375 mM KCl, 15 mM MgCl2).  
2.2.3 3’RACE 
3’-Rapid amplification of cDNA ends (RACE)-PCR was performed to determine the nucleotide 
sequence in the 3’-untranslated region (3’-UTR) of MYHM743-2 by using a specific forward primer 
(3’RACE-F) and an adapter primer (AP) (Table 2-1). PCR amplifications were carried out at 
94 °C for 3 min, followed by 30 cycles of denaturation at 94 °C for 30 s, annealing at 60 °C for 
30 s and extension at 72 °C for 1 min with a final extension step for 5 min, using a GeneAmp 
PCR system 9700 (Applied Biosystems). A single PCR reaction of 20 μL contained 1 μL each of 
forward and reverse primers (10 μM), 1 μL of cDNA template (dilution 1:100), 2 μL of 10× PCR 
buffer (20 mM Tris–HCl, pH 8.0, 100 mM KCl, 20 mM MgCl2), 1 U Taq DNA polymerase 
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(Takara, Tsu, Japan) and 13.8 μL of sterilized water. Amplified DNA fragments were subcloned 
into the pGEM-T vector (Promega, Madison, WI, USA) and the fragments were sequenced with 
an ABI 3100 genetic analyzer (Applied Biosystems) after labeling with ABI PRISM BigDye 
Terminator v3.1 Cycle Sequencing Kit (Applied Biosystems). 
Table 2-1. Nucleotide sequences of oligonucleotide primers used in different kinds of PCR 
 
Expt. Primer name Nucleotide sequence (5’----------3’) Length 
(bp) 
3’ RACE 
3’RACE-F AGA AGC TCG AGT CTG ATC TGG TT 23 
Oligo (dT) 
CCA GTG AGC AGA GTG ACG AGG  
ACT CGA GCT CAA GC(T)17 
52 
AP CCA GTG AGC AGA GTG ACG 18 
5’RACE GeneRacerTM CGA CTG GAG CAC GAG GAC ACT GA 23 
5’RACE-R CCA GGA CTT TGA CCG TGA CCT TAG C 25 
RT-PCR 
M743-F TGT TCA CTT GTC CAA GTG CCG GAAG 25 
M743-R CAA GAG CAA AAA TGT TTA TTA TGG 24 
Fugu β-actin-F CTG TAT GCC AAC ACT GTG CTG T 22 
Fugu β-actin-R TTA GAA ACA TTT GCG GTG GAC GAT 24 
SRF1-F ACG GTG GTC GTA AAG GGC TAG TTT 24 
SRF1-R TAG AGG TGT CAA TCC CGT GCC ATT 24 
SRF2-F ATG CTG TCC AGT CAG ACC GGA GC 23 
SRF2-R AGG TGG TGT ATC TCC GCA GTT TGT 24 
Zebrafish β-actin-F CCC ATT GAG CAC GGT ATT GTG AC 23 
Zebrafish β-actin-R ATT GTG AGG AGG GCA AAG TGG TAA 24 
 
2.2.4 5’RACE 
GeneRacerTM kit (Invitrogen) was used to define the transcriptional start site of MYHM743-2 
through RNA ligase-mediated rapid amplification of 5’ cDNA ends. Previously synthesized Total 
RNA from 4dpf torafugu embryos was used and treated with calf intestinal phosphtase (CIP). 
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Dephosphorylated RNA was then decapped by tobacco acid pyrophosphatase (TAP) and ligated 
with GeneRacer RNA oligos. After reverse transcription, the 5’ cDNA end was amplified by 
PCR using a MYHM743-2 specific reverse primer (5’RACE-R) together with GeneRacerTM 5’ 
primer included in the kit (Table 2-1). The PCR was carried out at 94 °C for 3 min, followed by 
30 cycles of denaturation at 94 °C for 30 s, annealing at 61 °C for 30 s and extension at 72 °C for 
1 min with a final extension step for 5 min, using a GeneAmp PCR system 9700 (Applied 
Biosystems). A single PCR reaction of 20 μL contained 1 μL each of GeneRacerTM 5’ primer and 
gene specific reverse primers (10 μM), 1 μL of cDNA template (dilution 1:100), 2 μL of 10× 
PCR buffer (20 mM Tris–HCl, pH 8.0, 100 mM KCl, 20 mM MgCl2), 1 U Taq DNA polymerase 
(Takara) and 13.8 μL of sterilized water. Amplified DNA fragments were subcloned into the 
pGEM-T vector (Promega) and the fragments were sequenced with an ABI 3100 genetic analyzer 
(Applied Biosystems). 
2.2.5 RT-PCR 
RT-PCR was performed to examine the expression of (1) MYHM743-2 to be restricted to embryonic 
and larval stages in torafugu and further possible expression in different tissues of adult torafugu 
and (2) two SRF genes (srf1and srf2) in zebrafish embryos and larvae. The synthesized cDNAs 
from embryos, larvae and various tissues of adult torafugu and zebrafish were used as template. 
PCR amplifications were carried out at 94 °C for 3 min, followed by 30 cycles of denaturation at 
94 °C for 30 s, annealing at 58-60 °C for 30 s and extension at 72 °C for 1 min with a final 
extension step for 5 min, using a Gene Amp PCR system 9700 (Applied Biosystems). A single 
PCR reaction of 20 μL contained 1 μL each of forward and reverse primers (10 μM), 1 μL of 
cDNA template (dilution 1:100), 2 μL of 10× PCR buffer (20 mM Tris–HCl, pH 8.0, 100 mM 
KCl, 20 mM MgCl2), 1 U Taq DNA polymerase (Takara) and 13.8 μL of sterilized water. The 
transcripts of torafugu β-actin (U38849) and zebrafish β-actin (NM_131031) genes were used as 
the internal control for RT-PCR (Table 2-1). 
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2.2.6 Bioinformatics analysis 
The nucleotide sequence of MYHM743-2 determined by 3’RACE was used to identify the genomic 
sequence of MYHM743-2 by searching the torafugu genome databases assembly ver. 3.0 and 4.0 at 
QMLU Fugu Genomic Project. Transcription factor-binding sites in the 5'-flanking region of 
MYHM743-2 were predicted by MatInspector, V7.1 (http://www.genomatix.de) and TFSEARCH 
program, V1.3 (http://www.cbrc.jp/research/db/TFSEARCH.html). Genes orthologous to 
torafugu MYHM743-2 were searched in zebrafish, medaka and green spotted pufferfish (Tetraodon 
nigroviridis) genomes using ensemble genome browser (http://www.ensembl.org). The 
homology search for the 5'-flanking region between torafugu MYHM743-2 and green spotted 
pufferfish MYH13 was carried out by rVISTA plot analysis through the Vista server 
(http://genome.lbl.gov /vista/index.shtml).  
2.2.7 Generation of a non-deletion and a series of 5’-deletion constructs 
Genomic DNA was isolated from the dorsal fin of adult torafugu by using DNeasy Tissue Kits 
(QIAGEN Sciences, Maryland, USA). The pT2AL200R150G (Tol2) vector (courtesy of Dr. 
Kawakami) containing EGFP was used as a reporter plasmid. The Tol2 vector was linearized by 
using XhoI and BamHI restriction enzymes. To identify the minimal promoter, a series of 
5’-deletion constructs within the 2,075-bp fragment was generated by PCR using torafugu 
genomic DNA as a template. First, PCR primers were designed and converted into In-Fusion® 
Primers that share 16 bases of identity with the sequence at the ends of the linearized cloning 
pT2AL200R150G (Tol2) vector by using online In-Fusion® Primers design tool (http://bioinfo. 
clontech.com/infusion/convertPcrPrimersInit.do). A total of 10 forward primers and one reverse 
primer (Table 2-2) were designed to amplify one non-deletion (2,075 bp) and a series of 5’-distal 
deletion regions. These primers were then used to amplify the 5’-distal deletion of MYHM743-2 by 
PCR and the reaction product was purified using QIAquick Spin Columns (QIAGEN Sciences). 
Chapter 2  
 
28 | P a g e  
 
Transcriptional regulation of MYHM743-2 expression 
All of these purified PCR products with 5’-distal deletion were sub-cloned individually into the 
BamHI-XhoI site of Tol2 vector by In-Fusion® Advantage PCR Cloning Kit (Clontech) 
following the manufacturer protocol and then transformed into JM109 competent cells. Positive 
colonies were selected by colony PCR and their sequences were confirmed by ABI3100 genetic 
analyzer (Applied Biosystems). The plasmid DNA for microinjection was isolated from each 
deletion construct using GenEluteTM plasmid Mini-prep Kit (Sigma-Aldrich). These constructs 
were P2075, P1482, P1006, P819, P600, P500, P468, P448, P425 and P340, in which numbers 
refer to the nucleotide positions upstream of the MYHM743-2 translation start codon. P2075 was 
generated as a non-deletion control and the rest deletion constructs contained a deleted MYHM743-2 
promoter region, EGFP, and SV40 polyA signal. 
Table 2-2: Nucleotide sequences of oligonucleotide primers used in the generation of 5’-distal 
deletion construct of MYHM743-2 
 
Primer name Nucleotide sequence (5’----------3’) Length (bp) 
P2075F GG ATC ATA GCA GTA GGT TTA 20 
P1482F CG TGA ATC CAA AAT GGC ACT AC 22 
P1006F CG GAT GAT TCC AAA TAC CCA G 21 
P819F GC CTC ATG AAA TCA AAA CTC 20 
P600F CA AGA ACA ACT GGT ATG AGG TG 22 
P500F CA CTA CAT ATA ACT TGG CTG TGT C 24 
P468F CC TGT GAA TAT AAG GAC CCC TTT G 24 
P448F TT TGG AGA CAT CAG TGT GGA ACA 23 
P425F AG GAG ACC CGT GAG TTG GTG GTA A 24 
P340F CC AAA TTC AAC AAA TCA AAA TGT TCA C 27 
Reverse AT GGT GGC GGC TTA TGT CTG 20 
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2.2.8 Generation of MYHM743-2 : EGFP transgenic line 
For this purpose, RNA encoding functional Tol2 transposase enzyme was transcribed in vitro 
from pCS-TP vector (Kawakami et al., 2004). At first, pCS-TP plasmid was linearized by 
digestion with NotI, and mRNA was synthesized in vitro by using mMESSAGE mMACHINE 
SP6 Kit (Ambion Inc., Texas, USA) and purified by using Ambion MEGAclearTM Kit. To 
generate the stable transgenic line, the Tol2-based construct (P2075) was co-injected with 
transposase mRNA in a final concentration of 50 ng/µl and 25 ng/µl of the P2075 construct and 
transposase mRNA, respectively, at 1-2 cell stage embryos.  
The transient embryonic excision assay (TEEA) is important to examine cis and trans activities 
of the transposons system. Therefore, about 8-10 h after the microinjection, embryos was 
subjected to Tol2 excision assay. For this purpose, the injected embryos were transferred one by 
one to 0.2-ml strip tubes (eight tubes per strip) and lysed in 50 µl of 10 mM Tris-HCl, pH 8.0, 10 
mM EDTA, 200 µg/ml proteinase K at 50oC for 2 h. Proteinase K was inactivated at 95oC for 5 
min. One microliter of the lysed DNA sample was used for PCR (35 cycles of 94 oC for 30 sec, 
55 oC for 30 sec, and 72 oC for 3 min). The excision products were amplified by using the primers 
T2AexL (5’- CGC AAT TAA CCC TCA CTA AAG G-3’) and T2AexR (5’-ACC CAA CTG 
ATC TTC AGC ATC T-3’). The PCR products were analyzed on 2% agarose gel electrophoresis. 
The excision product was detected from all embryos injected the transposase mRNA and a 
transposon-donor plasmid containing T2AL200R150G. These result indicated that excision 
occurred properly in the injected embryos. 
As the TEEA showed successful results, EGFP expression in embryos was observed with a 
MVX10 macro-zoom microscope (Olympus, Tokyo, Japan). The EGFP-positive embryos were 
identified at 2dpf and then transferred into the fish rearing unit of the Department of Aquatic 
Bioscience until sexual maturity. Individual flounder fish were outcrossed with wild-type fish for 
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examination of EGFP-positive expression in the offspring. EGFP-positive offspring of selected 
founder lines were raised to establish the F1 generation. The F2 generation was then established 
by incrossing F1 fish. 
2.2.9 Generation of deletions and mutations constructs of various cis-elements 
Inverse PCR-based site-directed mutagenesis technique was used to generate (1) the deletions 
and mutations of the cis-elements such as SRF, MEF2 and MyoD binding sites, and (2) the 
deletion construct in the conserved region (-664 to -364 bp) between torafugu MYHM743-2 and 
green spotted pufferfish MYH13. Specific forward and reverse primers were designed for the 
deletion of cis-elements (Table 2-3). Mutant constructs of SRF-like binding site (P468M1, 
P468M2, P468M3 and P468M4) were generated by using mutant reverse primers, each 
containing 2-bp mutant bases (Table 2-4, bold face). Then the primers were phosphorylated at 
37 °C for 1 h and the enzyme was inactivated by heating at 97 °C for 5 min using a GeneAmp 
PCR system 9700 (Applied Biosystems). A single reaction of 20 μL containing 7 μL each of 
forward and reverse primers (50 μM), 2 μL of 10× protruding end kinase buffer, 1μL of rATP 
and 2 μL of T4 kinase. Inverse PCR was performed using KOD FX DNA polymerase (TOYOBO, 
Osaka, Japan) and the plasmid DNA of a specific construct as template with phosphorylated 
primers. Then the amplified inverse PCR products were digested by DpnI at 37 °C for 1 h. The 
digested inverse PCR products were ligated with the DNA Ligation Kit (Mighty Mix-Takara, 
Tokyo, Japan) and then transformed into JM109 competent cells. Positive colonies were selected 
by colony PCR and their sequences were confirmed by ABI3100 genetic analyzer (Applied 
Biosystems). The plasmid DNA for microinjection was isolated from the positive colony of each 
of deletions and mutations constructs using GenEluteTM plasmid Mini-prep Kit (Sigma-Aldrich). 
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Table 2-3. Nucleotide sequences of oligonucleotide primers used in the generation of deletion 
constructs of various cis-elements from P2075 constructs of MYHM743-2  
 
Expt. Primer name Nucleotide sequence (5’----------3’) Length 
 (bp) 
 SRF 
deletion 
constructs 
P2075∆SRF1F TTCGTAAACATATGGAGATAATTAG 25 
P2075∆SRF1R TTTAGAGACATTATTACGAGGGT 23 
P2075∆SRF1-2F ACACTACATATAACTTGGCTGTGT 24 
P2075∆SRF1-2R GCTGACAACAAAAAAGGAGACAC 23 
P2075∆SRF1-3F TTTGGAGACATCAGTGTGGAACA 23 
P2075∆SRF1-3R GGGCTTTGCTGACACAGCCAA 21 
MyoD 
deletion 
constructs 
P2075∆MyoD1F GGGCAAAAACACTTAACCAAAGAA 24 
P2075∆MyoD1R ATGTTTAAAAAGAATCACATGGC 23 
P2075∆MyoD1-2F AACATTTACCATGAAAAAGGTGT 23 
P2075∆MyoD1-2R GGATGGTTGTTGGGATTTTTTTG 23 
P2075∆MyoD1-3F CATTTTACAATTTTAAGCCTCATG 24 
P2075∆MyoD1-3R TTCATAAAAATTACTGGGAGTTG 23 
 MEF2 
deletion 
constructs 
P2075∆MEF2_1F AAACATATGGAGATAATTAGACAAGATGG 29 
P2075∆MEF2_1R GCAGTTTAGAGACATTATTTCGAGG 25 
P2075∆MEF2_1-2F CAAACTAATATGTTACAAATAGATATCAAAC 31 
P2075∆MEF2_1-2R AATCACTTTTGCTCATATTTTGGC 24 
P2075∆MEF2_1-3F AACAAAGCTCATCGTAGAAAAGT 23 
P2075∆MEF2_1-3R TTAGTTTGAGATCTATTTTCAGTGC 25 
P2075∆MEF2_1-5F TCCAGGTGGCAAAAAGGTCGG 21 
P2075∆MEF2_1-5R TGAAAACAACCACATCAATGTTT 23 
P2075∆MEF2_1-6F CCAGCCCAAAAAAATCCCAACAA 23 
P2075∆MEF2_1-6R TGTGGTTGTCTTGCATATTGTGT 23 
P2075∆MEF2_1-7F ATCATTGATTATTGATCTGTTTAGG 25 
P2075∆MEF2_1-7R CACTCAACTTGATAATGTCCTAA 23 
P2075∆MEF2_1-8F CACAAATTAGTCGAGTCATTATC 23 
P2075∆MEF2_1-8R ATCCAGCTTAATACTGTAATTTA 23 
Conserved 
deletion 
P2075∆664-364F CCACTTAAATATCTTTCCAAATTCAAC 27 
P2075∆664-364R GATAATGTCCTAAAAGGAATGTTTGAT 27 
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Table 2-4. Nucleotide sequences of oligonucleotide primers used in the generation of mutation 
constructs of SRF binding site in P468 constructs of MYHM743-2 
 
Experiment Primer name Nucleotide sequence (5’----------3’) Length  
 (bp) 
SRF mutation 
constructs 
P468M1-F GAGACATCAGTGTGGAACAGGAG 23 
P468M1-R CAAAGGGGTCCTTCCATTCACAG 23 
P468M2-F GAGACATCAGTGTGGAACAGGAG 23 
P468M2-R CAAAGGGGTCCTTATACCCACAG 23 
P468M3-F GAGACATCAGTGTGGAACAGGAG 23 
P468M3-R CAAAGGGGTGGTTATATTCACAG 23 
P468M4-F GAGACATCAGTGTGGAACAGGAG 23 
P468M4-R CGGAGGGGTCCTTATATTCACAG 23 
Bold two bases indicate mutation sites 
 
2.2.10 Microinjection and EGFP expression analysis 
To perform microinjection, fertilized eggs of zebrafish were collected at 15-30 min after 
fertilization from the zebrafish rearing facility in the Department of Aquatic Bioscience. In 
microinjection, each EGFP reporter construct was diluted at 50 ng/mL with sterile distilled water 
containing 0.025% phenol red and introduced into fertilized eggs at the one to two-cell stage. 
Embryos were reared at 28 °C, and subjected to observation of EGFP expression patterns during 
development at the interval of every 24 h. The fluorescence derived from transgenes in embryos 
and larvae during development was observed with a MVX10 macro-zoom microscope (Olympus) 
and a FV1000 confocal laser scanning microscope (Olympus). Older embryos were anesthetized 
with 0.6 μM tricaine methyl sulfonate (Sigma-Aldrich) to inhibit movement during observation.  
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2.2.11 Immunohistochemical analysis 
Immunohistochemical staining was performed in whole mount and on the cryosections made 
from transgenic zebrafish and stable transgenic line embryos after fixation with 4% 
paraformaldehyde (PFA) (Westerfield, 1993). F310 (Developmental Studies Hybridoma Bank), 
F59 (Developmental Studies Hybridoma Bank) and anti-EGFP (Clontech) monoclonal antibodies, 
which are specific to fast-type myosin light chain, slow-type myosin heavy chain and EGFP, 
respectively, were used as the primary antibodies. For immunohistochemistry, embryos were 
fixed with 4% PFA in Tris-buffered saline (25 mM Tris, 137 mM NaCl, 2.7 mM KCl, pH 7.4) 
containing 0.1% Tween 20 (TBSTw) overnight at 4°C. Fixed embryos were washed with TBSTw, 
and blocking was performed using  a1.5% blocking reagent (Roche , Mannheim, Germany) in 
TBSTw. Transverse sections were prepared at a thickness of 16 µm with a cryostat Tissue-Tek 
Cryo3 (Sakura Finetech, Japan) at −20 °C before the first immunoreactions. Living colors EGFP 
antibody (Clontech) was used at a dilution of 1:1,000 in blocking solution, and MF20 and F59 at 
1:20. Immunoreaction with the first antibody was performed overnight at 4 °C. After incubation, 
embryos were washed with TBSTw and labeled with the second antibodies, anti-mouse IgG 
Alexa Fluor 555 and anti-rabbit IgG Alexa Fluor 488 (Invitrogen) at a dilution of 1:250 for 
overnight at 4 °C. The localization of cell nuclei was observed after staining for 10 min with 40, 
6-diamidine-20-phenylindole dihydrochloride (DAPI, Roche) diluted at 1 µg/ml in TBSTw. The 
signals in the whole mount and cryosection samples were visualized using an Olympus Fluo 
View1000 confocal laser scanning microscope (Olympus, Tokyo, Japan). 
2.2.12 Real time PCR analysis 
For relative quantification of EGFP expression, total RNAs from 10-12 EGFP-expressed 
embryos of each of injected constructs were isolated by standard procedures with an isogen RNA 
extraction kit (Nippon Gene) following the instruction of the manufacture. To avoid any possible 
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contamination with genomic DNAs, the RNA preparation was treated with Turbo DNA-free™ 
(Applied Biosystems) at 37 °C for 1 h. cDNA templates for use in real-time PCR were 
synthesized using SuperScript III reverse transcriptase (Invitrogen) in accordance with the 
manufacturer's recommendation. Real-time PCR primers (Table 2-5) were designed for EGFP 
and the control gene by using primer express 2.0 (Applied Biosystems). A housekeeping gene 
encoding β-actin (NM_131031) was selected as references for the calculation of relative 
expression levels of target genes. The specificity of primers was ensured with NCBI primer blast 
webpage server (www.ncbi.nlm.nih.gov/tools/primer-blast/).  
Real-time quantitative PCR was performed in 96-well optical plates with an ABI Prism 7300 
Sequence Detection System (Applied Biosystems). After several pilot experiments, the optimal 
PCR condition was established: PCR reaction mixture contained 10 μL 2×SYBR premix ExTaqII 
kit (Takara), 10 μM each of forward and reverse primers (Table 2-5), 1 μL diluted template 
cDNA (about 10 ng) and 0.4 μL ROX reference dye. PCR consisted of pre-incubation at 50 °C 
for 2 min and denaturation at 95 °C for 10 min, followed by 40 cycles of denaturation at 95 °C 
for 15 s and annealing and extension at 60 °C for 1 min. The absence of nonspecific products was 
confirmed by dissociation curve analysis (60 to 95 °C). Fluorescence was monitored at the end of 
each cycle to obtain the amount of PCR products. The point at which the SYBR fluorescent 
signal was statistically significant above background was defined as the cycle threshold (Ct), the 
optimal value of which was chosen automatically. PCR efficiency of each primer pair was 
determined by running standard curves for 10-fold serial dilutions of cDNA templates prepared 
from EGFP- expressed zebrafish larvae. The transcript quantities were represented as the relative 
expression levels of target genes to those of reference genes. To exclude the variation caused by 
different PCR efficiency, the relative expression levels were calculated by using the comparative 
Ct difference method (Schmittgen and Livak, 2008).  
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Table 2-5. Nucleotide sequences of oligonucleotide primers used in real-time PCR analysis 
 
Primer name Nucleotide sequence (5’----------3’) Length (bp) 
EGFP -Forward AGC AAA GAC CCC AAC GAG AA 20 
EGFP-Reverse GCG GCG GTC ACG AAC TC 17 
β-actin-Forward TGC TGT TTT CCC CTC CAT TG 20 
β-actin-Reverse TCT GTC CCA TGC CAA CCA T 19 
 
2.2.13 Statistical analysis 
To compare the percentages of embryos with EGFP expression in skeletal, craniofacial and 
pectoral fin muscles in various constructs and relative quantification of target gene, statistical 
analyses were conducted using one-way analysis of variance (ANOVA) followed by Tukey's test 
in Statistical Package for Social Science (SPSS) version 11.5 (SPSS Inc., IL, USA). Data were 
represented as the mean ± SD and the differences were considered significant at P<0.05. 
 
 
Chapter 2  
 
36 | P a g e  
 
Transcriptional regulation of MYHM743-2 expression 
2.3 Results 
2.3.1 Expression of torafugu MYHM743-2 
In order to know the information regarding the expression of torafugu fast-type MYHM743-2, 
RT-PCR was performed by using specific forward and reverse primers synthesized based on the 
sequence in 3' UTR. RT-PCR revealed that the expression of MYHM743-2 was dependent on the 
developmental stage. The transcripts of MYHM743-2 appeared in embryos at 3 dpf and continued to 
be expressed through successive embryonic and larval development (Fig. 2-1). These results were 
almost consistent with those reported by Ikeda et al. (2007), who studied the expression of 
MYHM743-2 by in situ hybridization and RT-PCR analysis. 
 
 
 
 
 
Fig. 2-1: Expression analysis of torafugu MYHM743-2 from embryos, larvae and various tissues of 
adult fish. The transcripts of β-actin (U38849) were used as the internal control. dpf, days post 
fertilization; FA, fast; LS, lateralis superficialis; ED, erectors and depressors; CA, cardiac. 
 
2.3.2 Characterization of 2,075 bp 5’-flanking sequences of torafugu MYHM743-2 
To determine the regulatory region for the muscle-specific expression, we first characterized the 
2,075 bp 5’-flanking region of MYHM743-2. The 2,075 bp DNA fragment included an 1,610-bp 
5’-upstream region, three exons, and two introns. The transcription start site was determined by 
5’-RACE at 465 bp upstream of the ATG start codon in exon 3 (Fig. 2-2). Using the Genomatix 
Matinspector and TFsearch programs, we found that the 2,075-bp 5’-flanking region contained 
transcription factor-binding sites for SRF, MEF2 and MyoD, all of which have been implicated in 
the expressional regulation of muscle-specific genes during development (Fig. 2-2). 
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Fig. 2-2: The DNA sequence of the 2,075 bp 5’-flanking region of MYHM743-2. The transcription 
initiation site determined by 5’-RACE is indicated by an arrow. Based on the transcription-factor 
binding site analysis by Genomatix and TFsearch program, MyoD, MEF2, and SRF-like binding 
motifs are indicated by boxes. Three exons are marked bold. The translation start codon located 
on the third exon is underlined. 
 
To analyze the transcriptional activity, the 2,075 bp 5’-flanking region of MYHM743-2 was fused to 
EGFP in pT2AL200R150G vector. The resultant gene construct (P2075) was microinjected into 
fertilized eggs of zebrafish for transient expression analysis. EGFP expression in injected 
embryos was monitored by direct observation under a fluorescent microscope. About 90% (n = 
105) of the injected embryos showed a strong EGFP expression along skeletal muscle fibers. In 
zebrafish, the expression was detected at 1 dpf in the somite formation stage (Fig. 2-3A–B). After 
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hatching, EGFP continued to be expressed in the whole myotomal region of larva (Fig. 2-3C). In 
addition to the skeletal muscle expression, EGFP expression was also detected in pectoral fin and 
craniofacial muscles at 4 dpf (Fig. 2-3D-F). These data confirmed that the 2,075 bp 5’-flanking 
region of torafugu MYHM743-2 contained the essential regulatory sequences for muscle-specific 
expression. 
 
 
 
 
 
 
 
 
 
 
Fig. 2-3: The expression patterns of P2075 construct in embryos and larvae of zebrafish. A-C: 
EGFP expression patterns in whole myotomal region of zebrafish embryo (1 dpf, A, B) and larva 
(2 dpf, C) injected with the reporter construct of P2075. D-F: EGFP expression patterns in 
pectoral fin (D) and craniofacial muscles (E, F) in zebrafish larvae at 4 dpf. Arrows indicate 
muscle fibers expressing EGFP. Scale bars: 100 μm. 
2.3.3 Generation and expression pattern of MYHM743-2: EGFP transgenic zebrafish 
To confirm the expression patterns of P2075 during early muscle development more clearly, we 
attempted to establish stable transgenic lines. For this purpose, we used the Tol2 transposon 
vector system, which was originally identified in medaka (Koga et al., 1996) and later adapted as 
a vehicle to efficiently integrate ectopic DNA into the zebrafish genome (Kawakami et al., 2000, 
2004). Transient injection of Tol2 based plasmids was previously shown to be a valuable method 
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to analyze tissue-specific promoters in zebrafish (Fisher et al., 2006; Korzh, 2007). In this 
method, P2075 was co-injected with transposase mRNA, which was transcribed from pCS-TP 
vector. The injected embryos were subjected to the TEEA at 8-10 h after microinjection to 
confirm whether the excision occurred properly. The excision product was detected from all 
embryos injected with the transposase mRNA and a transposon-donor plasmid containing 
T2AL200R150G (Fig. 2-4). Muscle-specific EGFP expressing embryos were selected and raised 
to adulthood. After 3 months, the surviving founders were mated with wild-type zebrafish to find 
germline-transmitted transgenic zebrafish.  
 
 
 
 
 
Fig. 2-4: The transient embryonic excision assay. DNA samples prepared from embryos injected 
with the transposes mRNA and Tol2 based P2075 construct were analyzed by PCR. Top bands 
represent PCR products from unexcised transposon constructs and bottom bands represent 
excision products. Lanes 1-21: PCR products amplified from DNA samples prepared from 
different injected embryo. M, marker. 
 
The 20% (4 out of 20 fish tested) of F0 injected zebrafish were found to be founders, which 
produced F1 embryos expressing EGFP in the myotomal compartments. About 50% of F2 
offspring embryos carried muscle-specific EGFP expression by outcrossing F1 fish with 
wild-type fish, suggesting that the germline transmission rate of transgene complied with the 
Mendelian inheritance law. All of the F1 transgenic line fish were mated and produced normal 
offspring. The temporal and spatial EGFP expression was analyzed in these transgenic lines. 
Similarly with the transient assay, the embryos of stable zebrafish line also showed a strong 
expression of the reporter gene along muscle fibers. In the stable transgenic line, the expression 
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was also detected at 1 dpf (Fig. 2-5A-B). After hatching, EGFP continued to be expressed in the 
whole myotomal region of larva (Fig. 2-5C). The observation with a fluorescent microscope on 
24 h intervals confirmed that zebrafish expressed EGFP in pectoral fin at 3 dpf and craniofacial 
muscles at 4 dpf (Fig. 2-5D-F). The observed EGFP expression in the stable transgenic line was 
consistent with the expression pattern of P2075. Taken together, these data suggest that the 
2,075-bp 5’-flanking region contained the necessary regulatory elements for MYHM743-2 
expression in skeletal, craniofacial and pectoral fin muscles. 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2-5: The expression patterns of MYHM743-2:EGFP in stable transgenic line embryos and 
larvae of zebrafish. A-C: EGFP expression patterns of MYHM743-2:EGFP in the whole myotomal 
region of stable transgenic line zebrafish embryo (1 dpf, A, B) and larva (2 dpf, C). D-F: EGFP 
expression patterns in pectoral fin (D) at 3 dpf and craniofacial muscles (E, F) at 4 dpf in stable 
transgenic line zebrafish larvae. Arrows indicate muscle fibers expressing EGFP. Scale bars: 100 
μm.  
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2.3.4 Immunohistochemical observations  
Immunohistochemical observations were conducted to clarify types of muscle fibers that express 
EGFP. EGFP-expressing embryos were stained with F310 (Crow and Stockdale, 1986) and F59 
(Crow and Stockdale, 1986; Devoto et al., 1996) monoclonal antibodies specific to fast-type 
myosin light chain and slow-type MYHs, respectively. EGFP-expressing muscle fibers of 
P2075-injected larvae consisted of both fast and slow types reacted with F310 (Fig. 2-6A-B) and 
F59 antibodies (Fig. 2-6C–D), respectively. 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2-6: Localization of EGFP expression to both fast and slow muscle fibers in P2075-injected 
larvae. A-B: Fast muscle fibers expressing EGFP as reacted with F310 antibody in a 
P2075-injected larva at 3 dpf (A, lateral view; B, transverse section). C-D, Slow muscle fibers 
also expressing EGFP as reacted with F59 antibody (C, lateral view; D, transverse section) in a 
P2075-injected larva at 3 dpf. Some EGFP expressing muscle fibers were stained with F59 
antibody (arrows in D). Scale bars: 50 μm. 
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In situ hybridization demonstrated that the transcripts of MYHM743-2 were restricted to fast muscle 
fibers in torafugu embryos (Ikeda et al., 2007). Transient transgenic analysis sometimes showed 
ectopic reporter gene expression. Therefore, immunohistochemical staining was also performed 
on the cryosection made from the MYHM743-2:EGFP stable transgenic line zebrafish larvae at 3 
dpf. Interestingly, EGFP-expressing muscle fibers in stable transgenic line larvae consisted of 
only fast types as reacted with F310 (Fig. 2-7A-C) but not in the slow types as no EGFP muscle 
fibers reacted with F59 (Fig. 2-7D-F). This study confirmed that MYHM743-2 expression is 
fast-muscle specific in agreement with the previous findings by Ikeda el al. (2007). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2-7: Localization of EGFP expression only to fast muscle fibers in stable transgenic line 
(MYHM743-2:EGFP) larvae. A-F: MYHM743-2:EGFP transgene in a stable transgenic line larva 
showed EGFP expression in fast muscle fibers as reacted with F310 antibody (A, B, C; transverse 
sections) but not in slow muscle fibers as no EGFP expressing muscle fiber reacted with F59 
antibody (D, E, F; transverse sections). Scale bars: 50 μm. 
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2.3.5 Deletion analysis of torafugu MYHM743-2 promoter in zebrafish embryos 
To identify the minimal promoter that could drive MYHM743-2 expression in the myotomal 
compartment, a series of constructs containing progressive deletions from the 5’-end of the 
2,075-bp fragment were generated. The resulting six deletions constructs (P1482, P1006, P819, 
P600, P500 and P340) contained fragments of 1,482, 1,006, 819, 600, 500 and 340 bp, 
respectively, which were fused to EGFP and SV40 polyA signal (Fig. 2-8A). P2075 was 
generated as a non-deletion control.  
When P2075 was microinjected into one to two-cell embryos, approximately 90% of the injected 
embryos had EGFP expression in the myotomal compartments (Fig. 2-8B). Embryos 
microinjected with P1482, P1006, P819, P600 and P500 displayed a gradual reduction in 
percentages of EGFP expression in myotomal compartments (Fig. 2-8B). Notably, EGFP 
expression was not detected in any embryos microinjected P340. Fluorescent optics also showed 
that EGFP expression was reduced in embryos microinjected with these deletion constructs and 
such EGFP fluorescent reduction typically correlated with a smaller MYHM743-2 promoter region 
(Fig 2-8C-G). To precisely map the minimal active promoter, three additional deletion constructs, 
P468, P448 and P425, were generated and microinjected into one to two-cell embryos. Only 
embryos microinjected with P468 had EGFP expression in the myotomal compartments, and 
embryos injected with P448 and P425 did not show any EGFP expression in myotomal 
compartments (Fig. 2-8B). Thus, the 468-bp regulatory sequence contained the minimum basal 
promoter that could drive EGFP expression in the myotomal compartment. These results also 
suggest that 20 nucleotides spanning the region from −468 to − 449 bp contain positive 
cis-elements required for MYHM743-2 expression (Fig. 2-8H). 
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Fig. 2-8: Effects of MYHM743-2 promoter deletions on EGFP expression in the myotomal 
compartments of zebrafish embryos and larvae. A: Schematic representations of 
consensus-binding sites within 2,075-bp upstream region of torafugu MYHM743-2, as well as a 
deletion series in the torafugu MYHM743-2 promoter region. Vertical lines represent 
consensus-binding sites for transcriptional factors of MEF2, MyoD and SRF. All promoter 
deletions (black lines) are linked to EGFP and SV40-polyA sequence in pT2AL200R150G 
vector. B: Bar graph showing percentages of embryos that express EGFP in the myotomal 
compartments in microinjection of each deletion construct. The total number of embryos injected 
with each construct is shown in parentheses. C-G: Embryos injected with a series of distal 
promoter deletion constructs at one- or two-cell stages were examined for transient EGFP 
expression at 1-2 dpf using fluorescent microscopy. Reduced EGFP fluorescence typically 
correlates with a smaller MYHM743-2 promoter (C-F) and no EGFP expression was observed in 
P448 (G). An arrowhead indicates a single fiber expressing EGFP in P468 (F). Scale bars: 100 
µm. H: 20 nucleotides spanning the region from -468 to -449 contain positive cis-elements 
required for MYHM743-2 expression. Blue color with bold face in the SRF sequence indicates a 
central core sequence. 
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2.3.6 SRF-like binding elements are necessary for directing MYHM743-2 expression 
Deletion analysis suggested that the 20 nucleotides spanning the region from −468 to −449 bp 
(CCTGTGAATATAAGGACCCC) may contain positive cis-elements required for MYHM743-2 
expression. Genomatix Matinspector program predicted a transcription factor known as SRF-like 
binding site within this 20 bp sequence of MYHM743-2. SRF is a member of the MADS box 
superfamily of transcription factors (Shore and Sharrocks, 1995) and regulates skeletal as well as 
cardiac and smooth muscle genes by binding to a DNA sequence known as the CArG box 
(Camoretti-Mercado et al., 2003; Miano, 2003). A growing number of genes have been shown to 
contain functional CarG boxes, particulary those encoding proteins involved with a cell’s 
cyto-architecture (Minty and Kedes, 1986; Philippar et al., 2004; Zhang et al., 2005; Sun et al., 
2006). Further, conditional knockout studies in mice have demonstrated a critical role of SRF in 
the normal organization of the cyto-contractile apparatus in cardiac, smooth and skeletal muscle 
cells (Miano et al., 2004; Li et al., 2005). Zebrafish has two SRFs (srf1 and srf2), with partially 
overlapping expression patterns in larave at 3 and 7 dpf (Davis et al., 2008). In order to know the 
information regarding the expression of zebrafish srf1 and sfr2 more precisely, RT-PCR was 
performed by using specific forward and reverse primers. RT-PCR revealed that the transcripts of 
both srf1 and sfr2 appeared in embryos as early as 2 hpf and continued to be expressed through 
successive embryonic and larval development (Fig. 2-9).  
 
 
 
 
 
Fig. 2-9: Expression analysis of srf1 and sfr2 in embryos and larvae of zebrafish. The transcripts 
of β-actin (NM_131031) were used as the internal control. 
pM743-2075-Tol2EGFP∆SRF1-3
Zebrafish srf1
Beta-actin
2 hpf        6 hpf        20 hpf       36 hpf     48 hpf      72 hpf
Zebrafish srf2
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Therefore, we hypothesized that this SRF-like binding site may be necessary to mediate 
MYHM743-2 expression in the myotomal compartments. To examine this, four primers, each having 
two altered bases within and outside of SRF-like binding site, were used to generate mutant 
forms of P468 (Table 2-6). Embryos microinjected with P468M1, containing two base 
substitutions in the central core sequence, showed the complete disappearance of EGFP 
expression in the myotomal compartments (Table 2-6). Mutation of two bases adjacent to the 
core sequence (P468M2 and P468M3) caused a marked reduction of EGFP expression in the 
myotomal compartments (Table 2-6). In contrast, dinucleotide replacement (P468M4), which 
was apart from the SRF-like binding site, resulted in relatively higher levels of EGFP expression 
compared with P468M2 and P468M3 (Table 2-6). 
Table 2-6. Mutations in the SRF-like binding site in the P468 construct and their effects on 
EGFP expression in the myotomal compartments 
 
Constructs Sequence and mutation EGFP expression (%) 
P468 5'- CCTGTGAATATAAGGACCCCTTTGGAGA 9.17 (n = 109) 
P468M1 5'- CCTGTGAATGGAAGGACCCCTTTGGAGA 0 (n = 89) 
P468M2 5'- CCTGTGGGTATAAGGACCCCTTTGGAGA 2.67 (n = 75) 
P468M3 5'- CCTGTGAATATAACCACCCCTTTGGAGA 3.84 (n = 78) 
P468M4 5'- CCTGTGAATATAAGGACCCCTCCGGAGA 5.81 (n =8 6) 
 
Underlined, SRF-like binding site; bold, central core elements of the SRF-like binding site. n, total number 
of microinjections for each construct. Blue font color indicates mutation within and outside the SRF-like 
binding site 
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Genomatix MatInspector program identified three SRF-like binding sites within the 2,075-bp 
regulatory region of MYHM743-2. To examine functional redundancy of these SRF-like binding 
sites, we deleted these sites in P2075 and established the P2075∆SRF1, P2075∆SRF1-2 and 
P2075∆SRF1-3 with deletion of one, two, and three SRF-like binding sites, respectively (Fig. 
2-10A). Embryos microinjected with P2075∆SRF1 did not significantly reduce EGFP expression 
percentages in myotomal compartments compared to P2075-injected embryos (Fig. 2-10A). 
P2075∆SRF1-2 injection exhibited a marked reduction in EGFP expression, and embryos 
microinjected with P2075∆SRF1-3 displayed the largest reduction in EGFP expression 
percentage (Fig. 2-10A). Fluorescent optics showed that EGFP expression pattern in myotomal 
compartments was variable from embryo to embryo. Therefore, EGFP expressing embryos were 
grouped into three categories (high, medium and low), according to the intensity of fluorescence 
by visual observation under a fluorescent microscope (Fig. 2-10B-D). The purpose of this 
grouping was to investigate whether there was any correlation between the levels of transient 
expression and the deletion of SRF-like binding sites. Deleting all three SRF-like binding sites 
resulted in a marked reduction of high-EGFP expressing embryos and an increase of medium- to 
low-EGFP expressing embryos (Fig 2-10A). In order to confirm this, we validated the reduction 
of EGFP expression in P2075∆SRF1-2 and P2075∆SRF1-3 using real-time PCR analysis (Fig. 
2-10E). The deletion of all SRF-like binding sites reduced EGFP expression in P2075, although it 
failed to eliminate MYHM743-2 expression completely. Collectively, these data suggest that 
SRF-like binding sites, together with other cis-elements, are necessary for directing MYHM743-2 
expression. 
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Fig. 2-10: Effects of SRF-like binding sites deletions on EGFP expression in the myotomal 
compartments. A: Schematic representation showing SRF-like binding sites deleted one by one 
and the percentages of EGFP-expressing embryos (high, medium and low) in each SRF-deletion 
constructs. The total number of embryos injected with each construct is shown in parentheses. 
B-D: Lateral view showing high (B), medium (C) and low (D) EGFP expression in myotomal 
compartments in embryos injected with the P2075∆SRF1-3 construct. E: Bar graph showing 
reduced relative EGFP expression in the P2075∆SRF1-2 and P2075∆SRF1-3 constructs using 
real-time PCR analysis. Difference are significant in ANOVA followed by Tukey test at 
***<0.001. 
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2.3.7 MyoD and MEF2 binding sites are involved in the transcriptional control of 
MYHM743-2 expression in skeletal muscle 
Deletion analysis confirmed that EGFP expression in myotomal compartments typically 
correlated with a smaller MYHM743-2 promoter region. These results indicate that the key 
cis-acting element(s) that regulates the transcription of MYHM743-2 is located within the deleted 
promoter region. Analysis of the 2,075 bp 5’-flanking region by Genomatix MatInspector and 
TFsearch programs identified three putative MyoD and eight putative MEF2 binding sites (Fig. 
2-2). These binding sites have been reported to be involved in the transcriptional regulation of 
many muscle-specific genes during development in fish (Du et al., 2006; Kobiyama et al., 2006; 
Liang et al., 2008). To determine the role of these MyoD and MEF2 binding sites, we deleted 
these sites individually or in various combinations (Fig. 2-11A). All deletion mutant constructs 
were microinjected into zebrafish embryos for transient expression analysis. Deleting any one of 
these three MyoD or eight MEF2 binding sites alone had little or no effect on the MYHM743-2 
promoter activity and EGFP expression from these single MyoD or MEF2 binding site deletion 
constructs was almost comparable with the wild-type construct (P2075) (data not shown). 
Therefore, we decided to generate the multiple MyoD and/or MEF2 binding site-deleted mutant 
constructs by deleting these sites one by one (Fig. 2-11A). Deleting multiple MyoD and/or MEF2 
binding sites significantly reduced EGFP expression percentage compared with the non-deletion 
construct (P2075) (Fig. 2-11A). However, EGFP expression levels in myotomal compartments 
were variable from embryo to embryo. Therefore, similarly with the SRF-like binding site 
deletion analysis, EGFP-expressing embryos were also grouped into high, medium and low 
categories. Deleting all three MyoD or eight MEF2 binding sites resulted in a significant 
reduction of high-EGFP expressing embryos (Fig 2-11A). The reduction of such EGFP 
expression in MyoD and MEF2 binding sites deletion constructs were also validated by using 
real-time PCR analysis (Fig. 2-11B). These findings suggest that the deletion of MyoD and 
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MEF2 binding sites reduced EGFP expression in myotomal compartments. However, it should be 
noted that EGFP expression was not completely inhibited in skeletal muscles in all MyoD and/or 
all MEF2 binding sites deletion constructs. Collectively, these data suggest that multiple 
transcriptional factors including MyoD and MEF2 participate in the transcriptional regulation of 
MYHM743-2 expression. 
2.3.8 MyoD binding sites participates in the transcriptional control of MYHM743-2 
expression in craniofacial and pectoral fin muscles 
At larval stage (10 dpf) of torafugu, the indigenous transcripts of fast-type MYHM743-2 were 
localized to epaxial and hypaxial domains of myotome, and eye and pectoral fin muscles 
(Asaduzzaman et al., 2013). Similarly with the indigenous expression, EGFP expression was also 
observed in craniofacial and pectoral fin muscles in both P2075-injected and stable transgenic 
line larvae. Because MYHM743-2 was expressed in several types of muscle, it would be interesting 
to determine if the same or distinct regulatory elements are responsible for its transcriptional 
regulation in skeletal, craniofacial and pectoral fin muscles using transient expression and 
transgenic approach. Previous studies reported that MRFs such as MyoD and Myf5 had a 
significant role in driving pectoral fin and head myogenesis (Lin et al., 2006; Hinits et al., 2009). 
We therefore selected MyoD and MEF2 (in our interest) binding sites to investigate their roles in 
the transcriptional control of MYHM743-2 expression in craniofacial and pectoral fin muscles. 
During expression analyses, we observed that all skeletal muscle-specific EGFP-expressing 
embryos did not show EGFP expression necessarily in the above two muscles and that there were 
no embryos which exhibited EGFP expression only in these two muscles. Therefore, we 
calculated EGFP expression in these two muscles in terms of percentage in myotomal 
compartments-specific EGFP-expressing embryos. In non-deletion construct (P2075), about 
53.2% and 44.2% of the muscle-specific EGFP-expressing embryos showed EGFP expression in 
craniofacial and pectoral fin muscles, respectively, at 4 dpf (Fig. 2-11C). In the case of 
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craniofacial muscle, only embryos microinjected the construct deleting all MyoD binding sites 
could reduce EGFP expression (Fig 2-11C). For pectoral fin muscle, deleting MyoD binding sites 
gradually reduced EGFP expression (Fig. 2-11C). However, the deletion of all MEF2 binding site 
did not significantly reduce EGFP expression irrespective of pectoral fin and craniofacial muscles. 
These data suggest that the MyoD binding sites, but not the MEF2 binding sites, are crucial for 
MYHM743-2 promoter activity in craniofacial and pectoral fin muscles. It should be noted that the 
deletion of all MyoD binding elements could not completely abolish EGFP expression in these 
two muscles. Therefore, additional regulatory sequences other than MyoD binding sites, but not 
MEF2 binding site, might also be involved in the transcriptional control of MYHM743-2 expression 
in these muscles.  
2.3.9 The −664 to −364 bp is a key regulatory region in the MYHM743-2 promoter  
Initially, we aligned -2,075 bp 5’-flanking region of torafugu MYHM743-2 with the corresponding 
region of orthologues from zebrafish. The sequence analysis showed that there was no homology 
in the 5’-flanking region of torafugu MYHM743-2 with those of zebrafish (data not shown). 
However, torafugu MYHM743-2 showed homology over 55% in the 5' flanking region from −664 to 
−364 bp with the corresponding region of green spotted pufferfish orthologous gene, MYH13 (Fig. 
2-12A), suggesting a similar regulatory element function for these two genes. Therefore, to 
examine the functional roles of this conserved region, we deleted the −664 to −364 bp region 
from P2075 by an inverse PCR technique and established the P2075∆664-364 construct. When 
P2075 was microinjected into one to two-cell embryos, approximately 90% of them showed 
EGFP expression in the myotomal compartments (Fig. 2-12B). However, the embryos 
microinjected with P2075∆664-364 showed no fluorescence of EGFP in the whole myotomal 
region (Fig. 2-12C). These results indicate that the key cis-acting element(s) that regulates 
muscle-specific expression of MYHM743-2 is located in this region.   
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Fig. 2-11: Effects of MyoD and/or MEF2 binding sites deletions on transgene EGFP expression 
in the myotomal compartments, pectoral fin and craniofacial muscles. A: Schematic 
representation of different constructs in which MyoD and/or MEF2 binding elements were 
deleted one by one and the percentages of EGFP-expressing embryos (high, medium and low) in 
each MyoD and/or MEF2 binding site deletion constructs. The total number of embryos injected 
with each construct is shown in parentheses. B: Bar graph showing reduced relative EGFP 
expression in MyoD and MEF2 binding sites deletion constructs using real-time PCR analysis. C: 
Bar graph showing percentages of embryos showing EGFP expression in craniofacial and 
pectoral fin muscles to those expressing EGFP in myotomal compartments. 
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Fig. 2-12: The -664 to -364 bp region in the 5’-flanking region of MYHM743-2 crucial for its 
promoter activity.  A:. rVISTA plot showing homology (-664 to -364 bp region) in pairwise 
sequence alignments between −2075 bp of torafugu MYHM743-2 and the corresponding region of 
the Tetraodon orthologue. Peaks are shown relative to their positions in MYHM743-2  and their 
percent identities (50%–100%) are indicated on the vertical axis. B: EGFP expression was 
observed in the whole myotomal region in larvae microinjected with the P2075 construct. C: No 
EGFP expression was observed in embryos injected with the P2075∆664-364 construct. 
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2.4 Discussion 
In embryonic and larval stages of torafugu, multiple sarcomeric MYHs are expressed in different 
muscles in a sequential fashion. A greater understanding of factors regulating the expression of 
these embryonic- and larval-type MYHs in different muscles would provide insights into how 
these muscles are established and maintained. Although a considerable progress has been made in 
elucidating the molecular genetics underlying the muscle-specific expression of MYHs in carp 
and medaka mostly in a temperature dependent manner (Gauvry et al., 1996; Kobiyama et al., 
2006; Liang et al., 2008), little is currently known regarding the molecular mechanisms 
governing gene expression even within the fast subfamily at embryonic and larval stages of 
torafugu. We recently reported that the 2.1 kb 5’-flanking region of torafugu MYHM743-2 regulated 
developmental muscle-specific expression (Yasmin et al., 2011). This study identified several 
regulatory elements involved in the expression of MYHM743-2 in skeletal, craniofacial and pectoral 
fin muscles by transient and transgenic analyses. 
2.4.1 The 2,075 bp 5’-flanking region of MYHM743-2 is sufficient for muscle-specific 
expression 
Combining both transient and stable transgenic techniques, we demonstrated here that a 2,075-bp 
fragment upstream of torafugu MYHM743-2 could recapitulate muscle-specific gene expression. In 
transient transgenic assay, the 2,075 bp fragment of torafugu MYHM743-2 was cloned into a 
Tol2-based vector to reduce mosaicism, and significantly increase sensitivity. The expression 
patterns of the 2,075 bp construct (P2075) from the transient transgenic assay were confirmed by 
generating stable transgenic fish lines for P2075. In both transient and stable transgenic analyses, 
strong EGFP expression was observed along the whole myotomal regions in zebrafish embryos. 
This observation was in agreement with an earlier report by Ikeda et al. (2007), where the 
transcripts of MYHM743-2 were localized in the whole myotome of torafugu embryos.  
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Embryonic MYHs have been also reported to be expressed distinctly in craniofacial and pectoral 
fin muscles in common carp (Ikeda et al., 2010). Similarly, we observed zebrafish larvae 
expressed EGFP in pectoral fin and craniofacial muscles. These results were also in agreement 
with the expression of embryonic MYH orthologues in zebrafish (Xu et al., 2000) and medaka 
(Ono et al., 2006, 2010). The endogenous expression of MYHM743-2 by in situ hybridization was 
also found to be expressed in pectoral fin and eye muscles of torafugu by our laboratory member. 
EGFP expression patterns suggests the functional requirement of MYHM743-2 during larval 
pectoral fin muscle development which entirely consist of fast fibers (Thorsen and Hale, 2005; 
Patterson et al., 2008). It also suggests that MYHM743-2 functions in craniofacial muscles 
development which consists of both fast and slow fibers at larval stage (Hernandez et al., 2005).  
The whole mount in situ hybridization for torafugu embryos and larvae showed the MYHM743-2 
expression specific to fast-type muscle (Ikeda et al., 2007). The orthologous genes of MYHM743-2 
have been also reported to be expressed only in fast muscle of common carp (Nihei et al., 2006), 
zebrafish (Xu et al., 2000) and medaka embryos (Ono et al., 2006). While the injected P2075 
showed EGFP expression in both fast and slow muscle fibers of larvae as revealed by 
immunohistochemical analysis, zebrafish larvae from the stable transgenic line expressed EGFP 
in fast muscle fibers only. Finally, we can say that expressions directed by the 2,075 bp 
5’-flanking region of torafugu MYHM743-2 in skeletal, craniofacial and pectoral fin muscles in 
zebrafish is consistent with its endogenous expression patterns in torafugu. Taken together, these 
data suggest that this region of torafugu MYHM743-2 is sufficient for muscle-specific expression in 
zebrafish. 
2.4.2 SRF-like binding sites as a critical element of MYHM743-2 promoter activity 
SRF is a transcription factor, which binds to a serum response element associated with a variety 
of genes including muscle-specific genes such as those encoding actin and MYH. By regulating 
the expression of these muscle-specific genes, SRF controls muscle development and function 
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(Camoretti-Mercado et al., 2003; Miano, 2003). It binds to the 10 bp sequence CArG box 
[CC(A/T)6GG], a regulatory element identified in many muscle-specific genes (Miano, 2003). In 
this study, we revealed that the minimum 468-bp basal promoter drove EGFP expression in the 
myotomal compartment and suggested that the 20 nucleotides spanning from 468 to 449 bp and 
containing a SRF-like binding site may be required for MYHM743-2 expression. The predicted 
SRF-like binding site within this 20 bp basal promoter contained a CArG-like box that differed 
from the consensus sequence by two nucleotides (CCTGTGAATATAAGGACCCC, with bold 
face for CArG-like box and differing nucleotides underlined). Mutations in the central core 
sequence (TATA→TGGA) of this SRF-like binding site completely eliminated MYHM743-2 
expression in the myotomal compartment, suggesting that this SRF-like binding site was 
necessary for mediating the minimum basal expression of MYHM743-2. In general, no insertions or 
deletions are allowed in the central AT core as this would disrupt the planar topology of the G 
base and alter the inherent bending of the CArG element that appears critical for SRF binding 
(Pellegrini et al., 1995). Substitutions with C or G are best tolerated at the first and last positions 
of the AT core whereas similar substitution at the middle severely impaired SRF binding (Leung 
and Miyamoto, 1989; Hautmann et al., 1998; Miano et al., 2000). A very recent study reported 
that a single nucleotide difference (at 8th base pair position) in CArG motif of human MyHC-IIb 
sequence greatly reduced or abolished SRF binding (Harrison et al., 2011). Therefore, further 
studies are needed to confirm whether the difference at 1st and 2nd base pair position (TG in stead 
of CC) in the CArG motif of 486-bp promoter alters the SRF binding.  
A considerable progress has been made in elucidating the role of SRF underlying the 
transcriptional regulation of muscle-specific expression of MYH in mammals. A previous study 
showed that a CArG-like box (SRF binding site) residing in the -120 to -80 bp promoter region 
act as an enhancers of MyHC-IIb transcriptional activity predominantly in fast muscle of adult 
mice (Allen et al., 2005). In silico analysis combined with deletion and site-directed mutagenic 
analyses revealed that the low transcriptional activity of human MyHC-IIb is largely the result of 
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reduced SRF binding within the proximal promoter region (Harrison et al., 2011). Deletion 
studies using transgenic mice demonstrated that multiple SRF binding sites were involved in the 
expressional regulation of the smooth muscle-α actin gene (Mack and Owens, 1999). Functional 
analyses also indicated a major role of SRF in skeletal muscle fiber growth and maturation in 
mice (Arsenian et al., 1998; Li et al., 2005). Consistent with all of these studies, we revealed that 
deleting all three SRF-like binding sites together significantly reduced EGFP expression in 
myotomal compartments. This data argue that SRF-like binding sites participate in the 
transcriptional activity of MYHM743-2 expression. Although the role of SRF in transcriptional 
control of MYH expression has been reported in mammals (Allen et al., 2005; Harrison et al., 
2011), the combined deletion and mutation analyses in this study provided the new insight that 
SRF binding sites within the upstream promoter regulate the transcriptional activity of MYH in 
fish too. 
2.4.3 MyoD and MEF2 binding sites participate in MYHM743-2 transcriptional 
activity in skeletal muscle 
Members of MRF (MyoD, myogenin, myf5, and MRF4) and MEF2 have all been shown to 
regulate the transcription of numerous muscle-specific genes. The transcriptional regulation of 
these genes is often correlated with the presence of DNA consensus sequences in the regulatory 
region like E box (CANNTG) and AT rich sequence [(C/T)TA(T/A)4TA(A/G)]. In this study, 
deleting multiple MyoD and/or MEF2 binding sites together significantly reduced EGFP 
expression in myotomal compartments of fish. These findings argue that E box to bind MyoD 
family and AT rich sequences to bind MEF2 may regulate MYHM743-2 expression in skeletal 
muscles. The 5’-flanking region in three adult fast skeletal MYHs of mouse was found to have 
cis-elements such as MEF2 binding site, E-box and NFAT binding site (Lakich et al., 1998; 
Swoap, 1998). Members of the MRF and MEF2 families of myogenic transcription factors 
appear to be necessary for high level, muscle-specific expression of MYH-IIb, whereas NFAT 
preferentially activates the MYH-IIa promoter. It was also shown that the expression of common 
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carp fast skeletal MYH, named FG2, required the sequence in the 5’-flanking region between 
-901 to -824 bp, which contained both E box and MEF2 binding site (Gauvry et al., 1996). 
Previous studies also reported that MEF2 binding sites are crucial for a temperature-dependent 
expression of MYHs in medaka and common carp (Kobiyama et al., 2006; Liang et al., 2008). 
Functional analysis also indicated a major role of MyoD and Myf5 for fast muscle myogenesis in 
individual somites in zebrafish (Hinits et al., 2009). All of these studies indicate that MyoD and 
MEF2 binding sites are involved in the transcriptional regulation of MYHs expression in fish and 
mammals. It should be noted that deleting all MyoD and/or MEF2 binding sites in the torafugu 
MYHM743-2 regulatory region did not completely abolish its activity in directing EGFP expression 
in skeletal muscles, suggesting that other regulatory element(s) might be involved in its 
expression. Regulation of muscle specific MYHs expression by multiple regulatory sequences 
appears to be a common mechanism for the control of muscle-specific gene expression. 
Supporting this idea, because the deletion of −664 to −364 bp completely abolished the 
MYHM743-2 expression, it remains to be determined which cis-elements within this region regulate 
its expression in fast skeletal, craniofacial and pectoral fin muscles.  
2.4.4 MyoD also participates in the transcriptional regulation of MYHM743-2 
expression in craniofacial and pectoral fin muscles 
MyoD has an important role in abaxial pectoral fin and craniofacial muscle formation in 
zebrafish. Inactivation of Myf5 and/or MyoD leading to malformation of different populations of 
craniofacial muscles indicates distinct functions of Myf5 and MyoD during craniofacial 
myogenesis (Lin et al., 2006). Unlike most craniofacial muscles, pectoral fin muscle is somite 
derived and composed exclusively of fast fibers (Patterson et al., 2008). Hinits et al. (2009) 
showed that MyoD knockdown prevented myosin accumulation in pectoral fin buds. Therefore, 
MyoD is also the major MRF required for fast pectoral myogenesis. Because MYHM743-2 was also 
predominantly expressed in both craniofacial and pectoral fin muscles, we hypothesize that 
MyoD binding site may regulate MYHM743-2 expression in these muscles. In our observation, 
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deleting multiple binding sites of MyoD reduced EGFP expression in craniofacial and pectoral 
fin muscles. This data suggest that E-box binding to MyoD participate in MYHM743-2 expression in 
the two muscles. However, the deletion of all MyoD binding sites did not completely inhibit 
EGFP expression in these muscles, suggesting that other regulatory elements might be involved 
in the transcription regulation of MYHM743-2 expression, as in the case of skeletal muscle. Lin et al. 
(2006) showed that MyoD knockdown completely abolished red fluorescent protein (RFP) signal 
in some of the extraocular (superior rectus, medial rectus, inferior rectus, lateral rectus) and 
ventral pharyngeal muscles in the Tg (α-actin:RFP) fish, but other extraocular and dorsal 
pharyngeal muscles retained RFP with slightly reduced signals. Because of a certain level of 
mosaic problem with the transient expression assay, we did not characterize which craniofacial 
muscles are actually affected EGFP expressions by the deletion of MyoD binding sites. Further 
studies of MyoD knockdown by using MYHM743-2:EGFP transgenic fish are required for this 
purpose. This ambiguity is the next target of our research.   
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Abstract 
 
The myosin heavy chain gene, MYHM86-2, exhibited restricted expression in slow muscle fibers of 
torafugu embryos and larvae, suggesting its functional roles for embryonic and larval muscle 
development. However, the transcriptional mechanisms involved in its expression are still 
ambiguous. The present study is the first extensive analysis of slow muscle-specific MYHM86-2 
promoter in fish for identifying the cis-elements that are crucial for its expression. Combining 
both transient transfection and transgenic approaches, we demonstrated that the 2,614 bp 
5’-flanking sequences of MYHM86-2 contains a sufficient promoter activity to drive gene 
expression specific to superficial slow muscle fibers. By cyclopamine treatment, we also 
demonstrated that the differentiation of such superficial slow muscle fibers depends on hedgehog 
signaling activity. The deletion analyses defined an upstream fragment necessary for repressing 
ectopic MYHM86-2 expression in the fast muscle fibers. The transcriptional mechanism that 
prevents MYHM86-2 expression in the fast muscle fibers is mediated through Sox6 binding 
elements. We also demonstrated that Sox6 may function as a transcriptional repressor of 
MYHM86-2 expression. We further discovered that nuclear factor of activated T cells (NFAT) 
binding elements play a key role and myocyte enhancer factor-2 (MEF2) binding elements 
participate in the transcriptional regulation of MYHM86-2 expression. 
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3.1 Introduction 
Vertebrate skeletal muscle is heterogeneous tissue consisting of various types of muscle fibers 
and the fiber-type specification is crucial for muscle development. Several unique features of fish 
skeletal muscle make them an excellent model organism to study such fiber-type specification 
mechanisms. The most important feature is the anatomical separation of fiber types in contrast 
with higher vertebrates including mammals in which different types of muscle fibers form a 
mosaic within the same muscle. Fast-twitch fibers occupy a bulk of fish trunk myotomal muscle 
and are located deeply in the myotome, whereas slow-twitch fibers lie under the lateral line on 
the surface of myotome (Bone, 1978). In zebrafish fast and slow muscle cells are originated from 
different cell lineages, and the latter is differentiated at early developmental stages from adaxial 
cells, namely paraxial mesodermal cells which exist in direct contact with notochord (Devoto et 
al., 1996; Dagget et al., 2007). Adaxial cells migrate laterally from either sides of the notochord 
to the superficial part in the trunk and form slow muscle in a superficial region beneath the skin 
or remain as muscle pioneers in the horizontal myoseptum (Devoto et al., 1996; Felsenfeld et al., 
1991). These slow muscle fibers are mononuclear and span the entire length of each somite. 
Following the slow muscle formation, an undifferentiated somitic mesoderm differentiates into 
fast muscle. In contrast to slow muscle fibers, fast muscle fibers undergo fusion to generate 
multinucleated fibers. 
Terminal differentiation and specification of various types of muscle cells require expression of 
specific myosin heavy chain (MYH) isoforms. Recent development of genome databases has 
revealed that MYH genes (MYHs) consist of multigene family in the vertebrate genome (Weiss 
and Leinward, 1996). Among MYHs family members in fish, specific MYHs are expressed during 
embryonic and larval development. These lines of information indicate that the expression of 
MYHs contributes to the formation of specific muscle-fiber types during development of fish. 
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Therefore, expressional regulation of MYHs is critical for terminal differentiation of various types 
of muscle fibers, molecular basis of the complex expression of MYHs is still ambiguous. 
The torafugu Takifugu rubripes genome has been proposed as a model for rapid characterization 
of vertebrate genes due to its smallest size among vertebrates (Brenner et al., 1993). Our 
laboratory members have investigated the genomic organization of sarcomeric and 
non-sarcomeric MYHs of torafugu by in silico analysis of the total genome database, revealing 
that it contains 20 sarcomeric MYHs which are organized in different clusters (Watabe and Ikeda, 
2006; Ikeda et al., 2007). Detailed expression analysis by our laboratory members showed the 
strictly regulated spatial and temporal expression patterns of MYHs in torafugu musculature 
(Akolkar et al., 2010). Comprehensive in silico analysis of torafugu genome revealed that there 
are two paralogous isoforms of MYHM86, MYHM86-1 and MYHM86-2 (Ikeda et al., 2007). Recently, it 
was demonstrated that MYHM86-1 was predominantly expressed in fast muscle fibers with different 
diameters in adult torafugu (Akolkar et al., 2010). In contrast, MYHM86-2 exhibited restricted 
expression in slow muscle fibers of torafugu embryos and larvae only (Asaduzzaman et al., 2013). 
However, transcriptional regulatory mechanisms involved in the spatio-temporal expression of 
MYHM86-2 have remained unknown. 
Skeletal muscle cell differentiation is coordinated by endocrine, paracrine, and autocrine 
inductive factors that activate discrete intracellular signal transduction pathways, resulting in the 
modulation of transcription factor activity and the reprogramming of gene expression. The 
myogenic regulatory factors (MRF) family of transcriptional activators (Bergstrom et al., 2002; 
Berkes and Tapscott, 2005) and the myocyte enhancer factor-2 (MEF2) family of transcription 
factors (Berkes and Tapscott, 2005; Jordan et al., 2004) are believed to underlie the expression of 
most of muscle specific genes. Another pathway postulated as having a regulatory role in fiber 
type-specific gene expression is the calcineurin-NFAT (nuclear factor of activated T cells) 
pathways (Chin et al., 1998). MEF2 is also activated by calcineurin as well as by 
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calcium-calmodulin kinase and may activate transcription of some slow fiber-specific genes (Wu 
et al., 2000, 2001). Sox6, a member of the Sox family of transcription factors, is a multi-faceted 
transcription factor involved in the terminal differentiation of fetal skeletal muscle during 
myogenesis (Higawara et al., 2007). The transcriptional activities of MYHs have been extensively 
investigated on fast skeletal MYHs in fish (Gauvry et al., 1996; Kobiyama et al., 2006; Liang et 
al., 2008; Asaduzzaman et al., 2011). However, it is still far from comprehensive understanding 
of the transcription factors functioning in the regulation of slow-type MYHs expression in fish. 
To the best of our knowledge, this is the first report on the transcriptional regulation of 
exclusively slow muscle-specific MYH expression in fish by transient transfection and transgenic 
approaches.  
In the present study, we examined transcriptional regulatory mechanism of a torafugu slow 
muscle-specific MYH, named MYHM86-2. Combined analysis of torafugu genome data and 
transgenic approach in zebrafish successfully retrieved promoter-containing sequences which 
were sufficient for slow muscle-specific gene expressions. We established a stable transgenic 
zebrafish line that expresses EGFP in slow muscle fibers under the control of a MYHM86-2 
promoter. The deletion analyses defined an upstream fragment necessary for repressing ectopic 
MYHM86-2 expression in the fast muscle fibers. We demonstrated that Sox6 may function as a 
transcription suppressor of MYHM86-2 expression, and described an important Sox6 mediated-fast 
muscle-specific repression mechanism for governing slow muscle-specific expression. We 
further discovered that NFAT binding elements play a key role for directing MYHM86-2 expression 
in slow muscle fibers and demonstrated that MEF2-binding elements participate in the 
transcriptional regulation of MYHM86-2 expression. 
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3.2 Material and Methods 
3.2.1 Experimental fish 
Embryos and larvae of torafugu at different developmental stages were reared and different 
tissues of adult fish were collected as described in section 2.2.1 of Chapter 2. Zebrafish embryos 
and adult fish were also reared and maintained as described in section 2.2.1 of Chapter 2.  
3.2.2 Reverse transcription, amplification and sequence determination 
Total RNAs were prepared from whole embryos from 1 to 8 dpf and larvae at 10 and 16 dpf, and 
various tissues of adult torafugu by using ISOGEN (Nippon Gene, Tokyo, Japan). 5 µg of total 
RNAs were reverse-transcribed by using oligo-dT primer (Akolkar et al., 2010) and superscript 
reverse transcriptase IIITM (Invitrogen, Carlsbad, CA, USA) according to the manufacturer’s 
instructions. 3’-rapid amplification of cDNA ends (RACE)-PCR was performed to determine the 
nucleotide sequence at the 3’-untranslated region (UTR) of MYHM86-2 by using a specific forward 
primer 5’-GGA AGC TGA CCT CGT CCA GGT T-3’ and an adapter primer 5’-CCA GTG AGC 
AGA GTG ACG-3’. The amplified DNA fragments were sub-cloned and sequenced by the 
method described in section 2.2.2 of Chapter 2.  
RT-PCR was performed to examine the expression of MYHM86-2 by using gene specific forward 
primer 5’-CAT GTC CAG GCT GAG GAA GGT TCA -3’ and reverse primer 5’-GCA GTA 
AAA CGG TTT ATT GAG AT-3’ based on the nucleotide sequences in 3’ UTR. The transcript 
of torafugu β-actin (U38849) was used as the internal control for RT-PCR. 
3.2.3 In situ hybridization  
The cDNA fragment of about 250 to 300 bp which contained 3’UTR nucleotide sequences and 
those encoding a C-terminal part of MYHM86-2 was amplified and subcloned into pGEM-T vector 
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(Promega). Digoxigenin (DIG)-labelled antisense riboprobes were synthesized using T7 and SP6 
RNA polymerases (Roche Applied Science, Mannheim, Germany) according to the 
manufacturer’s instructions. In situ hybridization was performed in embryos at 4 dpf and on 
transverse sections (16 µm thickness) for larvae at 16 dpf and juveniles (4.5 g bodyweight) of 
torafugu by the method of Darby et al. (2006). Samples were rehydrated with 75% 
methanol/phosphate buffered-saline with 0.1% tween 20 (PBSTw), 50% methanol/PBSTw and 
25% methanol/PBSTw consecutively at room temperature for 5 min each. Subsequently, the 
samples were washed for 5 min twice in PBSTw. Then the samples were permeabilized with 
proteinase K (Takara) at room temperature for a time period depending on the developmental 
stages. After several rinses in PBSTw and re-fixation in 4% PFA, the samples were completely 
dehydrated before hybridization with riboprobes. Hybridization was performed in a humidified 
incubator at 58°C for at least 16 h followed by two high-stringency washes for 30 min in 2 x 
saline-sodium citrate (SSC) and two rinses in 1xSSC at the same temperature, respectively. 
Unhybridized probes were removed after incubation with RNase A in solution containing 0.01 M 
Tris-HCl (pH 8.0) and 0.5 M NaCl at 58°C for 30 min, followed by two washes in 0.1xSSC for 
30 min each at room temperature. Then the samples were blocked with 2% blocking solution for 
60 min at room temperature. Blocking buffer was replaced with a solution containing alkaline 
phosphatase-conjugated anti-DIG antibody (1: 2000 in blocking solution) (Roche Applied 
Science) for 1 h at room temperature. Unbound DIG antibodies were removed after six washes in 
PBSTw for 15 min each followed by incubation with a staining buffer containing 0.1 M NaCl, 
1.1 M Tris-HCl (pH 9.5) and 0.05 M MgCl2 three times for 5 min each. Finally the samples were 
stained with nitroblue tetrazolium (NBT) and 5-bromo-4-chloro-3-indoyl-phosphate (BCIP) 
(Roche Applied Science) for detection of riboprobes. The serial tissue sections were examined 
with a stereomicroscope MVX10 (Olympus, Tokyo, Japan).  
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3.2.4 Immunohistochemical analysis 
For immunohistochemistry, larvae were fixed with 4% PFA in Tris-buffered saline (25 mM Tris, 
137 mM NaCl, 2.7 mM KCl, pH 7.4) containing 0.1% Tween 20 (TBSTw) overnight at 4°C. 
Transverse sections were prepared at a thickness of 16 µm with a cryostat Tissue-Tek Cryo3 
(Sakura Finetech) at −20°C before the first immunoreactions. Immunohistochemical analysis was 
carried out by the method described in section 2.2.11 of Chapter 2.  
3.2.5 Bioinformatics 
The nucleotide sequence of MYHM86-2 determined by 3’RACE was used to identify the genomic 
sequence of MYHM86-2 using ensemble genome browser (http://www. ensembl.org). MyoD and 
MEF2 binding elements in the 2614 bp 5'-flanking region of MYHM86-2 were predicted by 
MatInspector, V7.1 (http://www.genomatix.de).  Putative Sox6 binding sites based on sequence 
(A/T)(A/T)CAA(A/T)G (Cantu et al., 2011) and NFAT binding site based on core sequence 
GGAAA or TTTCC (Latinis et al., 1997) were manually screened in the 2614 bp 5′-flanking 
region of torafugu MYHM86-2. 
3.2.6 Construction of reporter vectors 
The 5’-flanking sequences of different length (5500 bp, 5000 bp, 3750 bp, 2614 bp, 2000 bp and 
1500 bp) from the start codon in MYHM86-2 were amplified with specific primers and the genomic 
DNA as a template. A total of 6 forward primers and a common reverse primer were designed to 
amplify these fragments (Table 3-1). The constructs were prepared and plasmid DNA for 
microinjection was isolated by the method as described in section 2.2.7 of Chapter 2. Each of 
these constructs contained a specific MYHM86-2 promoter region, EGFP, and SV40 polyA signal. 
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Table 3-1: Nucleotide sequences of oligonucleotide primers used in the generation of 5’-distal 
deletion construct of MYHM86-2 
 
Experiment Primer name Nucleotide sequence (5’----------3’) Length 
(bp) 
 
Generation of 
deletion 
constructs 
P5500F CAGCAGCAAGAATAGAAAGA GTCG 24 
P5000F CCAAGAAGAAAGAACTGGAGGAG 23 
P3750F TTCACGGATGACAAAGGGGCTTTG 24 
P2614F CAACGTGTGTTTGGATGAGTTAATG 25 
P2000F GACACATACACACGTGGGTCACACA 25 
P1500F CAGTTGACAGATCCTTCACTTAT 23 
Reverse GATGGCACCTTAGGATACTGAAAG 24 
 
3.2.7 Generation of MYHM86-2: EGFP transgenic zebrafish line 
To generate the stable transgenic line, the Tol2-based construct (P2614) of MYHM86-2 was 
co-injected with transposase mRNA into one- to two-cell staged embryos. The stable transgenic 
line of MYHM86-2: EGFP was generated by the method described in section 2.2.8 of Chapter 2.  
3.2.8 Generation of deletion constructs of various cis-elements 
Inverse PCR-based site-directed mutagenesis technique was used to generate the deletion 
constructs of Sox6, NFAT, MyoD and MEF2 binding sites. Specific forward and reverse primers 
were designed for the individual deletion each of Sox6, NFAT, MyoD and MEF2 binding sites 
(Table 3-2). The individual and multiple deletion constructs of various cis-elements from 
5’-flanking region of MYHM86-2 were generated by the method described in section 2.2.9 of 
Chapter 2.  
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Table 3-2: Nucleotide sequences of oligonucleotide primers used in the generation of deletion 
constructs of various cis-elements from P2614 constructs of MYHM86-2 
 
Expt. Primer name Nucleotide sequence (5’----------3’) Length  
MyoD 
binding 
site 
deletion 
P2614∆MyoD-1F GTTTACTGTCATGCATTATTGTCAAG 26 
P2614∆MyoD-1R TCCCTGTCCCTGGTGACAATAG 22 
P2614∆MyoD-2F GCTATAAATTTGGACACAAGGAG 23 
P2614∆MyoD-2R ACATTATAGTTTTAATATACACAGTTG 27 
MEF2 
binding 
site 
deletion 
P2614∆MEF2-1F 
ATTTTTTGTATTACACAATTAAACACCAAT
TAT 
33 
P2614∆MEF2-1R 
TAAATTTTGTTCAGTTTAAATTAACTTTATT
TATTTA 
37 
P2614∆MEF2-2F AGGGGTACTTTGACCTTCCCTGA 23 
P2614∆MEF2-2R 
TTGTGAATACTTGAAATGTCTGAATATAAT
TG 
23 
P2614∆MEF2-3F 
TTATATACATGTATAATTTATTTTACATGTA
TATACA 
37 
P2614∆MyoD-3R TAAATAGAGGACAAATATAAAAGTGCC 27 
NFAT 
binding 
site 
deletion 
P2614∆NFAT-1F GAACTGCCTAAATATGTACTGTGC 24 
P2614∆NFAT-1R ATTTATTACAGTAAGAGGCAGATTTC 26 
P2614∆NFAT-2F TTTATTGAAGAACAAAGGCCAAGC 24 
P2614∆NFAT-2R TGACCTTGTTGAATGTCACCTGT 23 
P2614∆NFAT-3F AAAACCATATTCTGTTGCCTCTCG 24 
P2614∆NFAT-3R AAGCACATAAATGTCAGGGGTTTA 24 
P2614∆NFAT-4F TTTTTCAATCCAACAAGGTGTGGA 24 
P2614∆NFAT-4R ACACATCACACGGTACAAATGAAT 24 
  
Sox6 
binding 
site 
deletion  
P2614∆Sox6-1F GCCAAGCAATAATATGTGGTAAATTTAG 28 
P2614∆Sox6-1R CTTCAATAAAGGAAATGACCTTGTTG 26 
P2614∆Sox6-2F TTGTATTTATTTATTGAAACAAGCAGTTG 29 
P2614∆Sox6-2R AATGATCTTCAGAGTTATTAATTCTAAAC 29 
P2614∆Sox6-3F TAATCATGAAACAATGAGACAACATG 26 
P2614∆Sox6-3R GAGGTAGGTTTTGAATTAATGTAAATG 27 
P2614∆Sox6-4F AGACAACATGAGATGCATGTAGTG 24 
P2614∆Sox6-4R TCATGATTACATTGTAGAGGTAGGTT 26 
P2614∆Sox6-5F AAAATCCCTTCTTTCAGTATCCTAA 25 
P2614∆Sox6-5R AAAAATGTCTCTGCTATTTATTTCATTAT 29 
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3.2.9 Microinjection 
To perform microinjection, fertilized eggs of zebrafish were collected at 15-30 min after 
fertilization from the zebrafish rearing facility in the Department of Aquatic Bioscience. In 
microinjection, each EGFP reporter construct was diluted at 50 ng/mL with sterile distilled water 
containing 0.025% phenol red and introduced into fertilized eggs at the one to two-cell stage. 
Embryos were reared at 28 °C, and subjected to observation of EGFP expression patterns during 
development at the interval of every 24 h. The fluorescence derived from transgenes in embryos 
and larvae during development was observed with a MVX10 macro-zoom microscope (Olympus) 
and a FV1000 confocal laser scanning microscope (Olympus). Older embryos were anesthetized 
with 0.6 μM tricaine methyl sulfonate (Sigma-Aldrich) to inhibit movement during observation.  
3.2.10 Cyclopamine treatment 
Fertilized eggs of MYHM86-2: EGFP stable transgenic zebrafish line were obtained by crossing 
matured heterozygous F1 transgenic fish. Transgenic embryos at 2-4 cell stages were transferred 
into 2.5, 5 and 10 μg ml-1 cyclopamine solution (Wako, Osaka, Japan) containing 0.25, 0.5 and 
1% ethanol and incubated at 28.5 °C. Control embryos for 2.5, 5 and 10 μg ml-1 cyclopamine 
treatment were developed in 0.25, 0.5 and 1% ethanol, respectively, containing water without 
cyclopamine. EGFP expressions in cyclopamine treated and untreated control embryos were 
observed from 1 dpf to 5dpf. 
3.2.11 Real-time PCR analysis 
For relative quantification, the reaction was performed in a total volume of 20 μl, containing 10 
μl 2×SYBR premix ExTaqII kit (Takara), 10 μm each of primers, 1 μl diluted template cDNA 
(about 10 ng) and 0.4 μl ROX reference dye. Real-time quantitative PCR was performed with an 
ABI Prism 7300 Sequence Detection System (Applied Biosystems). PCR consisted of 
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pre-incubation at 50 °C for 2 min and denaturation at 95 °C for 10 min, followed by 40 cycles of 
denaturation at 95 °C for 15 s and annealing and extension at 60 °C for 1 min. The samples were 
analyzed in triplicates. A housekeeping gene encoding β-actin (NM_131031) was selected as 
reference for the relative expression levels of target genes, which were calculated using the 
comparative CT difference method (Schmittgen and Livak, 2008). Primers used in real-time PCR 
for EGFP are listed in Table 3-3. 
 
Table 3-3. Nucleotide sequences of oligonucleotide primers used in real-time PCR analysis 
 
Primer name Nucleotide sequence (5’----------3’) Length (bp) 
EGFP -Forward AGC AAA GAC CCC AAC GAG AA 20 
EGFP-Reverse GCG GCG GTC ACG AAC TC 17 
β-actin-Forward TGC TGT TTT CCC CTC CAT TG 20 
β-actin-Reverse TCT GTC CCA TGC CAA CCA T 19 
 
3.2.12 Statistical analysis 
To compare the percentages of embryos with EGFP expression in superficial slow muscles for 
various constructs and relative quantification of target gene, statistical analyses were conducted 
using one-way analysis of variance (ANOVA) followed by Tukey's test in Statistical Package for 
Social Science (SPSS) version 14 (SPSS Inc., IL, USA). Data were represented as the mean ± SE 
and the differences were considered significant at P<0.05. 
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3.3 Results 
3.3.1 MYHM86-2 expression is restricted to slow muscle fibers in torafugu embryos and larvae 
In silico analysis of torafugu genome showed that MYHM86 encodes two paralogous 
muscle-specific isoforms, MYHM86-1 and MYHM86-2 (Ikeda et al., 2007). Previously we 
demonstrated that MYHM86-1 was predominantly expressed in fast muscle fibers with different 
diameters in adult torafugu (Akolkar et al., 2010). RT-PCR using highly specific primers 
synthesized on the basis of the 3’UTR sequences of MYHM86-2 revealed its expression in 
developmental stage-dependent and tissue-specific manners (Fig. 3-1A-E). The transcripts of 
MYHM86-2 appeared in embryos at 4 dpf and continued to be expressed in later embryonic and 
larval development stages (Fig. 3-1A). However, no transcripts of MYHM86-2 were detected in 
adult muscles, suggesting their important role in embryonic and larval muscle development of 
torafugu. The in situ hybridization for torafugu embryos at 4dpf (Fig. 3-1B-C) and larvae at 16 
and 10 dpf (Fig. 3-1D-E) confirmed that the expression of MYHM86-2 was restricted to slow and 
pectoral fin muscles. Thus, an expression pattern of MYHM86-2 was in a marked contrast to its 
previously reported adult fast-type paralogous gene, MYHM86-1 (Akolkar et al., 2010). 
 
 
 
 
 
 
 
 
Fig. 3-1: Endogenous expression patterns of MYHM86-2 in torafugu. A) In contrast to MYHM86-1, 
MYHM86-2 expression was restricted to embryonic and larval stages. B-E) In situ hybridization 
showing the transcripts of MYHM86-2 were localized at superficial slow muscle in torafugu 
embryos at 4dpf (B,C) and larvae at 16 dpf (D) and pectoral fin muscles in larvae at 10 dpf (E) 
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3.3.2 Slow muscle specificity of the torafugu MYHM86-2 promoter 
In situ hybridization study showed that MYHM86-2 is highly expressed in slow muscle fibers and 
pectoral fin muscles of torafugu embryos and larvae (Fig. 3-1B-E). To examine whether or not 
the 5’-flanking sequence of torafugu MYHM86-2 would function similarly in zebrafish, we 
constructed a reporter vector containing the 2,614 bp 5’-flanking region of MYHM86-2 fused to the 
open reading frame (ORF) of EGFP in pT2AL200R150G vector. The resultant gene construct, 
P2614, was microinjected into one- to two-cell zebrafish embryos for transient EGFP expression 
analysis. The EGFP expression in injected embryos was monitored by direct observation under 
fluorescence microscope. Over 93% (n=113) of the injected embryos exhibited EGFP expression 
at 1 dpf in the somite formation stage (Fig. 3-2A). After hatching at 2 dpf, EGFP continued to be 
expressed in the whole myotomal region of larva (Fig. 3-2B-C). In addition to the myotomal 
muscle expression, EGFP expression was also detected in pectoral fin muscles at 4 dpf (Fig. 
3-2D). However, a very few embryos showed ectopic EGFP expression in cardiac muscles (data 
not shown). Immunohistological observations were conducted to clarify types of muscle fibers 
that express EGFP. EGFP-expressing embryos were stained with F310 (Crow et al., 1986) and 
F59 (Crow et al., 1986; Devoto et al., 1996) monoclonal antibodies specific to fast-type myosin 
light chain and slow-type MYHs, respectively. EGFP-expressing muscle fibers of P2614-injected 
larvae were contained in only slow types as reacted with F59 antibody (Fig. 3-2E-F) but not in 
the fast types as EGFP expressing muscle fibers did not react with F310 antibody (Fig. 3-2G). 
Therefore, the observed EGFP expression of transient analysis in zebrafish embryos was 
consistent with the endogenous MYHM86-2 expression in torafugu embryos and larvae. These data 
confirmed that the 2,614 bp 5’-flanking region of torafugu MYHM86-2 contained the essential 
regulatory sequences for slow muscle-specific expression. 
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3.3.3 Characterization of MYHM86-2 expression using MYHM86-2: EGFP transgenic 
zebrafish 
To confirm the slow muscle-specificity of the 2,614 bp 5’-flanking sequence of MYHM86-2, we 
next attempted to establish a stable transgenic zebrafish line carrying the MYHM86-2: EGFP 
transgene. For this purpose, we used the Tol2 transposon vector system (Kawakami et al., 2000, 
2004). In this method, the P2614 construct was co-injected with transposase mRNA, which was 
transcribed from pCS-TP vector. Superficial slow muscle-specific EGFP-expressing embryos 
were selected and raised to adulthood. Stable muscle-specific EGFP-expressing zebrafish line 
(F1) was established from 24 founders tested. In F2 offspring, 48-50% embryos carried 
muscle-specific EGFP expression by outcrossing F1 fish with wild-type fish. All of the F1 
transgenic line fish were mated, producing normal offspring. The temporal and spatial EGFP 
expression was analyzed in this transgenic line. Similarly with the transient transgenic assay, 
stable transgenic line embryos showed EGFP expression at 1 dpf (Fig. 3-2H). After hatching at 2 
dpf, EGFP continued to be expressed in the whole myotomal region of larva (Fig. 3-2J-L). The 
observation with a fluorescent microscope also confirmed that zebrafish expressed EGFP in 
pectoral fin muscles at 3 dpf (Fig. 3-2I). To further confirm that the EGFP-expressing muscle 
fibers are indeed slow types, we performed the immunohistochemical analysis as reported 
previously. The EGFP-expressing muscle fibers of stable transgenic line larvae were found only 
in the slow type (Fig. 3-2M-N) but not in the fast type (Fig. 3-2O-P). The observed EGFP 
expression in the stable transgenic line zebrafish embryos and larvae was consistent with the 
expression pattern of P2614-injected zebrafish embryos and larvae, and endogenous expression 
of MYHM86-2 in torafugu embryos and larvae. Taken together, these data suggest that the 2,614-bp 
5’-flanking region contained the necessary regulatory elements for MYHM86-2 expression in slow 
and pectoral fin muscles. 
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Fig. 3-2: The consistent expression patterns of P2614 with MYHM86-2:EGFP transgene in stable 
transgenic line embryos and larvae of zebrafish. A-D) EGFP expression patterns of P2614 in 
whole myotomal region of embryo (A) and larva (B,C) and in pectoral fin (D). C) Indicates a 
higher magnification view of the expressed transgene. E-G) EGFP-expressing muscle fibers in 
P2614-injected larvae consisting of only superficial slow types as reacted with F59 antibodies (E, 
lateral view; F, transverse section) but not fast types (G, transverse section). H-L) EGFP 
expression patterns of MYHM86-2:EGFP in whole myotomal region of stable transgenic line 
embryos (H) and larva (J,K,L) and in pectoral fin muscles (I). (K) and (L), indicates a higher 
magnification view of the expressed transgene in trunk and posterior regions, respectively. M-P) 
EGFP expressing muscle fibers in MYHM86-2:EGFP stable transgenic larvae consisting of only 
superficial slow types (M,N) but not fast types (O,P). (N) and (P) are the magnified view of the 
boxed area of (M) and (O), respectively. Arrowheads indicate EGFP expression in superficial 
slow muscle fibers. Green colors indicate EGFP expression, red colors indicate slow (for F59) or 
fast (for F310) muscle fibers and merge (yellow) indicate EGFP expression in superficial slow 
muscle fibers. Scale bars: 100 μm in A,B,H,J and 20 μm in others. 
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3.3.4 MYHM86-2 promoter activity depends on the hedgehog signaling 
Hedgehog signaling is important for slow muscle development in vertebrates. In zebrafish, 
adaxial cells differentiate into slow muscle cells by receiving hedgehog signaling. To further 
characterize EGFP expression in slow muscle fibers of MYHM86-2: EGFP transgenic fish, we 
examined the involvement of hedgehog signaling pathway, a positive regulator of adaxial cell 
differentiation, in MYHM86-2 expression using cyclopamine, a well-known hedgehog signaling 
inhibitor (Incardona et al., 1998; Chen et al., 2002). The stable transgenic line embryos were 
treated with three different concentrations (2.5, 5 and 10 µg/ml) of cyclopamine where no change 
was observed in the survival rate of embryos. By treatment with cyclopamine, zebrafish embryos 
showed fused-eye, a representative phenotype by hedgehog signaling inhibition (Fig. 3-3A-B). 
Depending on the dose, cyclopamine treated embryos showed reduced or complete elimination of 
EGFP expression in slow muscle fibers (Fig. 3-3C-G). The rate of embryos at 2dpf expressing 
MYHM86-2: EGFP transgene in slow muscle fibers was significantly decreased after cyclopamine 
treatment and found to be only 4.0% (2.5 µg/ml) and 2.5% (5 µg/ml) compared to 92% in those 
without treatment (Fig. 3-3H). However, the stable transgenic line zebrafish embryos treated with 
10 µg/ml cyclopamine showed complete inhibition of MYHM86-2: EGFP transgene expression (Fig. 
3-3H), indicating that hedgehog signaling pathways control differentiation of slow muscle fibers 
where the MYHM86-2 promoter works. 
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Fig. 3-3: Hedgehog signaling and MYHM86-2 promoter activities. A-G) Inhibition of the hedgehog 
signaling by cyclopamine treatment on the transgene EGFP expression. Stable transgenic line 
(MYHM86-2:EGFP) zebrafish embryos at 2-4 cell stages were transferred into 2.5, 5 and 10 μg/ml 
cyclopamine containing 0.25, 0.5 and 1% ethanol. Control embryos were developed in 0.25, 0.5 
and 1% ethanol containing water without cyclopamine. A,B) Ventral views of head of zebrafish 
embryo. Inhibition of hedgehog signaling caused fused eye phenotype (B). C,E) Lateral views 
showing control embryos at 1 dpf (C) and larvae at 2 dpf (E) displayed normal EGFP expressions 
in superficial slow muscle fibers. F) Lateral view showing reduced (only few fibers) EGFP 
expression in larvae treated with 2.5 μg/ml cyclopamine. D,G) Lateral views showing complete 
inhibition of EGFP expression in embryos at 1 dpf (D) and larvae at 2 dpf (G) treated with 10 
μg/ml cyclopamine. H) The rate of transgenic embryos expressing the MYHM86-2: EGFP 
transgene in larvae at 2dpf with and without cyclopamine treatment. Scale bars: 100 μm.  
 
3.3.5 Characterization of key upstream fragments in the MYHM86-2 promoter 
To identify the key regulatory regions for the slow muscle-specific expression, we performed a 
deletion analysis within the 5.5-kb 5’-flanking region of MYHM86-2. A series of constructs 
containing progressive deletion from the 5’-end of the 5.5-kb fragment were generated and 
analyzed by transient expression in zebrafish embryos. The resulting six deletion constructs 
(P5500, P5000, P3750, P2614, P2000 and P1500) contained fragments of 5,500, 5,000, 3,750, 
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2,614, 2,000 and 1500 bp, respectively, which were fused to EGFP and SV40 polyA signal in 
pT2AL200R150G vector. Deleting the 5’-flanking region up to -2614 bp upstream of the 
MYHM86-2 promoter had no or marginal effect on the activity and slow muscle-specificity of the 
promoter (Fig. 3-4A-H, 3-5). EGFP expression remained strong and specific in slow and pectoral 
fin muscles. However, deleting the 5’-flanking region from -2,614 to -2,000 bp upstream of the 
MYHM86-2 promoter resulted in significant reduction of EGFP expression in slow muscle fibers 
(Fig. 3-4I-J, 3-5). This finding indicates that cis-acting element(s) in between -2,614 to -2,000 bp 
5’-flanking region may participate in the transcriptional regulation of MYHM86-2 expression. 
Interestingly, deleting the 5’-flanking region from -2,000 to -1,500 bp upstream of the MYHM86-2 
promoter resulted in ectopic EGFP expression in fast muscle fibers (Fig. 3-4K-L). Such ectopic 
EGFP expression in the fast muscle fiber was further confirmed by immunohistochemical 
analysis using the F310 monoclonal antibody specific to fast-type myosin light chain (Fig. 3-4M). 
Therefore, the deletion analysis defined an upstream fragment necessary for repressing ectopic 
MYHM86-2 expression in the fast muscle fibers. It also suggests that the cis-element(s) located 
between -2,000 to -1,500 bp upstream of the MYHM86-2 promoter mediate the transcriptional 
mechanism that prevents its expression in fast muscle fibers. 
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Fig. 3-4: Effects of torafugu MYHM86-2 promoter deletions on transgene EGFP expression in the 
superficial slow muscle fibers of zebrafish larvae at 2dpf. A-J) EGFP expression in superficial 
slow muscle fibers of zebrafish embryos injected with a series of distal promoter deletion 
constructs that contain the 5500 bp (A,B), 5000 bp (C,D), 3750 bp (E,F), 2614 bp (G,H) and 
2000 bp (I,J) 5’-flanking sequences. All panels in the right side are the magnified view of boxed 
areas of the left side panels. K-M) Deleting the 500 bp (-2000/-1501) of 5’-flanking region of the 
MYHM86-2 resulted in ectopic EGFP expression in fast muscle fiber. M) Immunohistochemistry 
confirming the ectopic EGFP expression in the fast muscle fiber as reacted with F310 antibody 
(an arrowhead). L,M) A higher magnification of the boxed region in (K). Arrowheads indicate 
EGFP expressing fast muscle fibers. Scale bars: 100 μm. 
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Fig. 3-5: Effects of torafugu MYHM86-2 promoter deletions on the number of muscle fibers 
expressing transgene EGFP in the superficial slow muscle fibers of zebrafish larvae at 2dpf. 
 
3.3.6 MYHM86-2 promoter harbors fast muscle-specific repression elements to govern 
slow muscle-specific expression 
During deletion analysis, careful examination of zebrafish embryos injected with P1500 
constructs revealed that approximately 70-80% embryos had ectopic EGFP expression in fast 
muscle fibers (Fig. 3-4K-M). On the other hand, nonspecific EGFP expression in fast muscle 
fibers was typically observed in less than 10% of embryos injected with other deletion constructs 
(P5500, P5000, P3750, P2614 and P2000), suggesting that the fast muscle-specific ectopic EGFP 
expression is sequence specific, possibly due to regulatory cis-elements in the MYHM86-2 promoter. 
To identify the transcription factor(s) involved in regulating slow muscle-specific MYHM86-2 
transcription, we used an in silico approach to predict transcription factor binding sites, focusing 
on those previously reported to be involved in muscle specificity. In silico analysis revealed five 
putative Sox6 binding sites based on sequence (A/T)(A/T)CAA(A/T)G, which spanned the 
regions at -1953/-1947 (Sox6_1), -1525/-1519 (Sox6_2), -808/-802 (Sox6_3), -792/-786 
(Sox6_4) and -41/-35 (Sox6_5) in the 2,614 bp 5’-flanking region of MYHM86-2 (Fig. 3-6).  
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Fig. 3-6: The DNA sequence of the 2,614 bp 5’-flanking region of MYHM86-2. The translation start 
codon is underlined. MyoD and MEF2 binding elements were predicted by MatInspector program. 
Putative Sox6 and NFAT binding elements were manually screened based on sequences 
(A/T)(A/T)CAA(A/T)G and GGAAA or TTTCC, respectively. 
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Interestingly, first two Sox6 binding sites from 5’-site (Sox6_1 and Sox6_2) were located within 
the -2000/-1500 bp region of the MYHM86-2 promoter, the deletion of which caused ectopic EGFP 
expression in fast muscle fibers. It has been reported that Sox6 plays a critical role in vertebrate 
skeletal muscle fiber type specification (Hagiwara et al., 2007; Hagiwara, 2011). We thus deleted 
one site or multiple sites of Sox6 in combination from the P2614 construct to determine the role 
of these Sox6 binding sites. Deleting Sox6_1, Sox6_2, Sox6_3 and Sox6_4 binding sites 
individually or in various combinations caused ectopic EGFP expression in fast muscle fibers but 
the deletion of Sox6_5 binding site did not cause any ectopic EGFP expression in fast muscle 
fibers (Fig. 3-7, 3-8), which was comparable to the slow muscle-specific expression pattern of the 
P2614 injection (Fig. 3-7A-B).  
In addition to slow muscle-specific expression, such ectopic EGFP expression in fast muscle 
fibers larvae injected with Sox6_1, Sox6_2, Sox6_3 and Sox6_4 binding sites deletion constructs 
was further confirmed by immunohistochemical analysis (Fig. 3-9A-N). Immunohistochemical 
analysis also confirmed that the deletion of Sox6_5 did not show any ectopic EGFP expression in 
fast muscle fibers (Fig. 3-9O-P). These data suggest that Sox6 binding sites spanning the region 
-1953/-1947 (Sox6_1), -1525/-1519 (Sox6_2), -808/-802 (Sox6_3) and -792/-786 (Sox6_4) are 
functional for repressing the MYHM86-2 expression in fast muscle fibers. 
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Fig. 3-7: Individual deletion of Sox6 binding elements causes ectopic EGFP expression in fast 
muscle fibers. A-H) Fluorescent optics showing larvae microinjected with the individual Sox6 
binding sites deletion constructs of P2614ΔSox6_1 (C,D), P2614ΔSox6_2 (E,F), P2614ΔSox6_3 
(G,H) and P2614ΔSox6_4 (I,J) revealed ectopic EGFP expression in fast muscle fibers. K-L) 
Embryos microinjected with the deletion constructs P2614ΔSox6_5 did not show any ectopic 
EGFP expression in fast muscle fibers. All panels in the right side are the magnified view of 
boxed areas of the left side panels. White arrowheads indicate EGFP expressing fast 
muscle fibers and purple arrowheads indicate EGFP expressing slow muscle fibers. Scale 
bars: 100 μm.  
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Fig. 3-8: Multiple deletions of Sox6 binding elements cause ectopic EGFP expression in fast 
muscle fibers. A-F) In consistent with individual Sox6 binding site deletion constructs, larvae 
microinjected with multiple Sox6 binding sites deletion constructs of P2614ΔSox6_1-2 (A,B), 
P2614ΔSox6_1-3 (C,D) and P2614ΔSox6_1-4 (E,F) displayed similar but enhanced ectopic 
EGFP expression in fast muscle fibers. All panels in the right side are the magnified view of 
boxed areas of the left side panels. White arrowheads indicate EGFP expressing fast muscle 
fibers and purple arrowheads indicate EGFP expressing slow muscle fibers. Scale bars: 100 μm. 
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Fig. 3-9: Immunohistochemistry localizing ectopic EGFP expression in fast muscle fibers due to 
the deletion of Sox6 binding elements. A-H) EGFP expression was localized in both slow and 
fast muscle as reacted with F59 and F310 antibodies in larvae microinjected with the individual 
Sox6 binding sites deletion constructs. I-N) Enhanced EGFP expression was also localized in 
both slow and fast muscle fibers in larvae microinjected with multiple Sox6 binding sites deletion 
constructs. O-P) Embryos microinjected with the deletion construct of P2614ΔSox6_5 did not 
show any ectopic EGFP expression in fast muscle fibers. Arrowheads indicate EGFP expressing 
slow muscle fibers. Arrows indicate EGFP expression not in the fast muscle fiber. Scale bars: 20 
μm. 
Chapter 3  
 
86 | P a g e  
 
Transcriptional regulation of MYHM86-2 expression 
3.3.7 Sox6 function as a transcriptional repressor of MYHM86-2 promoter activity  
The loss of Sox6 activity led to the up-regulation of numerous slow fiber–specific genes in mice 
and zebrafish, suggesting that Sox6 functions as a transcriptional suppressor of slow 
fiber-specific genes (Hagiwara et al., 2007; von Hofsten et al., 2008). Embryos microinjected 
with Sox6_1 (-1953/-1947), Sox6_2 (-1525/-1519), Sox6_3 (-808/-802) and Sox6_4 (-792/-786) 
binding sites deletion constructs showed a marked increase of EGFP expression in skeletal 
muscle (Fig. 3-7C-J) compared to the P2614 injected embryos (Fig. 3-7A-B). Such effects were 
more pronounced when these binding sites were deleted in various combinations rather than 
individually (Fig. 3-8A-F). This observation originally led us to hypothesize that the deletion of 
Sox6 binding sites may cause over-expression of EGFP in the skeletal muscle and increase the 
MYHM86-2 promoter activity. Such enhanced expression of EGFP in Sox6 binding sites deletion 
constructs was validated by real-time PCR analysis (Fig. 3-10). In consistence with the data by 
microscopic observation of EGFP expressing embryos, real-time PCR data demonstrated that 
EGFP mRNA expression was significantly higher in embryos microinjected with the Sox6_1, 
Sox6_2, Sox6_3 and Sox6_4 binding sites deletion constructs compared to the P2614 injected 
embryos (Fig. 3-10). Deleting multiple Sox6 binding sites resulted in further increase of EGFP 
mRNA expression in skeletal muscle (Fig. 3-10). These data suggested that Sox6 function as a 
transcriptional suppressor of MYHM86-2 promoter activity. In contrast, EGFP mRNA expression 
from the embryos microinjected with Sox6_5 deletion constructs was comparable with the 
embryos microinjected with wild type P2614 constructs (Fig. 3-10).  
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Fig. 3-10: Sox6 functioning as a transcriptional repressor of MYHM86-2 expression as revealed by 
real-time PCR analysis. Bar graphs show relative EGFP mRNA expression folds in larvae at 2dpf 
microinjected with different Sox6 binding elements deletion constructs. NS, not significant; *** 
P<0.001. 
 
3.3.8 NFAT elements play a key role in the regulation of MYHM86-2 expression 
During deletion analysis, we observed that the deletion of 614-bp (-2614/-2001) 5’-flanking 
region of MYHM86-2 significantly reduced the number of EGFP expressing muscle fibers per 
embryos (Fig. 3-5). It suggested that the 614 nucleotides in the region spanning from 2614 to 
2001 may contain positive cis-elements required for MYHM86-2 expression. We used an in silico 
approach to predict transcription factor binding sites within this 614-bp promoter region of 
MYHM86-2, focusing on those previously reported to be involved in the expressional regulation of 
slow-muscle specific genes. In silico analysis predicted a putative site for NFAT at -2258/-2254 
(NFAT_1) based on the core motif: GGAAA or TTTCC within the -2,614 to -2000 bp promoter 
sequence of MYHM86-2 (Fig. 3-6). The calcineurin/NFAT pathways appear to be involved in the 
slow muscle-specific gene expression (Calvo et al., 1999; Jiang et al., 2004; Naya et al., 2010). In 
slow twitch soleus muscle of mice, NFAT has been identified as a key transcription factor for the 
activity-dependent reprogramming of MYH expression (McCullagh et al., 2004). Therefore, we 
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hypothesized that this NFAT binding site might have a significant role in the expressional 
regulation of slow muscle-specific MYHM86-2 gene. Upon getting positive results for the deletion 
of this NFAT binding site (Fig. 3-11A), we became interested about the presence of any other 
NFAT binding elements outside of this region. Based on the same approach, in silico analysis 
also revealed another three putative NFAT binding sites at -1968/-1964 (NFAT_2), -1604/-1600 
(NFAT_3) and -306/-302 (NFAT_4) bp upstream regions from the start codon of MYHM86-2 (Fig. 
3-6). In order to determine which NFAT binding sites are functional in the transcriptional 
regulation of MYHM86-2, we carried out experiments using deleted promoter constructs in which 
one site, multiple sites in combination, or all of the NFAT binding sites were deleted from the 
P2614 construct. Embryos injected with the deletion constructs of either NFAT_1, NFAT_3 or 
NFAT_4 site significantly reduced EGFP expression in slow muscle fibers compared to the 
embryos injected with the P2614, and elimination of multiple and all the sites of NFAT elements 
showed more pronounced effects (Fig. 3-11A). This suggests the relative importance of sites 
NFAT_1, NFAT_3 and NFAT_4, with a comparatively minimal role of NFAT_2 binding site in 
NFAT induced transcriptional activation of MYHM86-2. The deletion of NFAT binding sites also 
reduced the number of EGFP expressing muscle fibers (Fig. 3-11B-J). In control (non-deletion of 
any NFAT binding sites), most embryos had EGFP expression in more than 20 muscle fibers (Fig. 
3-11B,J). However, the deletion of NFAT binding sites significantly reduced the number of 
muscle fibers expressing EGFP per embryos (Fig. 3-11C-J). Such effects were more pronounced 
when all NFAT binding sites were deleted and under such conditions most embryos showed 
EGFP expression in only 1-2 muscle fibers (Fig. 3-11I-J). These results clearly demonstrated that 
NFAT binding sites play a key role in the transcription regulation of MYHM86-2 expression. 
However, the deletion of all NFAT binding sites could not completely abolish the EGFP 
expression, suggesting that NFAT binding sites require other cis-elements for directing the 
MYHM86-2 expression. 
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Fig. 3-11: NFAT binding cis-elements playing a key role in the transcriptional regulation of 
MYHM86-2 expression. A) Bar graph showing percentages of embryos that expressed EGFP in 
superficial slow muscle fibers in microinjection with different NFAT binding elements deletion 
constructs. B-I) All panels are side views showing EGFP expression in superficial slow muscles 
fibers of zebrafish larvae at 2 dpf in different NFAT binding sites deletion constructs. 
Arrowheads indicate EGFP expressing slow muscle fibers. J) Bar graph showing the number of 
EGFP expressing superficial slow muscle fibers per embryo in different NFAT binding sites 
deletion constructs. Scale bars 50 µm. NS, not significant; ** P<0.01; *** P<0.001. 
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3.3.9 MEF2 but not MyoD elements participate in the transcriptional regulation of 
MYHM86-2 expression 
Of interest, analysis of the 2,614 bp 5′-flanking region of MYHM86-2 by the Genomatix 
Matinspector program identified three putative MEF2 binding sites in the region spanning 
-2171/-2149 (MEF2_1), 2090-/-2068 (MEF2_2) and -671/-655 (MEF2_3) and two MyoD 
binding sites spanning at -2357/-2339 (MyoD_1) and -535/-520 (MyoD_2) (Fig. 3-6). These 
binding sites have been reported to be involved in the transcriptional regulation of many 
muscle-specific genes during development in fish (Kobiyama et al., 2006; Liang et al., 2008; 
Asaduzzaman et al., 2011). Therefore, we deleted these MEF2 and MyoD binding sites 
individually or in various combinations from the P2614 construct (Fig. 3-12A-B). Deleting any 
one of these three MEF2 or two MyoD binding sites alone had little or no effect on the MYHM86-2 
promoter activity. EGFP expression from this single MEF2 or MyoD binding site deletion was 
comparable with the wild-type P2614 construct (Fig. 3-12A-B). Therefore, we decided to 
generate the multiple MEF2 or MyoD binding site-deleted mutant constructs by deleting these 
sites successively (Fig. 3-12A-B). Embryos microinjected with both two MyoD binding sites 
deletion construct did not significantly reduced EGFP expression percentage in slow muscle 
fibers compared to wild type P2614-injected embryos (Fig. 3-12A,D). These data suggest that 
MyoD binding sites do not participate in the transcriptional regulation of MYHM86-2 expression. 
However, deleting multiple MEF2 binding sites significantly reduced EGFP expression 
percentages in slow muscle fibers (Fig. 3-12B). Fluorescent optics showed that deleting all three 
MEF2 binding sites significantly reduced the number of muscle fibers expressing EGFP per 
embryos (Fig 3-12E-F). It should be noted that EGFP expression was not completely inhibited in 
slow muscle fibers. These data indicate that these MEF2 binding sites in the MYHM86-2 promoter 
were involved in the slow muscle-specific expression, however, additional regulatory sequences 
might also be involved in regulating MYHM86-2 gene expression in skeletal muscles.  
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Fig. 3-12: Effects of MyoD or MEF2 binding sites deletions on transgene EGFP expression in 
slow muscle fibers. A-B) Bar graph shows percentages of embryos that expressed EGFP in the 
superficial slow muscle fibers in microinjection with different MyoD (A) and MEF2 (B) binding 
elements deletion constructs. C-E) Fluorescent optics show similar EGFP expression in larva 
injected with P2614 (C) and P2614ΔMyoD_1-2 (D) constructs and reduced EGFP expression in 
P2614ΔMEF2_1-3 construct (E). All panels are side views showing EGFP expression in 
superficial slow skeletal muscles fibers of zebrafish larvae at 2 dpf. F) Bar graph showing the 
number of EGFP expressing superficial slow muscle fibers per embryo in different MEF2 
binding sites deletion constructs. Scale bars 50 µm. NS, not significant; * P<0.05; ** P<0.01. 
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3.4 Discussion 
Multiple sarcomeric MYHs are expressed in a sequential fashion in different muscles at 
embryonic and larval stages of fish. A greater understanding of factors regulating the expression 
of these embryonic- and larval-type MYHs would provide insights into how these muscles are 
established and maintained. The transcriptional regulation of these MYHs consists of a complex 
process that is often regulated by a cohort of transcriptional factors. The regulatory region of 
these MYHs requires a specific combination and co-operation of various transcription factors 
unique to each muscle fiber lineage at different stages of differentiation to achieve gene 
expression in an efficient and specific manner. MYHM86-2 is highly expressed in slow muscle 
fibers of torafugu embryos and larvae (see Fig. 1A-E), suggesting its functional roles for 
embryonic and larval muscle development. However, very little is known about the mechanisms 
by which its expression is regulated. Therefore, the present study was attempted to identify the 
cis-elements that are crucial for the expressional regulation of torafugu MYHM86-2 by transient 
transfection and transgenic approaches in zebrafish embryos. 
In teleost myogenesis, adaxial cell-derived slow muscle formation is crucial. This is the first step 
of specific muscle fiber formation (Devoto et al., 1996). Our combined analysis of torafugu 
genome data and transgenic approach using zebrafish successfully retrieved 2614 bp upstream 
region of MYHM86-2 containing sufficient promoter which acts in superficial slow muscle fibers 
(see Fig. 3-2). The superficial slow muscle-specific expression patterns with the P2614 construct 
by the transient transgenic assay were confirmed by generating stable transgenic zebrafish lines. 
Apart from the slow muscle-specific expression, both the endogenous MYHM86-2 and the reporter 
gene were also found to be expressed in pectoral fin muscles (see Fig. 3-1 and 3-2). Embryonic 
MYHs have been also reported to be expressed distinctly in pectoral fin muscles in common carp 
(Ikeda et al., 2010), zebrafish (Xu et al., 2010) and medaka (Ono et al., 2006, 2010). This is 
consistent with the functional requirement of larval pectoral fin muscles which mainly consist of 
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fast fibers initially and change to slow type during later stages for the initiation of maneuvering 
and resting in a horizontal position relative to the body during slow swimming (Thorsen and Hale, 
2005; Patterson et al., 2008). However, we did not examine the promoter activity in pectoral fin 
muscles in the present study. Our findings demonstrated that reporter gene expression patterns in 
transient and stable transgenic zebrafish well recapitulated intact MYHM86-2 expressions in 
torafugu (see Figs. 3-1 and 3-2). Torafugu and zebrafish are phylogenically far from each other in 
the teleost lineage. Therefore, the activity of our promoter is supposed to be conserved among 
teleost.  
During development, zebrafish embryo develop series of anatomically distinct slow twitch 
muscle fibers that characteristically express distinct members of a tandem array of slow MYHs 
(Elworthy et al., 2008). Based on the expression of slow MYHs repertoire and hedgehog signal 
dependencies, the subsets of slow muscle fibers can be classified into three distinct groups. The 
first group, called as primary slow muscle fibers, differentiated from adaxial cells. Primary slow 
muscle fibers express an MYH named smyhc1 and its differentiation depends on the hedgehog 
signaling (Elworthy et al., 2008). Following primary slow muscle differentiation, some secondary 
slow fibers (2nd group) also express smyhc1 but they can differentiate normally in the absence of 
hedgehog signaling activity, in contrast to their primary counterparts (Elworthy et al., 2008; 
Barresi et al., 2001). Conversely, other secondary slow fibers (3rd group) express smyhc2 and 
their differentiation depends on the hedgehog signaling activity. In our study, cyclopamine 
treatment completely repressed reporter gene expression by the MYHM86-2 promoter (see Fig. 3-3), 
suggesting that EGFP expressing cell may correspond to hedgehog signaling dependent  slow 
muscle fibers in zebrafish.  
The spatial and temporal control of MYHM86-2 expression lies in its regulatory cis-elements within 
2614 bp. By promoter dissection, we observed that the deletion of a distal 500 bp region 
(-2000/-1501) caused the ectopic MYHM86-2 expression in fast muscle fibers (see Fig. 3-4K-M). 
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This suggests existence of an inhibitory mechanism that mediates the repression of MYHM86-2 
expression in fast muscle fibers, which in turn ensures its expression in slow muscle fibers. We 
identified five Sox6 binding sites in the 2614 bp 5’-flanking region of MYHM86-2 including first 
two Sox6 binding sites (Sox6_1 and Sox6_2) in the 500 bp distal region (see Fig. 3-6). Notably, 
the deletion of these Sox6 binding sites (except Sox6_5) in the context of -2614 bp upstream 
region relieved the fast muscle-specific repression (see Figs. 3-7, 3-8 and 3-9). In zebrafish, 
transcription of Sox6 was clearly detectable at the 10-somite stage in the lateral region of each 
somite and the levels of its transcript reached their peak at 1 dpf and gradually diminished 
thereafter, though persisting at least until 6 dpf (Wang et al., 2011). Recent investigations using 
several model organisms have proposed an important function for Sox6 to play a conserved role 
in vertebrate skeletal muscle fiber-type specification. In mice, analysis of the MYH-β promoter 
revealed a Sox consensus sequence that likely functions as a negative cis-regulatory element 
(Hagiwara et al., 2007), implicating that Sox6 plays a critical role in the fiber type differentiation 
of fetal skeletal muscle. Our findings thus describe an important Sox6 binding element which 
mediates fast muscle-specific repression mechanism to govern the slow muscle-specific 
expression, a novel extension of the roles of Sox6 binding elements in regulating muscle fiber 
type-specific differentiation in fish. It has also been suggested that in mice as well as in zebrafish 
Sox6 directly represses the transcription of slow muscle fiber-enriched genes by binding to 
conserved cis-regulatory elements (Hagiwara et al., 2007; von Hofsten et al., 2008). In addition, 
in both zebrafish and mice overexpression of Sox6 resulted in a decreased expression of slow 
fiber-specific genes (von Hofsten et al., 2008; van Rooij et al., 2009). Very recent study on mice 
has also demonstrated that Sox6 binds to conversed cis-regulatory elements in slow twitch-fiber 
genes to represses their transcription (Quiat et al., 2011). These results identify Sox6 as a robust 
regulator of muscle contractile phenotype and metabolism, and elucidate a mechanism by which 
functionally related muscle fibers type-specific genes are collectively controlled. We also 
demonstrated that deleting Sox6 binding elements significantly increased the reporter gene 
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mRNA expression (see Fig. 3-10). Thus, in addition to fast muscle-specific repressive function, 
Sox6 may also function as a transcriptional suppressor of MYHM86-2 promoter activity. 
We demonstrated that the key regulatory sequence appeared to be located within the 2614 bp 
5’-flanking sequence of MYHM86-2, because the deletion of the 5’-flanking sequence up to 2614 bp 
region had marginal effect on the slow muscle specificity and the activity of the promoter in 
skeletal muscle (see Fig. 3-4). Further promoter dissection suggested that 614 bp spanning the 
region from -2614 to -2001 bp may contain positive cis-elements required for slow 
muscle-specific MYHM86-2 expression. In silico analysis identified four putative NFAT binding 
sites in 2614 bp 5’-flanking region of MYHM86-2 including first one (NFAT_1) in the 614 bp 
region (see Fig. 3-6). Several studies on various model systems have reported that 
calcineurin/NFAT pathways appear to be involved in the transcriptional regulation of slow 
muscle-specific gene expression including slow MYHs (Naya et al., 2010; Calvo et al., 1999; 
Jiang et al., 2004). Therefore, it was of interest to assess the role of the NFAT binding sites in the 
regulation of slow muscle-specific MYHM86-2 promoter. Our study demonstrated that NFAT 
binding sites play a crucial role in the transcriptional regulation of MYHM86-2 expression (see Fig. 
3-11). The role of NFAT binding sites in the transcriptional regulation of slow MYHs promoters 
has been well documented in avian and mammals muscles cells. So far, reports on the relevance 
of NFAT binding sites in slow MYH promoters are contradictory. During the innervations 
-induced expression of an avian MYH-slow promoter two proximal NFAT binding sites play a 
prominent role (Jiang et al., 2004) while mutation of NFAT binding sites in a distal enhancer of a 
rat MYH-β promoter had no effect on its activity (Giger et al., 2004). Transient transfection 
assays demonstrated that the calcineurin/NFATc1 signaling pathway is essential for slow MYH-β 
promoter activation during transformation of mouse C2C12 myotubes (Meissner et al., 2007). 
Relatively recent study (Calabria et al., 2009) provided evidence that the transcription of a slow 
muscle-specific gene, MYH-slow, is controlled in a cooperative way by all 4 NFAT family 
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members in vivo. It was also evident that the transcription of slow and fast MYHs uses different 
combinations of NFAT family members, ranging from MYH-slow, which uses all 4 NFAT 
isoforms, to MYH-2B, which only uses NFATc4. A very recent study (Meissner et al., 2011) also 
showed detailed investigation of the prominent role of an NFATc1 binding site for the slow 
MYHI/β promoter activity and gene expression induced by increased intracellular Ca2+. In 
consistence with the other studies on avian and mammalian muscles, our study also demonstrated 
an important role of NFAT binding sites in the transcriptional regulation of slow muscle-specific 
MYH expression in fish. However, it should be noted that deleting all four NFAT binding sites 
from the 2614 bp regulatory region did not completely abolish its activity in directing EGFP 
expression in slow muscle fibers, suggesting that other regulatory element(s) might be also 
involved in its expression.   
Members of MRF (MyoD, myogenin, myf5, and MRF4) and MEF2 have all been shown to 
regulate the transcription of numerous muscle-specific genes. Our previous study (Asaduzzaman 
et al., 2011) demonstrated that both MyoD and MEF2 binding cis-elements participate in the 
transcriptional regulation of fast muscle-specific torafugu MYHM743-2. Therefore, it was of interest 
to examine whether or not the MyoD and MEF2 binding sites similarly participate in the 
regulation of slow muscle-specific torafugu MYHM86-2. Sequence analysis identified two MyoD 
and three MEF2 binding cis-elements in the 2614 bp 5’-flanking region of MYHM86-2 (see Fig. 
3-6). We revealed that MEF2, but not MyoD, participates in the transcriptional regulation of 
MYHM86-2 expression (see Fig. 3-12). As like mammals, three types of zebrafish MEF2 genes 
(MEF2A, MEF2C and MEF2D) encode factors that function as DNA binding transcriptional 
activators of muscle specific promoters (Ticho et al., 1996). The consistent expression patterns of 
MEF2 isoforms in the developing somites suggested their potential roles to bind with MYHM86-2 
promoters and may participate in the transcriptional regulation of its expression. Previous studies 
reported that MEF2 binding sites are crucial for the transcriptional regulation of fast 
Chapter 3  
 
97 | P a g e  
 
Transcriptional regulation of MYHM86-2 expression 
muscle-specific MYHs in fish (Gauvry et al., 1996; Kobiyama et al., 2006; Liang et al., 2008; 
Asaduzzaman et al., 2011) and mammals (Allen et al., 2002; Meissner et al., 2007). Our results 
suggest that MEF2 is also active in the transcriptional regulation of slow muscle-specific MYHs 
in fish. In mammals, MEF2 was found to be active in both type I slow-twitch fibers and type IIa 
fast-twitch fibers. The involvement of MEF2 in the transcriptional regulation of slow 
muscle-specific MYHs represents a second pathway from calcineurin to DNA (Wu et al., 2000; 
Mckinsey et al., 2002). MEF2 activity may be regulated by intracellular calcium transients 
transduced by the calcium-dependent phosphatase, calcineurin, leading to the activation of 
transcription of some slow fiber-specific genes (Wu et al., 2000). In consistence with our findings, 
MEF2 was also found to be required for innervations-dependent expression of an avian 
MYH-slow promoter in vivo (Jiang et al., 2004). In calcium-ionophore-treated C2C12 myotubes, 
transient transfection studies revealed that a MEF2-D transcription factor transactivate the 
MYH-β promoter in a calcineurin-dependent manner (Meissner et al., 2007). Thus, MEF2 appears 
to be participated in the transcriptional regulation of MYHM86-2, however, additional regulatory 
sequences might also be involved in regulating MYHM86-2 expression. Regulation of MYHs 
expression by multiple regulatory sequences appears to be a common mechanism for the control 
of muscle-specific gene expression. Therefore, combined deletion of multiple cis-elements would 
provide more clear insight about transcriptional regulation of MYHM86-2. In mammalian skeletal 
muscle, recent study showed that the increased intracellular Ca+2level of slow muscle fibers can 
also activates the mitogen-activated protein kinase (MAPK)/extracellular signal-regulated kinase 
(ERK) kinase 1/2 (MEK1/2) pathway, which in turn was shown to enhance transcriptional 
activity of slow MYHI/β promoter and gene activation by post-translation modification of NFAT 
(Meissner et al., 2011).  In addition, the above pathways directly phosphorylated MEF2A and 
MEF2C in their transactivation domains and enhance their transcriptional activity (Ma et al., 
2005). Therefore, besides the mentioned combined deletion of multiple cis-elements, these 
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findings should also be taken into account for future experiments to understand the mechanisms 
of MYHM86-2 expression in fish.   
In summary, our study on the torafugu MYHM86-2 promoter suggests that slow muscle-specific 
expression is achieved through an inhibitory mechanism that suppresses expression in the fast 
muscle fibers. In addition, we conclude that NFAT binding elements play a key role and MEF2 
binding elements participate in the transcriptional regulation of the torafugu MYHM86-2. However, 
a putative consensus binding sequence may not necessarily bind the predicted transcription 
factors and deletions of complete putative binding sites may affect the binding of other 
transcription factors to adjacent sequences which can then subsequently be the cause of the 
measured effects. Therefore, the next important steps of our research would be to investigate 
whether these transcription factors interact with other cofactors to activate MYHM86-2, and whether 
and how these transcription factors bind to the MYHM86-2 promoters.
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CHAPTER 4 
 
 
 
 
Expressional regulation of myosin heavy chain genes 
associated with muscle hyperplasia in fish  
 
 
 
 
The partial content of this chapter was published in: 
 
 
 
 
 
M. Asaduzzaman, Dadasaheb B. Akolkar, S. Kinoshita and S. Watabe. 2013. The expression 
of multiple myosin heavy chain genes during skeletal muscle development of torafugu 
Takifugu rubripes embryos and larvae. Gene 515: 144-154. 
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Abstract 
The relationship of MYHs expression with muscle fiber formation has not been well 
understood in fish. In torafugu, the transcript of MYHM2528-1 appeared in embryos at 6 dpf and 
continued to be expressed in later embryonic and larval development successively as well as in 
adult fast and slow skeletal muscles. Interestingly, the transcripts of MYHM2528-1 were localized 
specifically in the dorsal and ventral extremes of larval myotome suggesting its involvement in 
stratified hyperplasia. Apart from the involvement in stratified hyperplasia in torafugu larvae, 
in situ hybridization study showed that MYHM2528-1 is also involved in mosaic hyperplasia in 
juvenile torafugu where its transcripts were expressed in fast fibers with small diameters as 
well as inner parts of superficial slow muscle fibers.  
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4.1 Introduction 
Molecular, genetic and cellular features of skeletal muscle growth have been documented in a 
number of vertebrate species. In mammals, all the muscle fibers required for growth are produced 
before birth and subsequent growth is mainly by fiber hypertrophy alone (Rowe and Goldspink, 
1969). Teleost fish represent a good model for studying vertebrate myogenesis, since slow and 
fast muscle fibers are arranged in anatomically discrete layers and myotube production is not 
restricted to early developmental stages, reflecting the large difference between embryonic and 
final adult body size (Weatherley et al., 1988). Furthermore, fast and slow muscles have a distinct 
embryological origin (Devoto et al., 1996) and show different patterns of postembryonic growth 
(Barresi et al., 2001; Johnston et al., 2004).  
Embryonic slow muscle fibers are differentiated at early developmental stages from adaxial cells, 
namely paraxial mesodermal cells which exist in direct contact with notochord. Adaxial cells 
migrate laterally from either side of the notochord to the superficial part in the trunk and form 
slow muscle in superficial region beneath the skin or remain as muscle pioneers in the horizontal 
myoseptum (Devoto et al., 1996). In subsequent stages, slow muscle fibers recruited new fibers 
mainly through SH based on the identification of germinal growth zones over a partial 
cross-sectional area of slow muscle and/or range of body sizes (Barresi, 2001; Johnston et al., 
2004). However, previous study reported new evidence that SH in slow muscle relies on the three 
different germinal zones arising sequentially to generate multiple waves of muscle fiber 
recruitment during ontogeny (Lee, 2010).  
Embryonic fast muscle fibers arise from the lateral presomitic mesoderm (Devoto et al., 1996), 
and additional fibers are produced from discrete germinal zones in the late embryo, larval, and 
early juvenile stages by stratified hyperplasia (Johnston et al., 1995; Barresi et al., 2001). The 
final and most important stage of myogenesis involves the formation of new fast muscle fibers 
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throughout myotomes, called mosaic hyperplasia because of the resulting pattern of fiber 
diameters (Rowlerson et al., 1995; Johnston et al., 2003). Myotube production in fast muscle only 
continues until the fish has attained ~40–45% of its maximum body length, with subsequent 
growth restricted to an expansion in the diameter and length of muscle fibers, and nuclear 
accretion (Weatherley et al., 1988; Johnston et al., 2003). However, in response to injury and as a 
component of the repair response, new myotube production can be initiated even after the end of 
fiber recruitment (Rowlerson et al., 1997). The nuclei for fiber recruitment and hypertrophy are 
derived from a population of MPCs that are equivalent to the muscle satellite cells found in 
mammals (Johnston and Hall, 2004). 
Morphological, functional and metabolic characteristics of skeletal muscle are mainly related 
to the cellular expression of different MYH isoforms and muscle fibers are characterized 
mainly based on MYHs they contain (Cobos et al., 2001). Fish are known to posses highly 
conserved MYH multigene family, although MYHs are much more than their higher vertebrate 
counterparts (Kikuchi et al., 1999; Watabe and Ikeda, 2006; Ikeda et al., 2007). Although the 
precise functions of each MYH in fish have been not well understood, subsets of fibers in fish 
skeletal muscles are identified by the transcripts of MYHs, suggesting that they play distinct 
physiological roles. Small diameter fibers that appear by mosaic hyperplasia in adult fast 
muscle of fish express distinct MYHs (Ennion et al., 1995; Akolkar et al., 2010), although their 
expression in early development remains unclear. 
The torafugu genome has been proposed as an ideal model for rapid characterization of vertebrate 
genes due to its smallest size and compactness, generally with short introns and a low proportion 
of repetitive elements (Aparicio et al., 2002). The genomic organization of sarcomeric and 
non-sarcomeric MYHs of torafugu has been investigated by in silico analysis of the total genome 
database, revealing that it contains 20 sarcomeric MYHs which are organized in different clusters 
(Watabe and Ikeda, 2006; Ikeda et al., 2007). The relationship of MYHs expression with muscle 
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fiber formation has not been well understood in fish and even in amniotes. In adult torafugu 
musculature, detailed expression analysis showed the strictly regulated spatial and temporal 
expression patterns of MYHs (Akolkar et al., 2010). Among these MYHs in adult torafugu 
musculature, MYHM2528-1 was expressed in fast fibers with relatively small diameters and slow 
fibers with relatively large diameters, implying that this gene is possibly associated with mosaic 
hyperplasia. However, it is still ambiguous to confirm whether or not this gene is involved in SH 
during development of torafugu. 
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4.2 Materials and Methods 
4.2.1 Experimental fish 
Juveniles (4 to 6 g) of torafugu were collected from Oshima Fisheries Hatchery Company, 
Nagasaki, Japan, and brought to The University of Tokyo, where they were reared in a 500 L 
tank in seawater at 18°C. Embryos and larvae of torafugu at different developmental stages 
were reared and different tissues of adult fish were collected as described in section 2.2.1 of 
Chapter 2.  
4.2.2 Reverse transcription, amplification and sequence determination 
Total RNAs were prepared from whole embryos from 1 to 8 dpf and larvae at 10 and 16 dpf, 
and various tissues of adult torafugu. 5 µg of total RNAs were reverse-transcribed by using 
oligo-dT primer (Akolkar et al., 2010) and superscript reverse transcriptase IIITM (Invitrogen, 
Carlsbad, CA, USA) according to the manufacturer’s instructions. 3’-RACE-PCR was 
performed to determine the nucleotide sequence at the 3’-untranslated region (UTR) of 
MYHM2528-1 by using a specific forward primer 5’-AGC TGG AAG GTG ACC TTG TTC 
AGG-3’ and an adapter primer 5’-CCA GTG AGC AGA GTG ACG-3’. The amplified DNA 
fragments were sub-cloned and sequenced as described in section 2.2.2 of Chapter 2.   
RT-PCR was performed to examine the expression of MYHM2528-1 to be restricted to embryonic 
and larval stages in torafugu and any further possible expression in different tissues of adult by 
using gene specific forward primer 5’-TCG GCA GGG GAA AGG ACG CTG AAG -3’ and 
reverse primer 5’-TTG CGT ATA GAT TTA TTG CAC TT-3’ based on the nucleotide 
sequences in 3’ UTR. The transcript of torafugu β-actin (U38849) was used as the internal 
control for RT-PCR. 
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4.2.3 In situ hybridization  
The cDNA fragment of about 250 to 300 bp which contained 3’UTR nucleotide sequences and 
those encoding a C-terminal part of MYHM2528-1 was amplified by using gene specific forward 
primer 5’-TGA CCA GGT ACA GGA AGG TG -3’ and reverse primer 5’-TTG AAT TGC 
GTA TAG ATT TAT TGC-3’ and subcloned into pGEM-T vector (Promega). Digoxigenin 
(DIG)-labelled antisense riboprobes were synthesized using T7 and SP6 RNA polymerases 
(Roche Applied Science, Mannheim, Germany) according to the manufacturer’s instructions. 
In situ hybridization was performed on transverse sections (16 µm thickness) for larvae at 16 
dpf and juveniles (4.5 g body weight) of torafugu by the method described in section 3.2.3 of 
Chapter 3. 
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4.3 Results 
4.3.1 Expression of torafugu MYHM2528-1 
RT-PCR revealed that the expression of torafugu MYHM2528-1 was dependent on the 
developmental stage. The transcripts of MYHM2528-1 first appeared in embryos at 6 dpf and 
continued to be expressed in embryonic and larval development successively as well as in 
adult fast and slow skeletal muscles (Fig. 4-1A). Interestingly, the transcripts of MYHM2528-1 
were localized specifically in the craniofacial muscles of head (Fig. 4-1B) and dorsal and 
ventral extremes of larval myotome (Fig. 4-1C-D). These results were further confirmed by in 
situ hybridization in juvenile torafugu (4.5 g body weight), where the transcripts of MYHM2528-1 
were found to be expressed in fast fibers with small diameters as well as the inner part of LS 
and ED slow muscle fibers (Fig. 4-2). The transcripts of MYHM2528-1 were also found to be 
expressed in myocepta (Fig. 4-2). 
 
 
 
 
 
 
 
 
 
Fig. 4-1: Expression patterns of MYHM2528-1 in different developmental stages of torafugu. A: 
RT-PCR showed the expression of MYHM2528-1 during development and adult muscle of 
torafugu. B-D: In situ hybridization showed localization of MYHM2528-1 in torafugu larvae at 10 
dpf. Scale bar 20 μm 
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Fig. 4-2: The expression of MYHM2528-1 in juvenile torafugu (body weight 4.5 g). Panel A, the 
cross-sectional view of the whole trunk muscle at the level of relatively anterior position, 
showing the expression of MYHM2528-1. Panel B, the magnified area marked in panel A showing 
the transcripts of MYHM2528-1 localized in inner parts of lateralis superficial (LS) slow muscle 
fibers. Panel C, the magnified area marked in panel A, showing the transcripts of MYHM2528-1 
localized only in fast muscle fibers with small diameters. Panel D, the cross-sectional view of 
the whole trunk muscle at the level of relatively posterior position. Panel E, the magnified area 
marked in panel D. Arrows indicate the positive signals in fibers around myosepta. Scale bars 
= 100 µm. 
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4.4 Discussions 
4.4.1 MYHM2528-1 is involved in hyperplastic muscle growth in torafugu 
MYHM2528-1 is a gene of special interests since we have recently demonstrated its involvement in 
the generation of fast-twitch fibers with small diameters possibly by mosaic hyperplasia in the 
adult trunk fast muscle (Akolkar et al., 2010). MYHM2528-1 is structurally an adult fast type 
(Akolkar et al., 2010). However, this gene was expressed not only in adult torafugu but also in 
embryos and larvae. The expression pattern of MYHM2528-1 provides a functional similarity of fish 
muscle growth with regeneration in mammalian skeletal muscles which is known to occur either 
after injury in skeletal muscle or when provoked experimentally or occurring as a part of a 
disease process (for details, see Schiaffino and Patridge, 2008). Such regenerating fibers in 
mammalian skeletal muscles transiently express embryonic MYHemb and perinatal MYHperi, 
which are replaced later by adult-specific ones (Sartore et al., 1982; Matsuda et al., 1983; Whalen 
et al., 1990). Although such regulation is thought to be a common feature of vertebrate skeletal 
muscles, no direct evidence has been provided at the molecular level regarding the involvement 
of embryonic MYH in generating fibers in adult skeletal muscle of fish. Earlier, Ennion et al. 
(1995) showed that new fibers generated by hyperplasia tend to express distinct MYHFG2 in 
adult fast skeletal muscle of common carp. However, the transcripts of MYHFG2 were 
undetected during development as well as in slow skeletal muscles of carp in a sharp contrast 
with the expression of torafugu MYHM2528-1. Recently, Johnston et al. (2009) have reported the 
up-regulation of fast-type myhz1 in small diameter fibers of zebrafish fast muscle that were still 
recruiting myotubes. The present finding regarding the expression of MYHM2528-1 in embryos and 
larvae during development has a high significance with regards to the establishment of 
hypothesis that the fibers generated by MH in fast muscle of torafugu tend to express structurally 
adult, but expressionally larval and adult, fast-type MYH which is later replaced by adult-specific 
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MYH. Such finding in torafugu suggests the equivalent mechanisms by which expressional 
regulation in a part of fiber generation is likely to occur in fish. 
Initial myogenesis in the embryo results in the formation of a superficial monolayer of slow 
fibers and underlying presumptive fast-white fibers. Further growth in fish skeletal muscles is 
established by the recruitment of new fibers in distinct zones by SH in post-embryonic 
myotome and in all over myotome of adult fast muscle by MH (Stickland, 1983; Rowlerson et 
al., 1985; Rowelerson and Veggetti, 2001), accompanied by the increase in fiber volume by 
hypertrophy. Interestingly, the transcripts of MYHM2528-1 were localized to the dorsal and 
ventral extremes of larval myotome (see Fig. 4-1C-D). The dorso-ventral extremes of larval 
myotome are considered as the main growth engines for recruitment of new fibers by SH 
(Rowlerson and Veggetti, 2001). The appearance of MYHM2528-1 transcripts before hatching 
further suggests the onset of SH in late embryonic stage prior to hatching in torafugu as also 
demonstrated in other fish (Stickland et al., 1988; Steinbacher et al., 2006; Steinbacher et al., 
2007). During SH, fibers are also formed in a layer between superficial slow and lateral fast 
muscles (Rowlerson and Veggetti, 2001; Steinbacher et al., 2007). The fibers located between 
LS slow and fast muscles with intermediate oxidative potentials contained the transcripts of 
MYHM2528-1 (Akolkar et al., 2010). Such fibers possibly appear either in late larval development 
(Scapolo et al., 1988) or at the onset of exogenous feeding that corresponds to the appearance 
of intermediate fibers (van Raamsdonk et al., 1982). Both slow and fast fibers are generated 
during the SH process. Interestingly, in zebrafish SH growth of slow muscle occurs even in 
mutant lacking hedgehog signaling pathway (Barresi et al., 2001). This indicates that the 
mechanisms specifying the identity of new slow muscle fibers during the SH process are 
different from those specifying the slow fate of adaxial cells in the early embryonic stage. 
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Generally, in fish which grow to a large final size, the vast majority of muscle fibers are 
formed in a long lasting hyperplastic process disseminated throughout the entire myotome. 
Both the phenotypic properties of new fibers and the age of the onset of the mosaic 
hyperplastic phase vary widely between species. Unfortunately, there are few studies about the 
onset of MH which focused on the muscle growth right through from embryonic stages to 
adult life. Apart from the involvement of MYHM2528-1 in SH of torafugu larvae, its involvement 
in MH was further confirmed in juvenile torafugu where the transcript of MYHM2528-1 were 
expressed in fast fibers with small diameters as well as inner part of LS and ED slow fibers 
(see Fig. 4-2). MH muscle growth principally occurs during juvenile life for most of the 
commercially important aquaculture fish species (reviewed in Kiessling et al. 1991). In some 
species, MH starts after the previous phase has ceased, but in others it may initially overlap 
with stratified growth (Stoiber and Sanger, 1996; Johnston et al., 1998). In general, the 
intensity of MH growth is greatest in early juvenile fish (Rowlerson et al., 1995). It is 
interesting to note that the novel function of MYHM2528-1 in fibers that are generated by SH and 
MH in torafugu suggests distinct functions of MYHs in different phases of muscle growth. 
Thus, to focus on a large final body size with a marked distinction of phases of muscle growth 
and functional specialization of members of MYH family, torafugu is considered to be an ideal 
fish for studies on the mechanisms underlying embryonic and post embryonic muscle growth.  
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The formation and growth of skeletal muscle in vertebrates proceed via successive phases of 
myogenesis that occur during embryonic and fetal development under the influence of various 
signals (Shi and Garry, 2006; Buckingham, 2007). A complex and sequential expression pattern 
of MYHs is observed during muscle fiber development in fish. The comprehensive analysis of the 
torafugu whole genome database by comparative genomics revealed over 20 sarcomeric MYHs 
(Ikeda et al., 2007). In this context, several MYHs were cloned from torafugu embryos, larvae and 
adult by our research group (Ikeda et al., 2007; Akolkar et al., 2010; Asaduzzaman et al., 2013). 
Furthermore, several MYHs were found to be expressed in fiber-type specific manner during 
early development or involved in hyperplastic muscle growth of torafugu (Ikeda et al., 2007; 
Akolkar et al., 2010; Asaduzzaman et al., 2013). However, our knowledge about factors that 
regulate fiber-type and developmental-stage dependent expression of MYHs in fish is still limited. 
In this study, a step-wise approach (Chapters 2-4) was followed to understand the transcriptional 
regulatory mechanisms involved in the MYHs expression during skeletal muscle development in 
fish. In this chapter, major findings of the previous chapters are integrated, interpreted and 
broadly discussed, and suggestions for further studies are given. 
5.1 The 5’-flanking region of torafugu MYHs functioned similarly in zebrafish embryos 
The expression analysis showed that MYHM743-2 and MYHM86-2 were expressed in fiber-type 
specific manners only in embryonic and larval stages of torafugu (Ikeda et al., 2007; 
Asaduzzaman et al., 2013). However, the regulatory mechanisms involved in the spatio-temporal 
expression of MYHM743-2 and MYHM86-2 have remained unknown. For the above purposes, 
regulatory sequences were isolated and identified as the first step to examine the spatial and 
temporal regulation of MYHM743-2 and MYHM86-2. In vivo reporter analysis to understand the 
regulatory mechanism of these genes expression in torafugu were found to be largely limited by 
the difficulties of routinely rearing and breeding them in the laboratory compared to other 
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experimental teleost model such as zebrafish (Alestrom et al., 2006). Therefore, zebrafish was 
used as a model in this study because transgenic fish expressing fluorescent protein under the 
control of MYHs promoters are useful tools for identifying the regulatory transcription elements 
and visualizing muscle fiber-specific gene expression patterns in live embryos (Long et al., 1997; 
Motoike et al., 2000; Zhang and Rodaway, 2007). The data showed that the 2,075 bp 5’-flanking 
region of MYHM743-2 (Chapter 2) and 2,614 bp 5’-flanking region of MYHM86-2 (Chapter 3) were 
sufficient to direct spatial and temporal muscle-specific EGFP expression in zebrafish embryos. 
The results from the transient assays were also confirmed by generating stable transgenic 
zebrafish lines. The expressions of the transgenes in a stable line (MYHM743-2:EGFP and 
MYHM86-2:EGFP) were consistent with the transient and endogenous expression patterns of 
MYHM743-2 (Chapter 2) and MYHM86-2 (Chapter 3). The zebrafish expressing muscle fiber-specific 
fluorescence developed normally and produced offspring that stably expressed EGFP.  
Several unique features of fish skeletal muscles make them an excellent model for studies on 
muscle development. The most important feature is the anatomical separation of fast and slow 
fibers in fish. Both the slow and fast muscle fiber contains characteristic MYHs which can be 
shown by immunostaining with MYH specific antibodies (Rowlerson et al., 1985; Scapolo and 
Rowlerson, 1987). The present study reported that MYHM743-2 is highly expressed in fast muscle 
fibers (Chapter 2) and MYHM86-2 is expressed in slow muscle fibers in torafugu embryos and 
larvae (Chapter 3). To determine whether or not the expression of EGFP was consistent with their 
endogenous mRNA expression patterns, EGFP-expressing embryos were characterized by whole 
mount antibody staining and immunohistological observations. In consistent with the endogenous 
mRNA expression in torafugu, transient and stable transgenic line zebrafish embryos showed 
consistent EGFP expression in fast muscle fiber for MYHM743-2 (Chapter 2) and slow muscle 
fibers for MYHM86-2 (Chapter 3). These findings confirmed that torafugu MYHs promoters can be 
analyzed in vivo in zebrafish embryos. 
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5.2 The activity of slow muscle-specific MYHM86-2 promoter depends on hedgehog signals 
In teleost, hedgehog (Hh) has been shown to play critical roles in muscle development. Hh is a 
secreted signaling protein from notochord that acts through at least two proteins, Patched (Ptc) 
and Smoothened (Smo). Ptc negatively regulates Hh signaling by inhibiting Smo. Hh binding to 
Ptc relieves this inhibition and allows Smo to transduce the signal (Ingham & McMahon 2001). 
Hh activity is necessary and sufficient to induce slow muscle and muscle pioneer cells both in 
vivo and in vitro (Weinberg et al., 1996; Du et al., 1997; Norris et al., 2000; Wolff et al., 2003). 
In zebrafish, the differentiations of adaxial cell-derived primary slow muscle fibers and a subset 
of secondary slow muscle fibers depend on the Hh signaling. The findings of this study (Chapter 
3) suggested that EGFP expressing cell may correspond to Hh signaling dependent slow muscle 
fibers in zebrafish. However, further studies are required to confirm whether the EGFP 
expressing fibers under the control of MYHM86-2 promoter are Hh dependent primary and/or a 
subset of secondary slow muscle fibers. 
5.3 The regulatory elements involved in the transcriptional regulation of MYHs expression 
in fish have been previously reported to perform similar function in mammals  
Interesting physiological difference exists between teleost fish and mammalians vertebrates. The 
same basic genes are present and appear functional; however slightly different regulatory 
mechanisms exist in the regulation of fish muscle development and growth. Fish musculature is 
much different from mammalian muscles in terms of segregated distribution of fast and slow 
muscle fibers. In mammals, most of the skeletal muscles contain a mixture of various fiber types, 
enabling individual muscle in providing long-lasting, low-intensity contractions together with 
fast burst activity. In contrast to mammals, different fiber-types are separated in fish. Fish fast 
muscle fibers locate deeply in the myotomal muscle whereas slow twitch muscle fibers are found 
in a narrow mid-lateral layer just under the skin. Based on these contrast arrangement patterns of 
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different fiber-types, it would be really interesting to investigate whether or not the similar 
transcriptional regulatory mechanisms of MYHs expression exists among fish and mammalian 
vertebrates. 
The formation of different types of muscle fibers depends on differential expression of a suite 
and contractile and metabolic proteins specialized for each fiber type. Characterization of the 
cis-acting sequences involved in the expression of muscle fiber type-specific genes should shed 
light on the factors involved in the establishment of different fiber types. A growing number of 
regulatory sequences involved in the pattern of expression of fast and/or slow muscle-specific 
genes have been characterized in both mammals and fish; among them, the most extensively 
studied ones are the MRF family of transcriptional activators, which includes MyoD, Myf5, 
myogenin, and MRF-4 (Bergstrom et al., 2002; Berkes and Tapscott, 2005; Allen et al., 2005). 
These “master” transcription factors play a central role in regulating muscle development and 
growth in mammals (Tapscott, 2005). Another transcription factor MEF2 was found to function 
predominantly in expression of muscle-specific MYHs in mammals (Swoap, 1998; Lakich et al., 
1998; Croissant et al., 2000). In consistent with mammals, the present study also demonstrated 
that MyoD (Chapter 2) and MEF2 (Chapter 2 and 3) binding sites participates in the 
transcriptional regulation of MYHs in fish.  
SRF, a MADS box transcription factor related to MEF2, also regulates skeletal, as well as cardiac 
and smooth muscle genes by binding a DNA sequence known as a CArG box in mammals 
(Norman et al., 1988; Miano, 2003; Davis et al., 2008). A previous study showed that a SRF 
binding site residing in the -120 to -80 bp promoter region act as an enhancer of MyHC-IIb 
transcriptional activity predominantly in fast muscle of adult mice (Allen et al., 2005). Combined 
deletion and site-directed mutagenic analyses revealed that the low transcriptional activity of 
human MyHC-IIb is largely the result of reduced SRF binding within the proximal promoter 
region (Harrison et al., 2011). Although the role of SRF in transcriptional control of MYH 
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expression has been reported in mammals (Allen et al., 2005; Harrison et al., 2011), the 
underlying roles of SRF in transcriptional regulation of muscle-specific expression of MYHs have 
been poorly reported in teleost. In consistent with the previous studies in mammals, the combined 
mutation and deletion studies also showed that SRF plays a pivotal role in the transcriptional 
regulation of fast muscle-specific expression of MYHM743-2 in fish (Chapter 2). Therefore, this 
study provided the new insight that SRF binding sites within the upstream promoter regulate the 
transcriptional activity of fast-type MYH in fish as like mammals (Chapter 2).  
In two evolutionarily distant organisms, mice and zebrafish, Sox6 is involved in specifying the 
muscle fiber-type (Hagiwara et al., 2007; von Hofsten et al., 2008). Therefore, it was of interest 
to assess the role of the Sox6 binding sites in the regulation of slow muscle-specific MYHM86-2 
promoter. In zebrafish and mice, the loss of Sox6 activity led to the up-regulation of numerous 
slow muscle fiber–specific genes, suggesting that Sox6 functions as a transcriptional suppressor 
of slow muscle fiber-specific genes (Hagiwara et al., 2007; von Hofsten et al., 2008). In addition, 
over-expression of Sox6 resulted in a decrease in expression of slow fiber-specific genes in mice 
as well as zebrafish (van Rooij et al., 2009; von Hofsten et al., 2008). In mice, it directly 
represses the transcription of multiple myosin and sarcomeric genes by binding to conserved 
cis-elements in their promoters (Quiat et al., 2011). The present study also demonstrated that 
deleting Sox6 binding elements significantly increased the reporter gene mRNA expression 
(Chapter 3). Thus, in addition to fast muscle-specific repressive function, Sox6 may also function 
as a transcriptional suppressor of MYHM86-2 promoter activity in fish as like mammals. 
The role of NFAT binding sites in the transcriptional regulation of slow MYHs promoters has 
been well documented in avian and mammals (Calvo et al., 1999; Jiang et al., 2004; Giger et al., 
2004; Calabria et al., 2009; Naya et al., 2010; Meissner et al., 2011) muscles cells but not in the 
fish. In consistence with the other studies on avian and mammalian muscles, our study also 
demonstrated an important role of NFAT binding sites in the transcriptional regulation of slow 
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muscle-specific MYH expression in fish (Chapter 3). Most of the regulatory elements identified in 
our study in fish were previously reported to be involved in the transcriptional regulation of 
MYHs expression in mammals.  
5.4 Different regulatory elements involved in the transcriptional regulation of fiber 
types-specific MYHs expression in fish 
Skeletal muscle fibers are classified based on two functional characteristics: contractile speeds 
and metabolic activity. These two functions are interrelated as the speed of contraction reflects 
how fast and by which mechanisms the cell metabolizes ATP. The fast-twitch fibers are 
characterized by low myoglobin and mitochondrial contents but rich in glycogen, making them 
suitable for intense short-burst activity. In contrast, slow oxidative fibers are high in 
mitochondria and myoglobin, making them suitable for longer sustained activity, or endurance 
acitivity (Goldspink et al., 2001; Sanger and Stoiber, 2001). Slow- and fast-twitch myofibers of 
skeletal muscles express unique sets of muscle-specific genes, and these distinctive programs of 
gene expression are controlled by variations in motor neuron activity. Several axes of regulation 
exist for the members of the MYHs family, including tissue-specific (muscle versus non-muscle), 
muscle type-specific (striated versus smooth muscle), fiber type-specific (fast versus slow). More 
recently, progress has been made in elucidating the cis-regulatory sites that contribute to slow 
versus fast muscle gene expression.  
Several mediators and transcription factors have been identified for the nerve dependent fiber 
type regulation in skeletal muscle in mammals. It is well established that, as a consequence of 
more frequent neural stimulation, slow fibers maintain higher levels of intracellular free calcium 
than fast fibers. Therefore, slow muscle-specific genes are often regulated by calcineurin 
-dependent signaling mechanisms. Calcineurin-dependent signaling mechanisms have been 
characterized extensively in the activation of cytokine gene expression in T and B lymphocytes 
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responding to stimuli that elevate intracellular free calcium concentration (Rao et al., 1997). 
Binding of calcium to a calmodulin-calcineurin complex stimulates serine/ threonine phosphatase 
activity of calcineurin, the major substrates of which are NFAT transcription factors. 
Dephosphorylation of NFATs by calcineurin promotes their translocation from the cytoplasm to 
the nucleus, where they bind a cognate nucleotide recognition sequence (Rao et al., 1997) and 
stimulate transcription of target genes. In the nucleus, NFAT proteins bind DNA in conjunction 
with other transcriptional regulators, including MEF2, binding sites for which are clustered in 
promoter/enhancer regions controlling transcription of genes encoding proteins of the slow-fiber 
program. In fast fibers, high-amplitude calcium transients stimulated by infrequent, phasic firing 
of the motor nerve are of insufficient duration to maintain calcineurin in the active state, so 
NFAT proteins remain phosphorylated and are excluded from the nucleus. When NFAT proteins 
are unavailable for DNA binding and protein–protein interactions at target promoters, the 
slow-fiber-specific program is down-regulated, and genes encoding fast-fiber-specific proteins 
are transcribed. MYHM86-2 is selectively expressed in slow, oxidative skeletal muscle fibers 
(Chapter 3), whereas MYHM743-2 is expressed in fast, glycolytic myofiber subtype in torafugu 
embryos and larvae (Chapter 2). In consistent with the above discussion, the present study also 
suggested that the expression of slow muscle-specific MYHM86-2 is largely regulated by NFAT and 
MEF2 binding elements in torafugu (Chapter 3).  
Sox6, a member of the SoxD family, transcription factors exhibits dual functions as a 
transcriptional activator or repressor (Wilson and Koopman, 2002; Han and Levebvre, 2008). 
Sox6 transcription factors play an important role in terminal differentiation of skeletal muscle by 
suppressing the transcription of mostly slow muscle fiber genes (Quiat et al., 2011). Recent study 
also showed that fast fiber-specific gene expression in Sox6 knock-out skeletal muscle reduced  
dramatically but the reason was unknown (An et al., 2011). In this study, Sox6 was also found to 
be functional as a transcription repressor of slow muscle-specific MYHM86-2 (Chapter 3) but its 
Chapter 5  
 
119 | P a g e  
 
General discussion 
role was not investigated in fast muscle-specific MYHM743-2. The present study also described a 
novel extension of the roles of Sox6 binding elements in regulating muscle fiber type-specific 
differentiation in fish (Chapter 3). Previous studies reported that SRF, although not strictly 
involved in the transcriptional regulation of fiber-type specific expression of MYHs as like 
calcineurin dependent NFAT elements, participates in the regulation of fast muscle-specific 
MYHs in mammals (Allen et al., 2005; Harrison et al., 2011). In this study, SRF was also found 
to play an important role to direct fast muscle-specific MYHM743-2 expression in fish (Chapter 2). 
Basic, bHLH proteins of the MyoD family and several other varieties of transcription factors 
collaborate to establish myogenic cell lineages in the embryo, and are essential for 
muscle-specific gene transcription (Olson et al. 1995), but it seems difficult to characterize these 
proteins in fiber type-specific gene expression. 
5.5 Diversity of involvement of MYHs in newly formed fibers in teleost fish and mammalian 
vertebrates 
In mammalian vertebrates, the definitive number of skeletal muscle fibers is pre-established in 
early development or shortly after the birth. Following birth, growth occurs through the 
enlargement of existing muscle fibers by increase in length, diameter and nuclear content, a 
process known as hypertrophic muscle growth. However, during the process of regeneration of 
mammalian skeletal muscles after injury or upon stress, hyperplastic growth occurs, thereby 
generating new fibers (Goldspink 1972). In contrast to mammals, the evidence suggest that fish 
species with a large final body size and rapid growth exhibit a second phase of muscle growth 
immediately after primary myogenesis by increasing of number of muscle fiber, a process known 
as hyperplastic muscle growth. These results suggest that the onset of the second and third phases 
of myogenesis occurs simultaneously and follow the first phase of growth, uninterrupted, in fish 
characterized by indeterminate growth.  
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Fish express different MYHs during this indeterminate muscle growth and studies have shown 
greater diversity in MYHs in fish than mammals. A complete shift in MYHs expression occurs 
during the development of muscle fibers. Histochemical and immunohistochemical analyses 
implicated that a different MYH was expressed in small-diameter fibers in the white myotomal 
region in carp (Rowlerson et al., 1995). In terrestrial vertebrates, new regenerative fibers have 
been reported to express embryonic- and neonatal-type MYHs (Sartore et al., 1982; Whalen et al., 
1990). In this context, no direct evidence on the mechanisms involved in the expression of 
embryonic MYHs in new fibers generated by hyperplastic growth has been reported in fish. 
Utilizing a carp genomic library and previously identified different lambda clones containing 
MYHs sequences, a novel MYH was isolated from small-diameter muscle fiber in carp, the FG2 
(Ennion et al., 1995). Interestingly FG2 was not expressed in slow or fast muscle fibers. In situ 
hybridization study revealed that FG2 expression in restricted to only small diameter white fibers 
in fast growing carps (Ennion et al., 1995). Ennion et al. (2005) showed that FG2 is expressed 
transiently during the differentiation of satellite cells into muscle fibers, suggesting a specific role 
in muscle cell recruitment. Various embryonic and neonatal MYHs are expressed in 
differentiating mammalian satellite cells following injury or trauma. However, carp FG2 is not 
expressed in juvenile, fry or developing embryos of carp, demonstrating that it is not an 
embryonic or neonatal isoform, but a more specific “growth isoform gene”. As equivalent growth 
isoform gene has not been identified in any terrestrial vertebrates, which highlights the unique 
growth attributes seen in fish. More interestingly, torafugu MYHM2528-1 is only MYH in fish that 
has been found to be involved in both SH and MH to date (Chapter 4). Unlike Carp FG2, 
torafugu MYHM2528-1 was found to be expressed in late embryonic, larval and juvenile stages in 
addition to adult stages, but its expression was restricted to only small diameter fibers, not like 
the expression of common embryonic and larval type MYHs in fish. In addition, torafugu 
MYHM2528-1 was also found to be expressed in inner part of the LS and ED slow muscle fibers 
(Chapter 4). New fibers formation and the age at the onset of SH and MH vary widely between 
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species (Rowelerson and Vigeetti, 2001). Less has been studied especially on the onset of SH and 
MH during development of fish by using MYH as a marker. By observing the expression pattern 
of MYHM2528-1, it was revealed that SH started immediately after hatching of torafugu around 10 
dpf and MH present in juvenile stages of torafugu at 4.5 g body weight (Chapter 4). The novel 
function of MYHM2528-1 in fibers that are generated by SH and MH in torafugu suggests distinct 
functions of MYHs in different phases of muscle growth. 
Conclusion and future prospective 
Finally, the present study provides greater insight into complex transcriptional regulation of 
MYHs that are specifically expressed in fast and slow muscle fibers during embryonic and larval 
development, and newly formed fibers during post-embryonic hyperplastic growth in fish. In 
most cases, expressions of muscle-specific MYHs in fish are transcriptionally regulated by 
multiple regulatory sequences in their 5’-flanking regions. Different cis-elements in the 
5’-flanking regions of MYHs are participated in the transcriptional regulation of slow and fast 
muscle-specific expression in fish. Although some of the previous studies reported the 
transcriptional regulatory mechanisms underlying the fast muscle-specific MYHs, to the best of 
our knowledge this study (Chapter 3) is the first report about the transcriptional regulation of 
slow muscle-specific MYH expression in fish. A greater understanding of factors responsible for 
the transcriptional regulation of MYHs expression in different muscle fibers-types would provides 
a greater insight into how these muscle fibers are established and maintained in fish. In this study, 
most of cis-elements are identified by deletions and mutations analysis in live zebrafish embryos. 
However, deletions of complete putative binding sites may affect the binding of other 
transcription factors and a putative consensus binding sequence may not necessarily bind the 
predicted transcription factors. Therefore, further studies are needed to investigate whether and 
how the predicted transcription factors bind to the promoters and whether the predicted 
transcription factors interact with other cofactors to activate MYH expression in fish. Regulation 
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of MYHs expression by multiple regulatory sequences appears to be a common mechanism for 
the control of muscle-specific gene expression. Therefore, combined deletion of multiple 
cis-elements of NFAT and MEF2 binding sites would provide more clear insight about 
transcriptional regulation of MYHM86-2. In teleost fish, there are no conclusive reports about the 
transcriptional regulatory mechanism of MYHs involved in hyperplastic muscle growth. 
Therefore, it would be really interesting to derive conclusive evidence from analysis of the 
promoter and the 5’-upstream region of torafugu MYHM2528-1 in future.  
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Summary and conclusion 
Summary and Conclusion 
Vertebrate skeletal muscle consists of heterogeneous tissues including various types of muscle 
fibers and the fiber-type specification is crucial for muscle development. Myosin is the major 
structural and functional muscle protein in the contractile apparatus. Terminal differentiation and 
specification of various types of muscle cells during development require specific expression of 
myosin heavy chain (MYH) isoforms; thereby MYH is thought to be a key molecule on the 
functional diversity of muscles. As in mammalian skeletal muscles, the members of the MYH 
genes (MYHs) of fish are expressed in a complex, sequential fashion during development and 
growth. Although a considerable progress has been made in elucidating the molecular genetics 
underlying the development-dependent, muscle-specific expression of MYHs in mammals, little 
is currently known regarding comparable issues in fish. In this study, the 5’-flanking sequences 
of development-dependent, fast- and slow-type MYHs of torafugu Takifugu rubripes, MYHM743-2 
and MYHM86-2, respectively, were cloned and analyzed for their transcriptional regulation in 
zebrafish Danio rerio embryos using transient and transgenic approaches. The present study also 
focuses on the expressional regulation of MYHs, which are supposed to be associated with 
hyperplastic muscle growth in fish. 
1. Transcriptional regulation of fast muscle-specific MYHM743-2 expression 
MYHM743-2 is highly expressed in fast muscle fibers of torafugu embryos and larvae. When the 
2075-bp fragment of MYHM743-2 was fused to the reporter gene, EGFP encoding enhanced green 
fluorescence protein, the construct could induce muscle-specific expression of EGFP in zebrafish 
embryos. In most cases, the EGFP expression was detected at 1 day post fertilization (dpf) in the 
somite formation stage. After hatching (2dpf), EGFP continued to be expressed in the whole 
myotome of larvae as well as in jaw, eye and pectoral fin muscles. The expression of the 
transgene in embryos and larvae from the stable transgenic line of zebrafish was consistent with 
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that of zebrafish embryos microinjected the 2075 bp construct. While the injected 2075 bp 
construct showed EGFP expression in both fast and slow muscle fibers of larvae as revealed by 
immunohistochemical analysis, embryos from the stable transgenic line expressed EGFP in fast 
muscle fibers only. These results clearly demonstrated that the 2075 bp 5’-flanking region of 
MYHM743-2 contains essential cis-regulatory sequences for myogenesis that are conserved among 
torafugu and zebrafish. 
Using the MatInspector and TFsearch programs, the 2075-bp 5’-flanking region from the start 
codon of MYHM743-2 was found to contain putative transcription factor-binding sites for myocyte 
enhancing factor 2 (MEF2), myogenic determining factor (MyoD) and serum response factor 
(SRF), all of which have been implicated in the expressional regulation of muscle-specific genes 
during development. Embryos microinjected a modified 2075 bp construct, where the total three 
SRF binding sites were deleted, showed a significantly reduced EGFP expression. However, the 
deletion of all SRF binding sites failed to eliminate MYHM743-2 expression completely. Moreover, 
the minimum 468-bp basal promoter region from the start codon containing the third SRF 
binding site from the 5’-end was found to direct EGFP expression in the myotomal compartment. 
Mutations of this SRF binding site in the 468-bp construct also reduced MYHM743-2 expression in 
the myotomal compartments, suggesting that this site is necessary for mediating the basal 
expression of MYHM743-2. In this regard, the expression of two zebrafish SRFs, srf1 and srf2, was 
observed as early as at 2 hours post fertilization and continued to be expressed throughout the 
successive developmental stages. Such expression pattern of srfs was consistent with their 
potential roles in regulating MYHM743-2 expression in zebrafish embryos.  
There were three MyoD and eight MEF2 binding sites within the 2075-bp 5’-flanking region of 
MYHM743-2. Functional analyses revealed that deletions of multiple sites of these factors 
significantly reduced the MYHM743-2 promoter activity in skeletal muscles. Such reductions were 
also validated by real-time PCR analysis. Deletion mutation analyses also suggested that MyoD, 
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but not MEF2, binding sites are crucial for MYHM743-2 promoter activity in craniofacial and 
pectoral fin muscles. However, the deletion of all MyoD- or MEF2-binding sites failed to 
eliminate MYHM743-2 expression completely. Taken together, it is indicated that multiple 
transcription factors including SRF, MyoD and MEF2 participate in the expression of MYHM743-2. 
Torafugu MYHM743-2 showed homology over 55% on the rVISTA analysis in the 5' flanking 
region from −664 to −364 bp with the corresponding region of a green spotted pufferfish 
Tetraodon nigroviridis orthologous gene, MYH13. Embryos microinjected the 2075-bp construct 
excluding this conserved region completely abolished the EGFP expression, suggesting that the 
conserved regulatory cis-elements in this region regulate the transcriptional activity of MYHM743-2. 
Further studies are required to precisely map responsible cis-elements in this region. 
2. Transcriptional regulation of slow muscle-specific MYHM86-2 expression 
MYHM86-2 transcripts are highly expressed in slow muscle fibers of torafugu embryos and larvae. 
To examine whether or not the 5’-flanking sequence of torafugu MYHM86-2 would function 
similarly in zebrafish, we constructed a reporter vector containing the 2614 bp 5’-flanking region 
fused to EGFP in pT2AL200R1150G vector. The microinjection of the 2614 bp construct in 
zebrafish embryos exhibited EGFP expression in slow muscle fibers at 1dpf and after hatching 
(2dpf) continued to be expressed in the whole myotomal region in larvae. The transient 
superficial slow muscle-specific expressions of MYHM86-2 were further confirmed by generating 
stable transgenic zebrafish lines. Apart from the slow muscle-specific expression, both the 
endogenous MYHM86-2 and the reporter gene were also found to be expressed in pectoral fin 
muscles. These data suggest that the 2614-bp 5’-flaking region contained the necessary 
regulatory elements for MYHM86-2 expression in slow muscle fibers. 
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Hedgehog signaling is important for slow muscle development in vertebrates. To further 
characterize EGFP expression in slow muscle fibers, stable transgenic line zebrafish embryos, 
carrying the transgene MYHM86-2: EGFP, were treated with cyclopamine (2.5, 5 and 10 μg/ml), a 
well-known hedgehog signaling inhibitor. Depending on the dose, cyclopamine-treated embryos 
showed reduction or complete elimination of EGFP expression in slow muscle fibers, suggesting 
that MYHM86-2 promoter activity depends on the hedgehog signaling. 
To identify the key regulatory region for the slow muscle-specific expression, a deletion analysis 
was performed within the 5.5-kb 5’-flanking region of MYHM86-2. The deletion of the 5’-flanking 
region up to -2614 bp upstream of the MYHM86-2 promoter had no or marginal effect on the 
activity and slow muscle-specificity of the promoter. The deletion of a distal 500 bp region 
(-2000/-1500) caused ectopic MYHM86-2 expression in fast muscle fibers. In silico analysis 
revealed five putative Sox6 binding sites which spanned the regions at -1953/-1947 (Sox6_1), 
-1525/-1519 (Sox6_2), -808/-802 (Sox6_3), -792/-786 (Sox6_4) and -41/-35 (Sox6_5) in the 
2,614 bp 5’-flanking region of MYHM86-2,  including first two Sox6 binding sites (Sox6_1 and 
Sox6_2) in the 500 bp distal region. Notably, the deletion of these Sox6 binding sites (except 
Sox6_5) individually or in various combinations caused ectopic EGFP expression in the fast 
muscle fibers. In mice and zebrafish, Sox6 directly represses the transcription of slow muscle 
fiber-enriched genes by binding to conserved cis-regulatory elements. In consistent with such 
finding, the deletion of these Sox6 binding elements (except Sox6_5) significantly increased the 
reporter gene mRNA expression. Thus, in addition to fast muscle-specific repressive function, 
Sox6 elements may also function as a transcriptional suppressor of MYHM86-2 promoter activity. 
Promoter dissection study also showed that the deletion of 614 bp spanning the region from 
-2614 to -2001 significantly reduced the number of EGFP expressing muscle fibers. It suggests 
that 614 bp region may contain positive cis-elements required for slow muscle-specific 
expression of MYHM86-2. Several studies on various model system have reported that 
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calcineurin/nuclear factor of activated T cells (NFAT) pathways appear to be involved in the 
transcriptional regulation of slow muscle-specific gene expression including those of slow MYHs. 
In silico analysis identified four putative NFAT binding sites spanning the region at -2258/-2254 
(NFAT_1), -1968/-1964 (NFAT_2), -1604/-1600 (NFAT_3) and -306/-302 (NFAT_4) bp in the 
2,614 bp 5’-flanking region of MYHM86-2, including first one (NFAT_1) in the 614 bp distal 
region. Embryos microinjected these NFAT binding sites deletion constructs (except NFAT_2) 
showed significantly reduced EGFP expression in slow muscle fibers, and elimination of multiple 
and all the sites of NFAT elements showed more pronounced effects. However, the deletion of all 
NFAT binding sites could not completely abolish the EGFP expression, suggesting that 
cis-elements other than NFAT binding sites require for directing the MYHM86-2 expression.  
Members of myogenic regulatory factors (MyoD, Myogenin, myf5 and MRF4) and MEF2 have 
all been shown to regulate the transcription of numerous muscle-specific genes. Analysis of the 
2614 bp 5’-flanking region of MYHM86-2 by Genomatix MatInspector program identified two 
putative MyoD and three MEF2 binding sites. The deletion of both two MyoD binding sites did 
not significantly reduce EGFP expression percentages in slow muscle fibers. However, the 
deletion of multiple MEF2 binding sites significantly reduced EGFP expression in slow muscle 
fibers. These data suggest that MEF2, but not MyoD, participates in the transcriptional regulation 
of MYHM86-2 expression. 
3. MYHs expression associated with hyperplastic muscle growth in fish 
The relationship of MYHs expression with muscle fiber formation has not been well understood 
in fish. In torafugu, the transcript of MYHM2528-1 appeared in embryos at 6 dpf and continued to be 
expressed in later embryonic and larval development successively as well as in adult fast and 
slow skeletal muscles. The dorso-ventral extremes of larval myotome are considered as the main 
growth engines for recruitment of new fibers by stratified hyperplasia. Interestingly, the 
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transcripts of MYHM2528-1 were localized specifically in the dorsal and ventral extremes of larval 
myotome, suggesting its involvement in stratified hyperplasia. Apart from the involvement in 
stratified hyperplasia in torafugu larvae, in situ hybridization study showed that MYHM2528-1 is 
also involved in mosaic hyperplasia in juvenile torafugu where its transcripts were expressed in 
fast fibers with small diameters as well as inner parts of superficial slow muscle fibers.  
Conclusion 
The present study provides a greater insight about the transcriptional regulatory mechanisms 
involved in MYHs expression during skeletal muscle development in fish. This study is the first 
report about the transcriptional regulatory mechanisms involved in the slow muscle-specific 
MYH expression in fish. A greater understanding of factors responsible for the transcriptional 
regulation of MYHs expression in different muscle fibers-types would provides a greater insight 
into how these muscle fibers are established and maintained in fish. In this study, the 
cis-elements are identified by deletions and mutations analyses in zebrafish embryos. However, a 
putative consensus binding sequence may not necessarily bind the predicted transcription factors 
and deletions of putative binding sites may affect the binding of other transcription factors. 
Therefore, further studies are needed to investigate whether and how the predicted transcription 
factors bind to the promoters and whether the predicted transcription factors interact with other 
cofactors to activate MYHs expression in fish. 
